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Abstract
The opportunity to investigate whole cellular systems using experimental and
computational high-throughput methods leads to the generation of unprecedented
amounts of data. Processing of these data often results in large lists of genes or
proteins that need to be analyzed and interpreted in the context of all other
biological information that is already available. To support such analyses, repos-
itories aggregating and merging the biological information contained in diﬀerent
databases are required.
To address this need, we created an integrative data warehouse containing
millions of up-to-date annotations related to human genes and proteins from over
thirty major molecular biology databases. In particular, this data warehouse was
instrumental in assessing the data quality of human protein interactions and in
predicting an important, but largely unidentiﬁed, group of proteins that function
as molecular scaﬀolds in the formation of signaling cascades. Additionally, the
data warehouse enabled us to devise the novel computational method BioSim
for the discovery of biological relationships based on the functional similarity of
gene and protein annotations. Furthermore, we showed how this method allows
identifying disease-associated genes.
To facilitate the analysis and interpretation of large lists of genes or proteins
derived from high-throughput methods, we built the new web portal BioMyn.
It provides a powerful search engine with public access to the data warehouse
and the BioSim method. BioMyn also oﬀers a number of useful tools for own
functional enrichment analysis and the visualization of the results.

Kurzfassung
Die Möglichkeit, ganze zelluläre Systeme mit experimentellen und computer-
basierten Hochdurchsatz-Methoden zu erforschen, führt zur Generierung beispiel-
loser Datenmengen. Die Verarbeitung dieser Daten ergibt oft große Listen von
Genen oder Proteinen, die im Kontext all der anderen bereits vorhandenen,
biologischen Informationen analysiert und interpretiert werden müssen. Um
solche Analysen zu unterstützen, werden Datensammlungen benötigt, die die in
verschiedenen Datenbanken enthaltenen biologischen Informationen zusammen-
führen und verknüpfen.
Um diesem Bedarf Rechnung zu tragen, wurde ein integratives Data-Warehouse
angelegt, das Millionen aktueller Annotationen bezüglich humaner Gene und
Proteine aus über dreißig wichtigen Datenbanken der Molekularbiologie bein-
haltet. Insbesondere war dieses Data-Warehouse nützlich bei der Bewertung der
Datenqualität humaner Proteininteraktionen und bei der Vorhersage einer be-
deutenden, jedoch größtenteils unidentiﬁzierten Gruppe von Proteinen, die als
molekulares Gerüst der Bildung von Signalkaskaden dienen. Zudem ermöglichte
es das Data-Warehouse, die neuartige Computermethode BioSim zur Aufdeckung
biologischer Ähnlichkeiten, basierend auf funktionellen Ähnlichkeiten von Gen-
und Proteinannotationen, zu entwickeln. Des Weiteren wurde gezeigt, wie diese
Methode die Identiﬁzierung krankheitsassoziierter Gene erlaubt.
Um die Analyse und Interpretation großer Listen von Genen oder Proteinen,
die aus Hochdurchsatz-Methoden stammen, zu erleichtern, wurde das neue Web-
portal BioMyn geschaﬀen. Es bietet eine starke Suchmaschine, die das Data-
Warehouse und die BioSim-Methode öﬀentlich zugänglich macht. Auch stellt
BioMyn eine Reihe praktischer Tools für eigene Funktionsanalysen und die Visu-
alisierung der Ergebnisse zur Verfügung.
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1Introduction
1.1 Motivation
Thanks to numerous technological breakthroughs, large scientiﬁc endeavors, and
computational power, the turn of the century has seen an exponential growth
of available biological data. Not only an increasing number of genomes is being
sequenced, but also large amounts of data that characterize genes, proteins and
their interrelations is nowadays available in specialized biological and medical
databases. This deluge of information has enabled a transition of the biological
sciences from a reductionistic approach where the focus lies on individual cellular
parts to a more holistic, modular approach where biological complexity is studied
through the structure, interaction and dynamics of the diﬀerent biological systems
(Kitano, 2002; Hartwell et al., 1999).
This new approach, called systems biology, aims to understand emergent cellu-
lar properties such as division, growth and other complex processes resulting from
the myriad of interaction between cellular constituents (Sauer et al., 2007). Those
emergent properties are not properties of the individual constitutive elements,
but instead arise as a result of the functioning of the system as a whole. For this
reason, systems biology studies are often based on high-throughput methods to
comprehensively interrogate diﬀerent biological states. Current high-throughput
methods include expression arrays, RNA interference screens, genome-wide asso-
ciation studies, yeast two-hybrid screens, proteomic methods based on mass spec-
trometry and, recently, next-generation sequencing. These experimental methods
usually explore diﬀerent aspects of the cell function and produce complementary
results that need to be procesed and combined through bioinformatic methods
(Ge et al., 2003).
The sheer amount of data produced by systemic approaches has brought for-
ward new informatic challenges concerning the storage, processing, statistical
analysis and biological interpretation of the data. In particular, the analysis and
biological interpretation of the experimental data requires the use of information
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found in the literature or stored in specialized databases in order to make useful
inferences. This important analysis in the context of all other information avail-
able is often cited as a critical step to achieve a systems level understanding of
biological processes (Reiss et al., 2011; Sauer et al., 2007). However, such infor-
mation is not readily available but scattered in multiple databases under different
formats. Moreover, the biological information found in databases comprise diverse
aspects of gene and protein function, regulation, location, phenotype, interaction,
etc. that are difﬁcult to merge and prepare for analysis specially because each
database tends to use a different reference system to identify genes and proteins.
For these reasons, the integration of this information in order to be used for the
analysis and interpretation of high-throughput data, has been acknowledged as
one of the greatest challenges in bioinformatics (Goble & Stevens, 2008).
Although many bioinformatic tools had been developed to match the analyt-
ical demands of large-scale studies, there are only few comprehensive and cen-
tralized repositories integrating existing biological information with experimental
and computationally generated data. Yet, the demand for such tools is growing
as more and more laboratories become involved in large-scale studies due to
increased availability and low costs of high-throughput methods. The unprece-
dented speeds in which this changes are occurring has met many institutions
and laboratories unprepared to face the challenges associated with the analy-
sis of large quantities of data. Also, most biologist and biochemists usually do
not have the time and knowledge to integrate available biological information to
properly analyze and interpret their results. Instead, they rely on the existence of
ready-to-use tools to carry out their analysis. Unfortunately, major established
biological databases are just starting to adapt to the rapid changes and are still
unprepared for analyzing large datasets. For instance, the popular web portals of
EBI (McWilliam et al., 2009), NCBI Entrez (Sayers et al., 2011) and UniProtKB
(The UniProt Consortium, 2011), and the genome browsers from Ensembl (Flicek
et al., 2011) and UCSC (Fujita et al., 2011) do not allow the submission of large
list of genes or proteins for analysis. Instead the information contained in such
databases has to be downloaded and processed for local analysis.
Considering the great importance to offer data mining and analysis tools that
are easily accessible, this work aims to: create the appropriate infrastructure to
unify and integrate biological information for genes and proteins from diverse
specialized databases; develop methods for the analysis of large sets of genes or
proteins; and make this information and methods freely available through simple
and easy-to-use web interfaces to promote its use.
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1.2 Overview
In this work, a data warehouse model was chosen to create a central repository
for storing the accumulated information of genes and proteins. This information
is usually referred as gene or protein annotations and describes diﬀerent aspects
of gene and protein function, location, structure, relations and expression.
The data warehouse supports eﬃcient searches over the integrated annotations
in which the annotations can be easily combined and ﬁltered. The use of this data
warehouse enabled system-wide bioinformatic investigations to study the quality
of protein-protein interactions (Ramírez et al., 2007) and the prediction human
scaﬀold proteins (Ramírez & Albrecht, 2010).
Apart from facilitating large-scale bioinformatic analyses, the integrated data
warehouse allowed the development of a comprehensive search method that iden-
tiﬁes closely annotated genes and proteins that are likely to be functionally re-
lated (?). Access to the centralized information also facilitated the application of
enrichment analysis based on the combined annotations. Similar available tools
for enrichment analysis of high-throughput data are currently based on only one
or two of the specialized databases. Instead, the tools developed in this work
allow the quick analysis of data using all major biological databases and offer
methods for searching, combining, ﬁltering and mining the data. Moreover, the
development of a web interface to easily interact with the integrated annotations
simpliﬁes the analysis of large sets of genes or proteins.
1.3 Outline
The remainder of this dissertation is composed of seven chapters followed by
summarizing conclusions and an appendix. Chapter 2 describes the guidelines
for the construction of the data warehouse and the diﬀerent types of biological
knowledge integrated.
The following two chapters describe bioinformatic studies based on integrated
data. In Chapter 3, predicted and experimental protein-protein interactions were
assessed by using functional annotations and domain-domain interactions. Our
results conﬁrmed the low quality of large-scale yeast-two hybrid screens and high-
lighted the good quality of some prediction methods.
Chapter 4 describes the prediction of scaﬀold proteins, important members of
signaling cascades. This research used the interaction-based deﬁnition of scaﬀold
proteins from Zeke et al. (2009) to obtain a set of candidates that was subse-
quently validated and characterized. This set of candidates was obtained by cross
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linking protein functions, biological processes and protein-protein interactions
from the diﬀerent biological databases stored in the data warehouse.
Chapters 5 and 6 of the thesis present a number of tools that were developed
to facilitate the mining of data within the data warehouse. Chapter 5 introduces a
method for quantifying the pairwise similarity of genes and proteins based on their
integrated annotations. The data warehouse can be quickly searched by using this
novel method to identify other genes or proteins matching the annotations of a
query gene or protein. The advantages of this method over similar methods are
thoroughly demonstrated using known functional relations. Moreover, new genes
associated with a disease were correctly inferred by searching the data warehouse
for genes, similarly annotated, to those already associated with the disease.
Chapter 6 presents the new web portal, BioMyn, that allows public access to
the data warehouse and to the functional similarity method. The aim of the web
portal is to open the use of the data warehouse to study large gene and protein
sets. For this, BioMyn oﬀers enrichment analysis over all integrated data and novel
visualization methods to explore the results. The development of this portal was
based on the experiences presented in previous chapters and established workﬂows
from other studies.
Chapter 7 summarizes and evaluates the main achievements of this work and
draws conclusions on the completed research. It also discusses methodological
improvements and future directions.
The Appendix lists all validated scaﬀold proteins described in Chapter 4 and
the disease-associated genes correctly discovered by the similarity method intro-
duced in Chapter 5. The appendix also contains a list own of publications related
to this thesis.
2Integration of Molecular Biology Databases
This chapter introduces the development of a data warehouse to integrate, into
a single database, the information about human genes and proteins that is usu-
ally found scattered in multiple molecular biology databases. First, this chapter
discusses the challenges behind biological data integration and the diﬀerent ap-
proaches that had been proposed. Then, the integrative approach adopted for
this dissertation, namely the data warehousing model, is presented along with
the design guidelines that have led its development. Finally, the description of
the relational database used for the data warehouse and the methods for acquiring
and storing the data are presented.
2.1 Introduction
The number and variety of biological databases have increased steadily during the
past years (Fig. 2.1) reaching over 1,000 molecular biology databases in the year
2011 according to the compilation prepared by the Nucleic Acids Research journal
(Galperin & Cochrane, 2011). Researchers can make inferences about the func-
tioning of complex biological systems by contrasting experimental results with
the complementary information deposited in these databases. (Goble & Stevens,
2008).
Despite the large amounts of available data, the spread of the information
across multiple locations hampers cross-database searches useful for data mining
and analysis. Working with available biological information is time-consuming as
often databases have to be visited and queried one by one using a web browser
to follow the links. Manual inspection of the data is not only impractical but
hardly scalable. Instead, methods to do batch searches over the multiple databases
to combine their information are more useful. This is particularly needed for
the interpretation of the results from high-throughput experiments that require
the analysis of hundreds to thousands of genes or proteins in the context of all
available knowledge.
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Numerous approaches are currently available to facilitate searches over nu-
merous biological databases. Roughly they fall into four categories (Stein, 2003;
Goble & Stevens, 2008): approaches that facilitate the navigation of the infor-
mation by cross-linking the information using hypertext links, approaches that
query multiple databases on-the-ﬂy and present the collected results to the user,
approaches based on workﬂows where databases are queried one after the other
and in which the results from one step feed the next, and ﬁnally, approaches in
which large amounts of information is downloaded from the biological databases
in advance and stored locally for eﬃcient searches. Of these approaches, the most
useful for complex and large searches is the last approach called data warehous-
ing. The ﬁrst approach does not allow batch searches while the other two require
a long time to fetch the results from all sources.
This chapter presents a solution, using the data warehouse approach, to in-
tegrate information for human genes and proteins found in numerous molecular
biology databases. Locally, the information from the source databases is stored
using a relational database that allows the eﬃcient querying of large amounts of
information. The development of such a data warehouse was motivated by the
need to collect, maintain, and analyze the available information on human genes
and proteins to support our research projects.
Data warehouse systems for integrating a large number of biological databases
include Atlas (Shah et al., 2005), BioWarehouse (Lee et al., 2006), and BN++
(Küntzer et al., 2006). These data warehouses contain a large number of ta-
bles and relations to store the heterogeneous information available. For instance,
BioWarehouse has over ﬁfty tables and BN++ over 200 tables. A large fraction
of these tables is dedicated to store the details of different types of biological
information such as the sequence of genes and proteins; signaling and metabolic
pathways, including reactions, reactants, and chemical compounds; protein-pro-
tein interactions, and many other features of genes and gene products. Our ap-
proach is different from these databases; instead of having tables for each type of
information we use a much simpler database schema in which the heterogeneous
information available is converted to a common model requiring only over a dozen
tables. This simpliﬁed schema facilitates the maintenance and development of the
data warehouse.
Furthermore, in current data warehouses the methods to merge the multiple
identiﬁer systems for referencing genes and proteins from the source databases
are not clearly exposed. This is a critical step required for properly integrating
biological information; in our approach, it is clearly documented.
There are two other data warehouses that are speciﬁc for signaling and
metabolic pathways: ConsensusPathDB (Kamburov et al., 2009) and Pathway-
Commons (Cerami et al., 2011). These two databases, however, do not allow the
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Fig. 2.1: Growth in the number of molecular biology databases. This ﬁgure describes the
cumulative growth in the number of molecular biological databases that are part of the Nucleic Acids
Research online Database Collection. The ﬁgure was generated using data compiled from the yearly
summary accompanying the Database Issue of the Nucleic Acids Research journal from 20002011.
integration of other important biological databases like the Gene Ontology (GO)
(Barrell et al., 2009) and OMIM (Amberger et al., 2009).
2.2 Challenges of data integration
There are numerous diﬃculties when integrating molecular biology information
besides the spread of the information in diﬀerent locations. Some of these prob-
lems are technical and deal with the diverse computational methods needed to
obtain the information from the databases and the different ﬁle formats in which
the information is stored. However, most diﬃculties stem from the complexity of
the information that reﬂects the underlying complexities of the biological objects
described. The following is a list of the most prominent problems encountered.
Heterogeneous information
One of the challenges hindering data integration is the diversity of information
that needs to be gathered, ranging from annotations containing the description
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of the molecular function of a protein to the complex biochemical steps involved
in a metabolic pathway.
Most molecular biology databases collect and catalogue published experimen-
tal results from the scientiﬁc literature; however the scope and coverage of these
databases vary extensively. Some databases contain several types of information
for one particular organism, for instance, the Saccharomyces Genome Database
(SGD) (Engel et al., 2010) and the Mouse Genome Database (MGD) (Blake
et al., 2010); while other databases specialize in cataloguing speciﬁc gene and
protein information across all organisms, as is the case of the ENZYME database
(Bairoch, 2000) which contains descriptions of all characterized enzymes and the
Protein Data Bank (PDB) (Rose et al., 2011) that stores all known 3D struc-
tures of proteins. Other databases maintain smaller collections of genes or pro-
teins pertaining to speciﬁc cellular processes such as the Autophagy Database
(Homma et al., 2011). Some databases serve as storage for data coming from
high-throughput methods, for instance GEO (Barrett et al., 2010) and ArrayEx-
press (Parkinson et al., 2010) contain the raw data from microarray experiments.
Several databases contain computationally derived knowledge such as protein do-
mains, linear motifs, predicted protein-protein interactions and microRNA target
predictions.
Several of the existing biological databases, mostly supported by large orga-
nizations and containing a wide range of information, have become an impor-
tant part of biological research. Among these popular databases are the genome
browsers Ensembl (Flicek et al., 2011) and UCSC (Fujita et al., 2011); the Na-
tional Center for Biotechnology Information (NCBI) (Sayers et al., 2011), the
European Bioinformatics Institute (EBI) (McWilliam et al., 2009) and the Uni-
versal Protein Resource (UniProtKB) (The UniProt Consortium, 2011).
This diversity of databases containing diﬀerent types of data complicates the
design of storage frameworks (e.g. relational database schemata), to store and
manipulate all data types. Furthermore, if a novel type of data becomes available,
either from new experimental or computational results, such a framework has to
be upgraded to accommodate the data type.
Multiple gene and protein identifiers
One particular problem of data integration is caused by the multiple means for
identifying or referring to genes and proteins. Biological data tends to have nu-
merous synonyms that are diﬃcult to recognize without expert knowledge and
that are often ambiguous. Some research communities use a terminology in which
the same words are used in diﬀerent contexts with diverging meanings. An ex-
ample is the word `pseudogene' which can be a (i) gene-like structure containing
in-frame stop codons or evidence of reverse transcription, (ii) a sequence with a
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full reading frame that is not transcribed or (iii) a transposable cassette that is re-
arranged in the course of antigenic variation (Goble & Stevens, 2008). Moreover,
large databases cataloguing genes and protein sequences had progressed more
or less independently from one another, resulting in a proliferation of reference
systems to identify genes, transcripts and proteins.
The following list of commonly used identiﬁer systems illustrates the diﬀerent
manner in which gene and protein identiﬁers are being used.
GeneInfo Identiﬁer (GI)
The GeneInfo Identiﬁer (Benson et al., 2006) was introduced for the release
of GeneBank 81.0 (Febrary, 1994) to identify every sequence (DNA, RNA
and protein translation) in the database. A GI number was assigned to each
nucleotide and protein sequence accessible through the NCBI search systems.
When a sequence changes (even a single nucleotide or amino acid), a new GI
number is assigned to the sequence. Changes not related to the sequence itself,
such as a change in some annotation of the sequence (e.g. PubMed id), do not
alter the GI.
Since the GI identiﬁer is a number that is incrementally assigned to each new
sequence submitted to the GeneBank, it is not possible to diﬀerentiate DNA,
RNA or amino acid sequences just by analyzing the GI number.
DDBJ/EMBL/GenBank accession
This reference system arose when the GenBank, EMBL and the DDBJ
databases started to collaborate and share information (Cochrane et al., 2011).
The accession number assignment process is managed by preﬁx agreements
from the collaborating databases. Nucleotide sequence version identiﬁers con-
tain two letters followed by six digits. For older nucleotide records the format
is one letter followed by ﬁve digits. Protein sequence version identiﬁers contain
three letters followed by ﬁve digits. In contrast to GI, updates to sequences in
the DDBJ/EMBL/GenBank accession are diﬀerentiated by adding a dot and
a version number after the accession number.
RefSeq
RefSeq is a curated non-redundant database for sequences that includes fea-
tures and bibliographic annotation (Pruitt et al., 2005). The RefSeq database
is built and distributed by the NCBI and the identiﬁers used in this database
are not related to a particular submission to GeneBank. RefSeq identiﬁers are
stable over time and have a version system similar to DDBJ/EMBL/GenBank
accession numbers; when a sequence is changed, only the version portion of
the identiﬁer is modiﬁed.
The RefSeq database aims to be a non-redundant collection of sequences,
summarizing and representing the current view of the sequence information,
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names and other annotations (Pruitt et al., 2005). The RefSeq identiﬁer sys-
tem distinguish between DNA, RNA and protein sequences by a characteristic
preﬁx in the accession number followed by underscore. NM stands for RNA,
NC for DNA and NP for protein. There are some other preﬁxes for untrans-
lated RNA and for predicted assemblies. Identical gene sequences at diﬀerent
location within the genome have the same RefSeq identiﬁer.
Entrez Gene ID
Entrez Gene id is part of the Entrez retrieval system of NCBI (Maglott et al.,
2007). The primary goals of Entrez Gene are to provide unique identiﬁers for
genes from a subset of model organisms and to report information associated
with those identiﬁers. The main diﬀerence with other identiﬁers is that Entrez
identiﬁers refer to any identiﬁed gene even if the sequence is not known. When
the gene sequence is known, the references to sequence identiﬁers are reported
in the gene description page part of the NCBI website. Duplicate sequences
in a genome have diﬀerent Entrez ids.
UniProtKB
The Universal Protein Resource Knowledge Base (UniProtKB) maintains
two types of protein sequences, the manually curated sequences in UniProt-
KB/SwissProt and the unreviewed and automatically annotated sequences
of UniProtKB/TrEMBL (The UniProt Consortium, 2010). Each Swiss-Prot
and TrEMBL entry has two identiﬁers, the entry name which is a mnemonic
string containing the protein and species name or, in the case of TrEMBL, an
alphanumeric string instead of the protein name. The second identiﬁer is the
accession number which is a stable identiﬁer of six alphanumeric characters.
Swiss-Prot and TrEMBL can not be distinguished by inspecting the acces-
sion numbers. Alternative products generated from the same gene caused by
alternative splicing, alternative promoters or alternative initiation are diﬀer-
entiated by adding a dash and a number to the accession number. Identical
protein sequences produced by duplicated genes have the same identiﬁers. In
contrast to Entrez gene, UniProtKB does not limit protein sequences to any
set of organisms.
UniParc
UniParc, which stands for UniProt Archive (Leinonen et al., 2004), is a non-
redundant archive of protein sequences extracted from diﬀerent publicly ac-
cessible databases. Each unique sequence identiﬁer has the preﬁx UPI followed
by ten hexadecimal numbers. In UniParc, identical sequences from diﬀerent
organisms receive the same identiﬁer, but sequence variants of the same gene
are given diﬀerent identiﬁers. UniParc does not maintain any annotations,
only contains protein sequences and cross-references to the source databases.
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Ensembl
Ensembl identiﬁers (Flicek et al., 2011) are assigned automatically by the
Ensembl pipeline to genes, transcripts and gene products. Ensembl contains
genome information for a number of organisms that have been fully sequenced.
For the human genome the Ensembl identiﬁers have the preﬁxes ENSG, ENST
and ENSP for gene, transcript and protein, respectively, followed by ten digits.
In Ensembl, diﬀerent identiﬁers are assigned to identical protein sequences if
they are produced by distinct genes.
HGNC
The Human Genome Organization (HUGO), through its Gene Nomenclature
Committee (HGNC) is in charge of assigning unique gene symbols and names
to human genes (Seal et al., 2011). HGNC symbols only contain upper-case
letters and Arabic numerals and must be at most six characters long. Dupli-
cated genes have diﬀerent identiﬁers.
This information is summarized in Table 2.1 which also includes example identi-
ﬁers for the BRCA1 gene. Currently, a human gene has numerous name synonyms
and at least ﬁve identiﬁers: the approved symbol given the the HUGO organiza-
tion, the Gene Identiﬁer assigned to its GenBank sequence, a RefSeq identiﬁer,
an Ensembl identiﬁer and an Entrez identiﬁer. The gene product have a simi-
lar proliferation of identiﬁers, including the UniProtKB accession numbers and
Ensembl identiﬁers for transcripts and peptides.
In order to eﬀectively integrate molecular biology databases, the uniﬁcation of
these diverse gene and protein identiﬁers is critical. Otherwise, it would be difﬁcult
and time consuming to recognize and combine the information associated with dif-
ferent instances of the same gene or protein. Yet mapping of all diﬀerent identiﬁers
that refer to the same gene or gene product is a diﬃcult task, normally requiring
the alignment of a growing amount of sequences or the use of mapping tables.
Even when using mapping tables, the mapping of identiﬁers is a complicated
process as demonstrated by Razick et al. (2008) who listed a number of problems
found when mapping identiﬁers from protein-protein interaction databases. Some
of the common problems they found are: the identiﬁer was retired from the source
database, the identiﬁer corresponds to a gene or sequence that was updated and
assigned to a new identiﬁer, the identiﬁer maps to several other identiﬁers, the
given taxonomy or source database for the identiﬁer are ambiguous, and the
identiﬁer contains typographical errors.
For these reasons, Alibés et al. (2007) and Côté et al. (2007) consider that one
of the most challenging task for data integration is precisely the uniﬁcation of
gene and protein identiﬁers.
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identifier cellular entity manually
reviewed
redun-
dant
examples of identifiers
gene transcript protein
GeneInfo Identifier
(GI)
DNA, RNA and
protein sequences
no yes 30039658 1498736 30039659
DDBJ/EMBL/GenBank
accession
DNA, RNA and
protein sequences
no yes AY273801.1
DQ190453.1
U64805.1
U14680.1
AAC00049.1
AAN61423.1
RefSeq DNA, RNA and
protein sequences
yes no NG_005905.2 NM_007294.3
NM_007297.3
NP_009225.1
NP_009228.2
Entrez Gene genes (even when
sequence is not
known)
yes yes 3039 — —
UniProtKB/Swiss-Prot protein sequences yes no — — P38398
BRCA1_HUMAN
UniProtKB/Swiss-Prot
(alternative variants)
protein sequences yes no — — P38398-1
P38398-2
UniProtKB/TrEMBL protein sequences no yes — — Q3LRJ6
Q3LRJ6_HUMAN
UniParc protein sequences no no — — UPI0000126AC8
UPI000013ECD3
Ensembl DNA, RNA and
protein sequences
no yes ENSG00000012048 ENST00000357654
ENST00000393691
ENSP00000350283
ENSP00000377294
HGNC human genes yes yes BRCA1 — —
Table 2.1: Gene, transcript and protein identiﬁer systems commonly found in molecular
biology databases. Biological databases have developed different systems to catalog and identify
nucleotide and amino acid sequences. In this table, the most commonly used identiﬁer systems are
listed. The `manually reviewed' column indicates whether the database providing the identiﬁers man-
ually revises and annotates each entry. The `redundant' column informs if the database providing the
identiﬁer contains redundant information for sequences. Non-redundant databases aggregate sequences
that correspond to the same gene, transcript or protein. In the case of Entrez Gene identiﬁer and
HGNC, the databases assign different identiﬁers to identical genes that are found at different location
in the genome. All the example identiﬁers refer to the breast cancer 1, early onset gene (BRCA1) for
which four alternative products are known, although in the table only two such alternative products
are shown.
Information available for genes, proteins and proteins
variants
While biological information is often annotated to genes, some databases con-
tain speciﬁc knowledge at the level of proteins, protein variants or even only
for proteins that are expressed in a particular cellular location or have speciﬁc
post-transcriptional modiﬁcations. If the integrated information is supposed to
be useful for analysis, the uniﬁcation around a single type of cellular entity (gene,
protein, protein variant) is often required. However, the uniﬁcation of the infor-
mation between diﬀerent cellular entities requires transferring information from
one type of entity to the other, potentially creating wrong associations or erasing
valuable information. As an example, consider a disease-associated gene that has
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two splice variants, each of which is expressed in a diﬀerent tissue. By annotat-
ing the disease association to both gene products, new disease associations are
made, but there is no certainty whether both or only one of the protein variants
is responsible for the disease. When annotating the diﬀerent tissue expression
from the two gene products to the gene, the information on the speciﬁcity of the
annotation to each protein variant is lost.
Moreover, when mapping from gene to protein identiﬁers a one-to-many rela-
tion is generally observed as each gene is translated into one or more products.
However, it is not rare to ﬁnd a many-to-one mapping for duplicated genes that
produce identical proteins. Also a number of genes are not translated into pro-
teins, like microRNA genes, and their associated information can not be trans-
ferred to proteins.
Different file formats
A technical issue aggravating the integration of data are the diﬀerent ﬁle formats
in which the data is found. Most often data is found in plain text ﬁles containing
two-dimensional arrays based on a tab-delimited or comma-delimited structure,
in which the contents (the internal table columns) are speciﬁc for each database.
Some of the biological information is recently becoming available using stan-
dards developed by consortia willing to facilitate the sharing of data. Some of this
standards are based on the Extensible Markup Language (XML), as for instance,
the BioPAX language to represent biological pathways (Demir et al., 2010) and
the Proteomics Standards Initiative for Molecular Interactions (PSI-MI) language
for molecular interaction data (Isserlin et al., 2011). Other standards are avail-
able in diﬀerent ﬁle formats, for example the Minimum Information About a
Microarray Experiment (MIAME) (Brazma et al., 2001) and the Open Biomedi-
cal Ontologies (OBO) can be stored both in XML or plain text formats.
Although these standards are meant to facilitate the data sharing, the com-
plexity of some formats has limited their acceptance in laboratories lacking ded-
icated bioinformatics support. However, the biggest problem that entail the use
of standards for data integration are the quirks found in the implementation of
the standards by the biological databases oﬀering such standards to share their
data. Frequently, the ﬁles available diﬀer in the interpretation of the standard or
contain errors that need to be identiﬁed on a case-by-case basis.
Diverse coverage and quality of the data
The quality of the information contained in the databases is expected to vary due
to the diﬀerent rates of false positives and false negatives of experimental and
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computational methods. The coverage of information is also not uniform. While
system-wide studies generate comprehensive results, most manually curated data
is usually focused in a limited number of medically relevant genes or proteins.
For most databases, however, the reliability of the data is unknown. Generally,
it is accepted that manually curated databases are more reliable than collections
containing high-throughput data. Nevertheless, a recent publication that analyzed
the reliability of manually curated databases has challenged this assumption,
claiming that some manually curated databases may contain up to 40% erroneous
annotations (Schnoes et al., 2009).
Few standard methods to access the data
Although most of the biological databases are public, the programmatic access to
the collected information is hampered by each site providing their own methods
for searching and retrieving the information. Moreover, there is no eﬃcient way
to detect which information has been updated or newly added. For most cases,
there is a download folder where the required information is contained in which
the time stamp of the ﬁles give an indication of the last update. Other sites have
to be manually accessed in order to obtain the information because forms need
to be ﬁlled to download the data. Finally, in some databases the information is
provided as single large ﬁles whereas others deliver multiple small ﬁles.
2.3 Data integration approaches
Numerous methods to support the data integration of biological databases have
been developed and explored during the past years. Roughly, the available meth-
ods can been categorized as link integration, view integration, workﬂow integra-
tion, and data warehousing (Stein, 2003; Goble & Stevens, 2008).
Link integration
This is the usual type of integration found in many biological databases. Also, it
is the most natural as it relies on the hypertext, one of the basic features of the
World Wide Web. Link integration directly cross references entry data from one
site with another entry in a diﬀerent site. Known tools that use this method are
SRS (Etzold et al., 1996), LinkDB (Fujibuchi et al., 1998), GeneCards (Safran
et al., 2002), and the Bioinformatic Harverster (Liebel et al., 2004).
Among the usually cited drawbacks of link integration is the diﬃculty to main-
tain unbroken links caused by name ambiguities and updates. Moreover, when
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following cross-references, the integration is actually being undertaken manually
by the researcher.
This integration method also lacks scalability. If more than a handful of entities
are to be inspected, the process of gathering information through cross-references
from relevant databases becomes diﬃcult and time consuming.
View integration
This type of integration collects information on-the-ﬂy from diﬀerent databases
and aggregates it for the user. This integration system uses a strategy where
the data are acquired using remote access to web services provided by the origi-
nal databases. The view integration clients responsible for querying the database
servers use deﬁned web service protocols, for instance RPC, REST, WSDL, and
DAS (Dowell et al., 2001). View integration has the advantage of being always
up-to-date. An example of this type of integration is DASMI (Blankenburg et al.,
2009a), a web-site that collects information from diﬀerent protein-protein inter-
action databases.
A drawback of this approach is the time required to gather the data from all
sources. For this reason, analyses involving thousands of entities are impractical
because of the amount of data needed to be transferred from each of the sources.
Moreover, view integration relies on the existence of services, when such services
are missing the data cannot be integrated.
Workflow integration
Workﬂows describe, execute and monitor a number of processes that can be
chained into a pipeline, where the results from one step are required to start the
next. In this approach the users can design their own workﬂows or use pre-ex-
isting ones. Examples of workﬂow software are Galaxy (Goecks et al., 2010) and
Taverna (Hull et al., 2006).
The software implementing the workﬂow is responsible for formatting the data
passed or obtained between the pipeline steps. In this approach the integration
model is exposed, allowing the users to create their own speciﬁc integration. A
disadvantage of workﬂows is that they are diﬃcult to design and require good
knowledge of the services available and their formats. Moreover, the software for
workﬂow integration is not optimal to handle large quantities of data compared
to specialized software such as relational databases. Also, workﬂows rely on the
existence of web services, when such services are missing the information can not
be integrated.
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Fig. 2.2: Data warehousing model for integrating molecular biology databases. Data ware-
houses periodically download the information found in molecular biology databases, process this infor-
mation and stores it into a central database. Diﬀerent software is required to acquire the data, unify it
and store it.
Workﬂow integration is partially similar to view integration because in this
approach information is collected on-the-ﬂy as well. However, the workﬂow soft-
ware does not query a predeﬁned list of services but instead those services are
chosen by the user.
Data warehousing
In data warehousing the information from biological databases is periodically
downloaded, cleaned, and re-formated for local storage (Fig. 2.2). In contrast
to other approaches, data warehouses truly integrate many databases into one
central repository (Stein, 2003). For this reason, they are traditionally considered
as the most useful for data mining purposes (Han et al., 2005).
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Data warehouses employ an update-driven approach in which information
from multiple, heterogeneous sources is integrated and stored in a relational
database for direct querying and analysis. Thus, data warehouses not only in-
tegrate, generalize and consolidate data to facilitate the mining of knowledge,
but also speed-up queries and data retrieval due to the central and local access
to the integrated data. Existing biological data warehouses include Atlas (Shah
et al., 2005), BioWarehouse (Lee et al., 2006), Biozon (Birkland & Yona, 2006),
BN++ (Küntzer et al., 2006), ConsensusPathDB (Kamburov et al., 2009) and
PathwayCommons (Cerami et al., 2011).
A major shortcoming of data warehouses is the dependence on stable data for-
mats from the biological databases. If such formats are changed, the appropriate
parsers that feed the data warehouse will have to be updated as well. Another
drawback of warehouses is that they may not contain the most up-to-date infor-
mation and therefore may lag behind compared to the source databases (Stein,
2003).
2.4 Implementation of a local data warehouse to
integrate multiple molecular biology databases
Despite the shortcomings of data warehousing this is the most eﬃcient method
for large-scale data analysis and was adopted for integrating molecular biology
databases that characterize human genes and proteins. Aggregating approaches,
such as workﬂows or view integration to integrate data are sub-optimal and
time ineﬃcient to answer queries that span the domain of more than one data
source. Also, analysis involving thousands of entities are impractical because of
the amounts of data that would need to be transferred from each of the sources.
For example, if a user wants to know all proteins expressed in brain that are
also kinases, the aggregating software (workﬂow or view integration) collecting
data will have to query the two sources that have the information, download all
proteins expressed in brain and all proteins that are kinases, and ﬁnally ﬁnd the
intersection from these two results. Moreover, data mining tools like and enrich-
ments analysis (see Chapters 5 and 6) that require access to all available data
are impractical under the workﬂow or view integration methods. In contrast, in
a data warehouse the execution of queries is more eﬃcient and reliable because
the data is stored locally on a powerful database system and not distributed over
the Internet.
The proposed approach is composed of three layers for processing, storing and
unifying the acquired information that would be discussed in detail in the next
sections.
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In the following, a number of constrains that guided the design of the data
warehouse are ﬁrst presented:
Simplicity
The data warehouse must be a simple system easy to maintain and extend
while being able to include as many diﬀerent types of biological information
as possible.
Incremental updates
It is required to keep track of the changes in the database content through
time without creating copies of the database. The aim is to recover the status
of the data warehouse at any time point and to easily identify recently added
information as well as information that is no longer available.
Independent uniﬁcation of identiﬁers
The mapping between the identiﬁers from diﬀerent references systems changes
continuously and the mapping process in charge of the uniﬁcation of gene and
protein identiﬁers should be able to remap identiﬁers once updates become
available. For this reason, uniﬁed identiﬁers should not be considered deﬁnitive
and should be stored separately from the original identiﬁers obtained from the
data sources to allow future re-mappings.
Standard identiﬁers
The creation of new identiﬁers for genes and proteins should be avoided by
relying as much as possible on existing identiﬁers.
Cellular entities
Integrated data should be easily available at the gene and protein level, but
also be ﬂexible enough to incorporate other cellular entities, for example, splice
variants or protein complexes.
2.4.1 Design of the relational database
Integrated data types
A novel relational database schema was designed to store the following frequent
types of information associated to genes and proteins:
Annotations based on categorical classiﬁcations
Often genes and proteins are annotated with categorical classiﬁcations of dis-
eases, protein complexes, protein domains, sequence clusters etc. These types
of associations are definitions assigned to one or many genes or gene products.
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Fig. 2.3: Gene Ontology (GO) Simpliﬁed example of a cellular component ancestor-child relation of
ontological terms. A gene or protein associated with any of the terms is considered to be also associated
with all the ancestor terms. In this ﬁgure, if a gene is associated to the term nuclear membrane then,
the gene is also associated to organelle membrane, membrane, and cell.
Annotations based on ontological terms
Ontologies are controlled vocabularies composed of hierarchically organized
terms to describe the concepts and relationships of a speciﬁc knowledge do-
main. In the hierarchical structure of ontologies there are few high-level terms
having broad definitions that become more and more precise down the hierar-
chy (Fig. 2.3). Ontological terms are annotated to genes and proteins at any
level of the hierarchy and, because of the so-called true path rule, all ancestor
terms in the hierarchy are considered to be annotated to the gene or protein
as well. Each annotation of a gene with a term also includes an evidence code
to indicate how the respective annotation was inferred.
Binary relations
Protein-protein interactions and gene co-expression are the most frequent
types of binary relations found in biological databases. In the case of protein-
protein interactions, some experimental methods like those based on co-
immunoprecipitation usually identify groups of interacting proteins for which
the physical pairwise interactions are unknown (Gavin et al., 2002). These
groups tend to be small but in a few cases they comprise hundreds of pro-
teins. Protein-protein interaction databases also inform about the experimen-
tal method used to detect the interaction and, in some cases, also contain
information about the experimental conditions, such as the host organism, or
whether protein participated as bait or prey.
Participation in signalling and metabolic pathways
Biological pathways summarize a series of biochemical reactions occurring
within a cell to eﬀect a cellular process such as DNA repair, apoptosis and
protein folding. They describe the sequential steps in which enzymatic re-
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actions occur, proteins complexes are formed, cargo is moved, genes are ex-
pressed, signals are transduced, etc. Biological pathways are rich in all sorts
of information from the diﬀerent processes occurring within the cell.
Numerical features
Some gene and protein features are given as numerical values, for example,
sequence length, molecular weight or the fold change in the expression of a
gene in microarray experiments.
Integration around molecular concepts
In order to integrate the diﬀerent types of information available in the biological
databases, the idea of molecular concepts (Tomlins et al., 2007) was used. This
term refers to sets of related cellular entities (genes or proteins) with shared prop-
erties. The use of molecular concepts allows to develop a common framework to
store most of the previously deﬁned types of information annotated to genes and
proteins as follows: For categorical classiﬁcations, each set of genes annotated to
a particular classiﬁcation constitutes a molecular concept. For ontologies, each set
of genes annotated to a term is also treated as a molecular concept. In the case of
ontologies the true path rule is followed and the association of genes is extended
to all ancestor terms while the hierarchical structure is stored separately. Binary
relations are considered as molecular concepts involving two genes or proteins or,
in the case of protein-protein interactions, involving as many interaction partners
as reported in the original database providing the information (although usually
there are only two). The experimental method and other information is stored
separately. For signalling and metabolic pathways, all genes or proteins members
are considered as belonging to a single molecular concept. The information about
the formation of protein complexes is stored as in the case of protein-protein
interactions. No other information from biological pathways is included, instead
links to the source database are kept such that the details can be accessed in the
respective source. Finally, numerical values of gene expression from microarray
and RNA-seq sources are treated as molecular concepts by using the threshold
values, as deﬁned in the respective publications, that indicate expression in a cer-
tain tissue or cell line. The numeric expression value is stored separately. Because
numerical values are binned, in order to store them as molecular concept, they
are considered in the data warehouse as categorical classiﬁcations.
In the following chapters, however, we will refer to the molecular concepts as
annotations. Even though we think that the term molecular concepts might be
more appropiate, the use of annotation for referring to any gene or protein feature
such as function, location, structure, relations, etc., has gained wide adoption and
we prefer to use it instead.
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type of data source databases
co-expressed genes COXPRESdb
disease associations PharmGKB, OMIM, UniProtKB keywords
drug associations PharmGKB
metabolic and signaling pathways BioCarta, KEGG, HumanCyc, Reactome, PID
molecular functions GO, UniProtKB keywords, ENZYME
orthologous species OrthoMCL
phenotype associations MGI mammalian phenotype
protein complexes CORUM, PID, BioCarta, PDB, Reactome
protein domain classifications Pfam (family, clan and architecture), UniProtKB keywords, In-
terpro
protein-protein interactions BioGRID, DIP, HPRD, IntAct, MINT
predicted protein-protein interactions HiMAP, HomoMINT, OPHID, PIPs, STRING
sequence clusters Ensembl Family, UniRef90
sub-cellular locations GO, UniProtKB keywords
tissue expression GNF expression, BurgeLab tissue expression
Table 2.2: Classiﬁcation of data sources included in the data warehouse.
2.4.2 Molecular biology databases integrated
Currently, 31 publicly available databases containing characterizations for human
genes and gene products have been integrated into the data warehouse.
These sources are: Gene Ontology annotations from the European Bioinfor-
matics Institute (Barrell et al., 2009); clusters of similar sequences from En-
sembl protein families (Flicek et al., 2008); protein domain architectures from
Pfam (Finn et al., 2008) and InterPro (Hunter et al., 2008); metabolic and sig-
naling pathways from BioCarta (Nishimura, 2001), HumanCyc (Romero et al.,
2005), KEGG (Kanehisa et al., 2008), PID (Schaefer et al., 2009), and Reac-
tome (Matthews et al., 2009); protein interactions and protein complexes from
BioGRID (Stark et al., 2011), CORUM (Ruepp et al., 2008), DIP (Salwinski
et al., 2004), HiMAP (Rhodes et al., 2005), HomoMINT (Persico et al., 2005),
HPRD (Prasad et al., 2009), IntAct (Kerrien et al., 2007), MINT (Ceol et al.,
2010), PDB (Velankar et al., 2005; Berman et al., 2003), OPHID (Brown & Ju-
risica, 2005), PIPs (McDowall et al., 2009), and STRING (Jensen et al., 2009);
disease associations from OMIM (Amberger et al., 2009); enzyme classiﬁcations
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Fig. 2.4: Core data warehouse tables. The main tables of the database schema are Molecule
where the references to genes and proteins from the integrated biological databases are stored, the
MolecularConcept table that contains the molecular concept deﬁnitions and source database, and the
Participant table which allows a many-to-many relation between the previous two tables.
from the Enzyme nomenclature database (Bairoch, 2000); gene tissue expres-
sion from the Novartis Gene Atlas (Su et al., 2002) and BurgeLab (Ramsköld
et al., 2009); mammalian phenotype ontology classiﬁcation of human genes by
the Mouse Genome Database (MGD) (Blake et al., 2010); drug associations from
PharmGKB (Klein et al., 2001); pairs of co-expressed proteins from COXPRESdb
(Obayashi & Kinoshita, 2011); ortholog grouping of protein sequences from mul-
tiple genomes from OrthoMCL (Chen et al., 2006); UniRef90 similar sequence
clusters (Suzek et al., 2007) and UniProt Keywords (The UniProt Consortium,
2010).
These sources are classiﬁed into the following fourteen categories: co-expressed
genes, disease associations, drug associations, metabolic and signaling pathways,
molecular function, orthologous species groups, phenotype associations, protein
complexes, protein domain classiﬁcations, binary relations interactions, predicted
protein-protein interactions, sequence clusters, sub-cellular locations and gene
expression in tissues. (Table 2.2).
Database schema
The core of the database schema is composed of three tables: MolecularConcept,
Molecule and Participant (Fig. 2.4). The ﬁrst table holds the molecular con-
cepts, the second contains the gene or protein identiﬁers and the third table
relates one with the other. All tables have time stamps to identify when an entity
was ﬁrst added (created_date) and when was the last time it was veriﬁed to be
up to date (verified_date). Data in the Molecule table contains the original
identiﬁers reported by each integrated biological database.
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


























Fig. 2.5: Relational database schema of the data warehouse. This schema shows the relations
of the core tables with diﬀerent other tables that contain other information: The Data_source and En-
try tables store the provenance of the integrated data, the Xref table stores the external identiﬁers of
genes, proteins molecular concepts and literature references. The MolecularConcept_has_Experiment
and the Experiment tables contain information about the experimental conditions that allowed the
association of a gene or protein with the molecular concept. This information is usually associated
to protein-protein interactions. The MolecularConcept_has_Attribute and the Attribute tables store
miscellaneous information about molecular concepts, for example synonyms and descriptions. The dot-
ted arrows shown represent 1:n non-identifying relations and the solid arrows represent 1:n identifying
relations.
The complete database schema is depicted in Fig. 2.5. The tables Data_source
and Entry contain the descriptions of all databases integrated in the data ware-
house. This information is stored in two tables because a single biological database
often provides different types of gene and protein features. In the database
schema, the Data_source table contains entries for each biological database inte-
grated and the Entry table contains the different types of knowledge found in the
original database. For example, the Gene Ontology Association database (GOA)
contains three distinct categories: Biological Process , Cellular Component , and
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Molecular Function. In this case, the table Entry has an entry for each subdivi-
sion and relates them to the parent Data_source table containing the descrip-
tion of the GOA database. The Entry table classiﬁes the integrated information
following the data types described earlier: categorical classiﬁcations, ontologies,
protein-protein interactions and pathways. Also, the Entry table subdivides the
integrated data into the fourteen categories shown in Table 2.2.
All data loaded into the core tables Molecule, MolecularConcept and Par-
ticipant is associated with the Entry table to discriminate the provenance of
the information. The Xref table stores all identiﬁers, either for gene and proteins,
molecular concepts identiﬁers, and literature references. The MolecularConcept
table is associated with a number of other tables: the MolConcept_ancestor
stores the ontological relations within molecular concepts, the Experiment table
stores information about the experimental conditions and the Attribute table
contains miscellaneous information like expression values.
The Entrez_Participant and UniProtKB_Participant tables contain uni-
ﬁed information for gene and protein identiﬁers, respectively, and are fed by an
identiﬁer mapping process described in the Section 2.4.4.
The proposed database schema allows fast queries requiring any combina-
tion of molecular concepts and/or biological sources by joining the uniﬁcation
tables. For example, to ﬁnd all diseases associated to kinase proteins the UniPro-
tKB_Participant table is joined with itself to yield the required information:
SELECT distinct m.fullName
FROM UniProtKB_Participant p1
JOIN UniProtKB_Participant p2 using(UniProtKB_id)
JOIN MolecularConcept m on m.molconcept_id = p2.molconcept_id
WHERE p1.molconcept_id = <molecular concept id for the kinase function>
AND p2.entry_id = <entry id corresponding to disease associations>
Because all imported information is stored as molecular concepts there is no
need to use additional tables to query the data warehouse to search for other an-
notations. This is in contrast to other existing databases where, depending on the
type of information being queried, different tables needs to be joined. Naturally,
this demands a deeper understanding of the underlying schema.
Currently, this schema is implemented using the relational database MySQL
(http://www.mysql.com); however, any other relational database using the SQL
query language can be used.
2.4.3 Processing of source database data
Software loaders are in charge of translating the original data ﬁles from the source
databases to the data warehouse schema. The loaders try to keep as much infor-
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integrated database download method
BioCarta manual download
BioGRID manual download
BurgeLab tissue expression not updated
CORUM automatic
COXPRESdb manual download
DIP manual download
Ensembl Family automatic
ENZYME automatic
GNF expression not updated
GO automatic
HiMAP not updated
HomoMINT automatic
HPRD manual download
HumanCyc manual download
IntAct automatic
Interpro automatic
KEGG automatic
MGI mammalian phenotype automatic
MINT automatic
OMIM automatic
OPHID automatic
OrthoMCL manual download
PDB automatic
Pfam manual download
PharmGKB automatic
PID manual download
PIPs automatic
Reactome automatic
STRING manual
UniProtKB keywords automatic
UniRef90 automatic
Table 2.3: Download method of integrated databases. The data in most biological databases is auto-
matically downloaded and integrated into the data warehouse. About a third of the data sources need
to be manually downloaded for diverse reasons: in some cases ﬁles are only available for download upon
request while, for other cases, there are no standard places to ﬁnd downloadable ﬁles, which have to be
found manually. The GNF expression and BurgeLab datasets that indicate the expression of genes in
the diﬀerent tissues, as well as the predicted protein-protein interactions from HiMAP have not been
modiﬁed after publication.
mation as possible from the source database while converting the information to
molecular concepts.
Using the Python programming language (http://python.org), we developed
loaders to read the standard ﬁle formats PSI-MI (for molecular interaction data
Isserlin et al. (2011)) and BioPAX (for biological pathways Demir et al. (2010)).
However, the implementation of the standard varies among the databases oﬀering
the data and it was necessary to create speciﬁc programs to read the ﬁles from
each database. Particular programs to extract information from ﬂat ﬁles contain-
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ing tables where columns are separated by tabs, were also developed. Ontological
information was acquired by reading and processing OBO ﬁles1.
For each biological source database, a loader was created to read, extract
and write the information into the data warehouse. In most cases, the loader
automatically downloads the data from the source database; however, for several
databases the data has to be downloaded manually, either because permission to
download the ﬁle has to be granted or because the ﬁles are not stored in standard
places or with standard names and must be searched for manually. However, only
the download of the information demands personal attention; once the data is
obtained the respective program is triggered to load the data into the data ware-
house.
In three cases the available data is part of a publication and does not requires
updating (Table 2.3).
2.4.4 Mapping and unification of gene and protein identifiers
The mapping of identiﬁers attempts to unify corresponding genes or proteins
labeled under different reference systems. This is done by selecting a target iden-
tiﬁer system (e.g. Entrez Gene) to which all other identiﬁers are mapped. During
the uniﬁcation process all information associated to the original identiﬁer, as re-
ported in the source database, is translated to the target identiﬁer system. In
the data warehouse we chose a gene and a protein identiﬁer systems for uniﬁca-
tion, namely: Entrez Gene (Maglott et al., 2007) and UniProtKB (The UniProt
Consortium, 2010). A gene and a protein identiﬁer system were selected to re-
duce, for each system, the trade-oﬀs involved when mapping from gene to protein
identiﬁers and vice versa (Section 2.2).
The uniﬁcation of identiﬁers uses mapping tables downloaded from third par-
ties. This method was preferred over web-only applications, such as the Protein
Identiﬁer Cross-Reference (PICR) service (Côté et al., 2007) and IDconverter
(Alibés et al., 2007), in which a mapping has to be requested from their sites on
a one-by-one basis.
Several mapping tables are available. The International Protein Index (IPI)
(Kersey et al., 2004) was considered as a good candidate to obtain mapping tables.
IPI, although not a mapping service, is suitable for mapping identiﬁers because
it maintains an updated and downloadable database of cross references between
gene and protein sequence sources. Although IPI focuses on protein sequences,
identiﬁers for gene sequences are also contained, thus permitting protein to gene
mappings. The IPI algorithm works by creating pairwise alignments from all the
sequences from the data sources and the reciprocally best matching pairs are com-
1 http://www.geneontology.org/GO.format.obo-1_2.shtml
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bined to form clusters of mapped proteins. However, a drawback of IPI is that
protein variants are often part of the same cluster and can not be distinguished.
UniProtKB also offers comprehensive mapping tables from many different identi-
ﬁer systems to their own identiﬁers. Yet the methods behind the mapping tables
are not documented and protein variants are not considered either. The NCBI
provides mappings only between their identiﬁers systems, Entrez and RefSeq,
and Ensembl identiﬁers. None of these mapping tables contain information about
obsolete or updated identiﬁers.
In order to obtain the best results, the mapping method implemented for
the data warehouse merges diﬀerent mapping sources. This method is centered
around UniParc records to map human protein sequences (including protein vari-
ants) to several other protein identiﬁers. NCBI and UniProtKB mapping tables
support mappings from protein identiﬁers to gene identiﬁers and from other iden-
tiﬁers not covered in UniParc. Deleted and updated identiﬁers from the Entrez
and UniProtKB systems are obtained from NCBI and UniProtKB respectively
(Fig 2.6).
The mapping algorithm is similar to the one presented by (Razick et al., 2008)
to map protein-protein interactions. First, the primary identiﬁer of a gene or pro-
tein referenced in a source database is analyzed. Although most source databases
only use a single identiﬁer, in some databases, specially in protein-protein interac-
tion databases, each gene or protein has a primary identiﬁer and several secondary
identiﬁers. The primary identiﬁer is revised to determine if it is considered ob-
solete and if replacement identiﬁers are found. This identiﬁer is then mapped to
gene and protein identiﬁers if mappings are available. When the identiﬁer maps
to several genes or proteins, secondary identiﬁers are used to resolve ambiguities.
Also, if the primary identiﬁer can not be mapped, secondary identiﬁers are used.
The mapping algorithm is shown in Fig. 2.7.
The mapping algorithm creates two tables: Entrez_Participant and Uni-
ProtKB_Participant that contain the uniﬁed relations to the molecular con-
cepts. These derived tables can be re-generated at any time from the core tables
to reﬂect updates in the mapping tables or changes in the mapping algorithm.
Furthermore, if uniﬁcation is required using another identiﬁer system, the map-
ping algorithm can be easily adapted because the process runs independently of
the data collection and storage.
2.5 Summary
In this chapter, we presented a data warehouse to integrate the biological
knowledge annotated to human genes and proteins found in several specialized
databases. Currently, the data warehouse integrates almost 3 million such annota-
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Downloaded tables
Entrez_gene_history
tax_id INT(11)
current_entrez_id INT(11)
old_entrez_id INT(11)
old_symbol VARCHAR(50)
dicontinued_date VARCHAR(20)
Indexes
UniParc
UniParc_id VARCHAR(15)
source_database VARCHAR(40)
id VARCHAR(20)
is_active ENUM('Y','N')
tax_id INT(11)
Indexes
Uniprot_info
uniprotkb_id CHAR(6)
entry_name VARCHAR(20)
status ENUM(...)
protein_name VARCHAR(250)
protein_alias TEXT
other_info TEXT
gene_names TEXT
length INT(11)
Indexes
Uniprot_secondary2primary
secondary_id CHAR(6)
primary_id CHAR(6)
Indexes
UniProtKB_idmapping
UniProtKB_id CHAR(6)
source VARCHAR(20)
id VARCHAR(20)
Indexes
Uniprot_deleted
uniprot_id CHAR(6)
Indexes
Entrez_gene_info
Entrez_id INT(11)
symbol VARCHAR(20)
synonyms TEXT
description TEXT
tax_id INT(11)
Indexes
Entrez_to_Ensembl_Refseq
tax_id INT(11)
Entrez_id INT(11)
Ensembl_gene_id VARCHAR(20)
RefSeq_rna_id VARCHAR(20)
Ensembl_rna_id VARCHAR(20)
RefSeq_protein_id VARCHAR(20)
Ensembl_protein_id VARCHAR(20)
Indexes
Derived UniParc tables
UniParc_protein_info
UniParc_id VARCHAR(16)
UniProtKB_sp_id CHAR(6)
UniProtKB_sp_isoform_id VARCHAR(10)
UniProtKB_tr_id TEXT
protein_synonyms TEXT
protein_name TEXT
tax_id INT(11)
is_primary_isoform ENUM('yes','no')
Indexes
UniParc_to_Entrez
UniParc_id VARCHAR(16)
Entrez_id INT(11)
Indexes
Derived id mapping tables
anyId_to_Entrez
Entrez_id INT(11)
source VARCHAR(40)
id VARCHAR(20)
Indexes
anyId_to_UniParc
UniParc_id VARCHAR(16)
source VARCHAR(40)
id VARCHAR(20)
Indexes
Fig. 2.6: Identiﬁer mapping tables. Identiﬁer mapping and identiﬁers information tables are ob-
tained from third parties and stored into the database. The main source for mapping information is
UniParc, which cross-references any amino acid sequence to diﬀerent identiﬁer systems. However, the
UniParc table does not contain gene to protein mappings and some other mappings that are obtained
from UniProtKB and NCBI and stored in the UniProtKB_idmapping and Entrez_to_Ensembl_Refseq
tables. The mapping tables anyId_to_UniParc and anyId_to_Entrez merge the information for all the
mapping sources mentioned.
tions from over 30 major molecular biology databases (Fig. 2.8). The integration
of this large number of heterogeneous types of information is achieved through the
transformation of the information acquired from the biological data sources into
sets of genes and proteins sharing a common molecular concept or annotation.
The integrative solution presented is composed of a relational database that
stores the information from the data sources implemented in MySQL; a series
of programs written in Python that fetch, process and write the data into the
database; and of a identiﬁer mapping method developed also in Python that
uniﬁes the diﬀerent identiﬁer systems to reference genes and proteins. The data
warehouse is composed over 10 thousand lines of programming code that have
been extensively tested and debugged.
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Fig. 2.7: Algorithm for mapping identiﬁers. An input gene or protein from a database source
is always associated to a primary identiﬁer and optionally to one or several secondary identiﬁers.
The mapping algorithm searches for obsolete identiﬁers and tries to ﬁnd replacements. If the primary
identiﬁer can not be mapped, secondary identiﬁers are used. If it is not possible to map the identiﬁer,
this issue is recorded for manual inspection.
The developed data warehouse is easy to maintain and expand because of
the simplicity of the underlying database schema based on the molecular concept
idea. This allows to store heterogeneous types of information from a large number
of different sources only using few tables. As a result, the methods to access and
store the information only need to interact with these few tables in a well deﬁned
and similar manner. If a new source of information needs to be added to the data
warehouse, no new tables are required.
Updating of the mapping algorithm, if required, is straightforward because
it is separated from the processes that acquire and store the data. This separa-
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• 22 sources
• 2.080.000 annotations
2008 2009 2010
• 15 sources
• 1.200.000 annotations
• 26 sources
• 3.260.000 annotations
• 31 sources
• 3.900.000 annotations
• ~70.000 proteins
• ~20.000 genes
2011
Fig. 2.8: Data warehouse growth. New biological data sources have been integrated steadily over
the years into the data warehouse.
tion also makes the data warehouse ﬂexible to consolidate uniﬁed results using
diﬀerent identiﬁers systems that may become popular in the future. Moreover,
it is possible to unify information in novel ways, for instance, around protein
complexes. Currently, integrated data is uniﬁed using both a gene and a protein
identiﬁer system.
3Analysis of Human Protein Interaction Networks
This chapter reports the ﬁrst use of our data warehouse for the analysis of human
protein-protein interactions. The comprehensive analyses that were carried out
helped to understand the quality of the publicly available data, particularly those
obtained by predictions and by high-throughput techniques like yeast two-hybrid.
The analysis contemplated six human predictions data-sets based on interspecies
homology mapping, two yeast two-hybrid screen sets, and two sets derived from
the scientiﬁc literature found on curated databases (Ramírez et al., 2007).
The assessment of the reliability and the potential bias of the datasets was
analyzed through the use of novel methods which included a new graph measure
called shared neighbors. The analysis revealed a lower quality of the interac-
tions from high-throughput experiments, particularly from the yeast two-hybrid
screens than that of the interactions obtained from computational predictions.
Moreover, computational predictions that mapped high-throughput interactions
from other organisms to humans reduced their quality. Although some compu-
tational predictions were found to be very reliable, they tended to have certain
bias towards highly connected parts of the interaction network. Highly reliable
interactions were those reported in at least three diﬀerent experiments.
3.1 Introduction
Charting human protein-protein interactions (PPIs) on a cell-wide scale can aﬀord
key insights into the molecular basis of life and disease. Such investigations can
uncover functional relationships of proteins in cellular processes and between the
human host and its pathogenic intruders (Cusick et al., 2005; Uetz et al., 2006).
However, we are still far from a complete human interactome map, which is
estimated to contain between 200,000 to 400,000 interactions (Bork et al., 2004;
Ramani et al., 2005). Most human PPIs known until recently have been obtained
in small-scale experiments and collected from the literature in several databases
(Zanzoni et al., 2002; Salwinski et al., 2004; Alfarano et al., 2005; Prasad et al.,
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2009; Kerrien et al., 2007). Altogether, there are no more than 30,000-40,000
non-redundant, experimentally measured, human PPIs currently available in the
literature and publicly accessible (Ramani et al., 2005; Gandhi et al., 2006).
Since experimental data on PPIs is still scarce, bioinformatics methods have
been used to predict human PPIs from experimentally derived interactions in
other organisms such as yeast, worm, and fruit ﬂy (Huang et al., 2004; Lehner &
Fraser, 2004; Brown & Jurisica, 2005; McDermott et al., 2005; Rhodes et al., 2005;
Persico et al., 2005). Lately, two comprehensive yeast two-hybrid (Y2H) screens
have been performed with about 2,500 human proteins, resulting in about 5,000
PPIs (Rual et al., 2005; Stelzl et al., 2005).
Unfortunately, even though several publications on PPI predictions and Y2H
screens oﬀer some evaluation of the provided interaction data, no comprehensive
comparison and quality assessment of the diﬀerent human datasets have been
performed. Therefore, the reliability, coverage, and inherent bias of predicted and
new high-throughput data is unclear. This situation makes diﬃcult the selection
or the combination of one or another PPI dataset for further studies of the human
interactome. Previous analyses of PPIs have mainly focused on high-throughput
data for yeast, concluding that the reliability is limited and that about 50% of
the interactions may be spurious (Mrowka et al., 2001; Bader & Hogue, 2002;
Deane et al., 2002; Edwards et al., 2002; von Mering et al., 2002; Sprinzak et al.,
2003; Bader et al., 2004; Reguly et al., 2006). Two studies on human PPIs have
primarily compared literature-derived human datasets with each other or with
interactions observed in other species (Ramani et al., 2005; Gandhi et al., 2006),
but do not consider predicted datasets and recent Y2H screens.
In this work, the aim is to introduce a more comprehensive evaluation of the
available human PPI datasets. This analysis diﬀers from others because it addi-
tionally includes six large predicted datasets together with three high-conﬁdence
predicted subsets, two sizable high-throughput Y2H datasets, and two of the
most comprehensive, manually literature-curated, datasets. It is noteworthy that
all predicted datasets were published shortly before the results of the Y2H screens
became available, making possible the independent assessment of diﬀerent pre-
diction methods with novel experimental data. The integrative data warehouse
was used to study the similarities between the diﬀerent datasets and also applied
various alternative quality measures based on the Gene Ontology (GO), struc-
turally known domain interactions, likelihood ratios, and topological network
parameters.
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Dataset Originalidentifier type
#Original
interactions
#Original
identifiers
#Mappable
identifiers
#Final
Entrez Gene
IDs
#Final
interactions
Predicted protein-protein interactions
Bioverse RefSeq 3218048 36996 16388 7711 233941
Bioverse-core RefSeq 18327 1753 1481 1263 3266
HiMAP Entrez Gene ID 38379 5790 5790 5790 38378
HiMAP-core Entrez Gene ID 8833 2901 2901 2901 8832
HomoMINT UniProt 10993 4129 4101 4184 10870
OPHID UniProt 26425 4787 4738 4559 28255
POINT GeneInfo Identifier 101783 13047 12982 12058 98528
Sanger Ensembl (gene) 71806 6231 5788 5923 67518
Sanger-core Ensembl (gene) 11652 3872 3661 3728 11131
Experimental Y2H protein-protein interactions
CCSB-HI1 Entrez Gene ID 2754 1549 1549 1549 2754
MDC Entrez Gene ID 2124 1124 1124 1124 2033
Manually curated protein-protein interactions
HPRD-LS Entrez Gene ID 3151 1983 1983 1983 3151
HPRD-SS Entrez Gene ID 27955 7686 7686 7686 27955
IntAct UniProtKB 6734 3484 2977 2988 5809
Table 3.1: Datasets of human protein-protein interactions included in the analysis and their conversion
to Entrez Gene IDs. The number of interactions and identiﬁers of a certain type contained in the original
datasets were obtained after removal of duplicates. The number of mappable identiﬁers is the number
of original identiﬁers for which corresponding. The high throughput Y2H screens CCSB-HI1 and MDC
were removed from the literature-curated sets HPRD-LS and IntAct. The complete HPRD without
the Y2H dataset contains 30,956 interactions among 8,329 proteins. The numbers of ﬁnal Entrez Gene
IDs and interactions refer to the number of unique identiﬁers and interactions after performing the
identiﬁer mapping.
3.2 Data sources containing protein-protein
interactions
Several human PPI datasets from diﬀerent sources were used as follows (Ta-
ble 3.1 and Table 3.2): six predicted datasets from Bioverse (McDermott et al.,
2005), HiMAP (Rhodes et al., 2005), HomoMINT (Persico et al., 2005), OPHID
(Brown & Jurisica, 2005), POINT (Huang et al., 2004), and Sanger (Lehner &
Fraser, 2004); two experimental high-throughput Y2H screens CCSB-HI1 (Rual
et al., 2005) and MDC (set LacZ4) (Stelzl et al., 2005); and two literature-curated
datasets HPRD (release 6 of 1 January 2007) (Prasad et al., 2009) and IntAct
(downloaded on 12 January 2007) (Kerrien et al., 2007). Interactions derived from
protein complexes were discarded and the two high-throughput Y2H screens were
removed from the literature-curated datasets. Also, the HPRD dataset was di-
vided into two subsets of small-scale (HPRD-SS) and large-scale (HPRD-LS)
experiments using 70 as threshold for the number of interactions reported in the
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Dataset Data Sources Species Homology Detection Method
Bioverse DIP, GRID, PDB 50 species PSI-BLAST (E-value < 1.0)
HiMAP Gavin, Giot, Ito, Li, Uetz fruit fly, worm,
yeast
InParanoid
HomoMINT MINT 15 species InParanoid, results subsequently filtered by match-
ing domain architecture between human and
species orthologs.
OPHID Giot, Li, Suzuki, von Mer-
ing, MIPS
fruit fly, worm,
yeast
BLASTP reciprocal best-hit (E-value < 10−5), fil-
tered for hits with length > 50% of human protein
sequence
POINT DIP fruit fly, worm,
yeast, mouse
BLASTP (E-value not given)
Sanger Gavin, Giot, Ho, Ito, Li,
Tong, Uetz, von Mering
fruit fly, worm,
yeast
InParanoid
Table 3.2: Predicted protein-protein interacting datasets. Comparison of interolog mapping methods
for each predicted dataset regarding data sources of the protein interactions, species of the data sources,
and homology detection methods applied. The listed data sources refer to the following studies: Gavin:
S. cerevisiae TAP puriﬁed complexes (Gavin et al., 2002); Giot: D. melanogaster Y2H screen (Giot
et al., 2003); Ho: S. cerevisiae HMS-PCI puriﬁed complexes Ho et al. (2002); Ito: S. cerevisiae Y2H
screen Ito et al. (2001); Li: C. elegans Y2H screen (Li et al., 2004); Suzuki: M. musculus Y2H screen
(Suzuki et al., 2001); Tong: S. cerevisiae synthetic genetic array (Tong et al., 2001); Uetz: S. cerevisiae
Y2H screen (Uetz et al., 2000); von Mering grouped the S. cerevisiae data from Gavin, Ho, Ito, Uetz,
Tong, and added 7,446 predicted interactions derived from gene neighborhood, gene fusion, and co-
occurrence of genes (von Mering et al., 2005); further databases are: DIP for Bioverse, DIP for POINT,
GRID, MINT, MIPS, and PDB.
same publication; HPRD-LS contains interactions primarily derived from Y2H
experiments (Table 3.3). CCSB-HI1 was assembled using full-length proteins as
baits and preys. The CCSB-HI1 authors reported that 78% of the interactions
from a random sample of 217 interaction pairs could be veriﬁed using in vivo co-
aﬃnity puriﬁcation assays (Rual et al., 2005). Since the MDC technology applied
protein fragments of varying size as baits and preys (Stelzl et al., 2005), also the
length of the fragments was considered in this study. The MDC authors described
a veriﬁcation rate of 62% interactions for a random sample of 116 interactions
using membrane co-inmunoprecipitation assays and of 66% interactions for a
random sample of 131 interactions obtained using pull-down experiments. In the
following, the union of CCSB-HI1 and MDC consists of 4,770 unique interactions
between 2,472 proteins and is referred to as the combined Y2H datasets.
Additionally, three core datasets available as subsets of Bioverse, HiMAP, and
Sanger were used. This core subsets are assumed to consist of particularly reli-
able predictions. The Bioverse-core subset contains interactions of human proteins
with a joint sequence similarity of at least 80% to the species interologs used to
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Publication Experimental method HPRD IntAct
Nakayama et al. (2002) Y2H 118 125
Bouwmeester et al. (2004) Y2H 128 1682
Colland et al. (2004) Y2H 706 —
Goehler et al. (2004) Y2H 154 151
Jin et al. (2004) Co-immunoprecipitation 297 —
Lehner et al. (2004) Y2H 110 95
Lehner & Fraser (2004) Y2H 264 231
Ramachandran et al. (2004) Protein array 102 109
Barrios-Rodiles et al. (2005) LUMIER 430 —
Guo et al. (2005) Far-western blotting 75 —
Rual et al. (2005) Y2H 2619 2671
Stelzl et al. (2005), 2005 Y2H 3116 3137
Lim et al. (2006) Y2H 704 706
Tsang et al. (2006) Y2H 75 —
Camargo et al. (2007) Y2H — 191
Table 3.3: List of publications reporting large numbers of protein-protein interactions included in
HPRD or IntAct.
predict the PPIs (Yu et al., 2004). As suggested in the original publication on
HiMAP, the HiMAP-core subset consists of interactions with a 4-to-1 odds ratio
that two proteins interact (that is, with a likelihood ratio exceeding the com-
puted threshold 1,526) (Rhodes et al., 2005). The Sanger-core subset comprises
predictions derived from high-throughput experiments in yeast, worm, and ﬂy
that were detected more than once in the experimental assays (Lehner & Fraser,
2004). Five consensus sets were assembled and named ConSetn (with n ranging
from 2 to 6) consisting solely of predicted PPIs contained in at least n of the
predicted datasets. This resulted in consensus sets of decreasing size: ConSet2
with 38,258, ConSet3 with 10,844, ConSet4 with 4,747; ConSet5 with 1,565, and
ConSet6 with 484 PPIs. To generate a random interaction dataset, a subset of
5,000 proteins was randomly picked from the list of all proteins contained in
the diﬀerent interaction datasets. From this subset, random selections with re-
placements were used to determine 30,000 interactions including homodimers. A
second randomized set named HPRD-random was constructed by shuing the
protein identiﬁers of the complete HPRD dataset (HPRD-SS and HPRD-LS),
thus preserving the network topology.
The diverse original protein and gene identiﬁers used in the interaction
datasets namely Ensembl (gene) (Birney et al., 2006), Entrez Gene ID (Ma-
glott et al., 2005), GenInfo Identiﬁer (Benson et al., 2006), RefSeq (Pruitt et al.,
2005), and UniProtKB (Wu et al., 2006a) were converted to Entrez Gene IDs
to allow comparison between datasets (Table 3.1). Outdated original identiﬁers
were substituted with new identiﬁers if they were available. Otherwise, identiﬁers
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removed from the original database were ignored. An extraordinary case was Bio-
verse with more than half of the original RefSeq identiﬁers removed without a
new substitute.
3.3 Network overlap computation
For pairwise comparisons of the human interaction datasets, three diﬀerent ma-
trices named F, S and T representing the mutual overlap were computed. In the
following, Vi and Ei are the sets of proteins (referenced by Entrez Gene IDs) and
their interactions, respectively, for an interaction dataset i ∈ {Bioverse, Bioverse-
core, HiMAP, HiMAP-core, HomoMINT, OPHID, POINT, Sanger, Sanger-core,
CCSB-HI1, MDC, HPRD-LS, HPRD-SS, IntAct, HPRD-random, Random}. In
the ﬁrst matrix F, the fraction fij of proteins shared between the two sets Vi
and Vj in ratio to the size of the smallest set used as normalizing denominator is
deﬁned as follows:
fij = |Vi ∩ Vj|/min(|Vi|, |Vj|)
Similarly, the second matrix S contains the fraction sij shared between two in-
teraction datasets Ei and Ej normalized by the size of the smallest interaction
set:
sij = |Ei ∩ Ej|/min(|Ei|, |Ej|)
In contrast to the second matrix, the third matrix T is normalized by another
denominator |Kij| in order to ignore all proteins that are not part of both Vi and
Vj. Here, if (u, v) ∈ Ei represents the interaction between the proteins u and v in
some interaction set i, Kij is deﬁned as:
Kij = {(u, v) ∈ Ei|u, v ∈ Vi ∩ Vj}.
Thus, Kij as a subset of Ei is diﬀerent from Kji and lacks all interactions of
proteins not shared between Vi and Vj. The values tij in the third matrix are
calculated accordingly:
tij = |Ei ∩ Ej|/min(|Kij|, |Kji|)
Fisher's exact test was applied to obtain a p-value for the observed overlap
between each pair of interaction datasets. For this purpose, the total number nij
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of all possible interactions including homodimers between all proteins contained
in Vi or Vj was calculated as follows:
nij = |Vi ∪ Vj| × (|Vi ∪ Vj|+ 1)/2
3.4 Quality assessment methods
Functional similarity using Gene Ontology
To compute functional similarities of interacting proteins the BPscore similarity
measure was used. This measure, introduced by Schlicker et al. (2006), is derived
from the information contents of the annotated BP terms and their distances
within the GO graph. The Gene Ontology (GO) (Harris et al., 2004) annotation
was acquired on the of 12 December 2006 from the NCBI (ftp://ftp.ncbi.
nih.gov/gene/DATA/gene2go.gz); annotations derived from protein-protein in-
teractions where not used1. The calculation of the information content of each
GO term was based on the term frequencies estimated using the annotation of
human proteins from UniProtKB release 8.4. BPscore values range from 0 to 1,
where 1 indicates the highest functional similarity. The BPscore computation did
not include interactions of proteins solely annotated with quite general GO terms
(very low information content ≤ 2).
To compare the functional similarity of interacting proteins qualitatively, the
proteins were grouped into BP categories of top levels of the GO hierarchy using
the script map2slim.pl from the GO Slim website (http://www.geneontology.
org/GO.slims.shtml) (von Mering et al., 2002). The 20 categories used for anal-
ysis were derived from the GO Slim ﬁle at http://www.geneontology.org/GO_
slims/goslim_goa.obo (Biswas et al., 2002). Maps of protein interaction density
were constructed for every pair of BP categories (Ge et al., 2001). Homodimers
were removed from the datasets for this analysis.
Structural domain interactions
To assess protein-protein interactions with structurally known domain-domain
interactions, the iPfam version 20.0, containing 3,020 interactions between 2,147
1 This is distinguished in the GO by the evidence code inferred from physical interaction (IPI)
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Fig. 3.1: Pairwise overlap of the human protein interaction datasets regarding proteins (matrix F),
interactions (matrix S), and interactions ignoring all Entrez Gene IDs not contained in either interaction
sets being compared (matrix T). The coloring schema from light yellow to dark red represents the
respective overlap relative to the size of the smaller one of the two compared sets (values from 0% to
100%). Dendrograms are based on average linkage clustering using the respective matrix values.
distinct Pfam-A domains, was used (Finn et al., 2008). The domain composition
of proteins was obtained from UniProtKB release 8.4.
Likelihood ratios
A set of positive and negative protein interactions was chosen to benchmark the
prediction methods using likelihood ratios. The experimental dataset HPRD-SS
and the combined Y2H datasets CCSB-HI1 and MDC were used as two diﬀerent
positive reference sets (PRS) because they have a low overlap with each other
(Fig. 3.1). Unlikely protein interactions between proteins localized in the cellular
membrane and proteins localized in the nucleus were used as negative reference set
(NRS) (Jansen et al., 2003). 4,921 proteins localized in the membrane and 3,630
proteins localized in the nucleus were found according to the GO annotations.
After removing 230 proteins annotated to both membrane and nucleus, the NRS
set contains 15,949,400 protein pairs. The true positive and false positive rates
and likelihood ratio (TPR, FPR and LR) were calculated as follows:
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Fig. 3.2: Interolog mapping. Experimentally veriﬁed interactions in one species are transferred to
other using protein homology.
TPR = |Ei ∩ PRS|/|PRS|
FPR = |Ei ∩ NRS|/|NRS|
LR = TPR/FPR
3.5 Evaluation of the interaction networks
3.5.1 Contents of the human interaction datasets
The following predicted datasets of human PPIs were used (Table 3.1): Bioverse,
HiMAP, HomoMINT, OPHID, POINT and Sanger. Three core subsets with high-
conﬁdence interactions were additionally obtained from Bioverse, HiMAP, and
Sanger. The prevailing bioinformatics methods used for the prediction of human
PPIs is known as interolog mapping (Fig. 3.2). This method uses evolutionary
relationships to infer interactions between human proteins from the interactions
of homologous proteins of other species (Yu et al., 2004; Walhout et al., 2000).
Thus, interolog mapping relies on the idea that protein interactions in one or-
ganism are likely to occur in another where homologous proteins exists (Gandhi
et al., 2006). Table 3.2 summarizes the diﬀerent approaches to determine human
homologs from yeast, worm and the fruit ﬂy by using either BLAST, PSI-BLAST
or InParanoid (Altschul et al., 1997; O'Brien et al., 2005) in the predicted datasets
studied.
Many interactions used by the PPI prediction methods originate from high-
throughput experiments that are found in databases such as DIP, GRID, MINT,
and MIPS (Table 3.2). Bioverse is the only predicted dataset that includes in-
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teractions taken from structural complexes in the PDB (Berman et al., 2000).
Additional procedures beyond interolog mapping were applied by some predic-
tion methods to ﬁlter interactions for quality, for instance, HiMAP is assembled
utilizing not only interologs, but also co-expression data, shared GO annotation of
proteins, and domain-domain interactions (Rhodes et al., 2005). Interestingly, the
authors of HiMAP report that interolog mapping is only moderately predictive
of human interactions, which is in agreement with another recent analysis (Mika
& Rost, 2006), and that conﬁdence of an interaction is often associated with the
existence of experimental data reported by diﬀerent experiments (Rhodes et al.,
2005).
Two comprehensive experimental Y2H datasets were used in this study: CCSB-
HI1 (Rual et al., 2005) and MDC (Stelzl et al., 2005), which were published shortly
after the predicted datasets became available. Also HPRD (Prasad et al., 2009)
and IntAct (Kerrien et al., 2007), which consist of PPIs manually curated from the
literature, were contemplated in this study. The number of curated publications
by HPRD and IntAct is 18,525 and 1,098, respectively, with an overlap of 629
publications.
3.5.2 Overlap of the human interaction datasets
A distinction is made between the set of binary interactions and the set of proteins
involved in the interactions. Each interaction can be formed by a pair of diﬀerent
proteins or by two instances of the same protein in the case of homodimers.
Pairwise comparisons were performed for all datasets containing 16,318 proteins
in total. The predicted dataset POINT contains the largest protein set with 12,058
diﬀerent proteins. All other protein sets are mainly subsets of POINT (Fig. 3.1).
HiMAP contains more proteins in common with Bioverse and HPRD-SS (over-
lap ≥ 60%) than with the other protein sets. Also, HomoMINT, OPHID, POINT,
and Sanger form a group of similar protein sets (pairwise overlap ≥ 67%). Regard-
ing the three predicted datasets HiMAP, HomoMINT, and Sanger, it is interest-
ing to note that HomoMINT and Sanger share 75% of their proteins in contrast
to HiMAP that shares no more than 52% of its proteins with HomoMINT or
Sanger, although all three datasets were produced using the InParanoid method
to identify human homologues (O'Brien et al., 2005). This observed discrepancy
may be a consequence of the diﬀerent prediction methods employed by HiMAP
(Rhodes et al., 2005). The proteins used by CCSB-HI1 and MDC in the Y2H
screens are particularly diﬀerent. Both sets share only 201 proteins overall (18%
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of MDC, 13% of CCSB-H1). Regarding the literature-curated datasets, HPRD-LS
and HPRD-SS share 66% and 76% proteins, respectively, with IntAct.
p-values were computed using Fisher's exact test to compare the size of the
pairwise overlaps between interaction sets against randomly ocurring overlaps.
The obtained p-values for the overlap between predicted data set were highly
signiﬁcant (p ≤ 1.44 × 10−179) indicating a good overall agreement within these
sets (Table 3.4, and Fig. 3.1S). Similar results were obtained when comparing
the predicted datasets with HPRD-SS. However, the statistical signiﬁcance of
the overlap sizes with the Y2H datasets is diﬀerent (Table 3.4). Larger p-values
were obtained for the overlap with CCSB-HI1 (3.64× 10−207 ≤ p ≤ 1.34× 10−11)
and even larger values for MDC (1.76 × 10−41 ≤ p ≤ 0.018). Presumably, since
HPRD-LS is composed mainly of Y2H interactions, the p-values obtained are
similar to those of the Y2H datasets CCSB-HI1 and MDC (0 ≤ p ≤ 2.53×10−4).
When reducing the interaction sets to those interactions that involve solely
proteins contained in each of the respective two protein sets (Fig. 3.1T), Ho-
moMINT, OPHID and Sanger are very similar (>70% pairwise overlaps). This
presumably reﬂects the common methodology and data sources used by them
(Table 3.2). A large fraction of 74% of the interactions in HomoMINT are also
contained in POINT. The two predicted datasets Bioverse and HiMAP show only
a small 24% interaction overlap. The Y2H dataset CCSB-HI1 has an overlap of
58% with Bioverse-core and fall into a group containing Bioverse, Bioverse-core,
and HPRD-SS. The overlap of the two Y2H screens CCSB-HI1 and MDC amounts
to 17 interactions only, and the MDC overlap with other datasets is limited to at
most 41 out of 2033 interactions. Those results are in good agreement with other
studies that have demonstrated a generally low overlap of high-throughput inter-
action data (Ramani et al., 2005; Gandhi et al., 2006; Mrowka et al., 2001; Deane
et al., 2002; Edwards et al., 2002; von Mering et al., 2002; Sprinzak et al., 2003;
Bader et al., 2004; Reguly et al., 2006; Goll & Uetz, 2006). However, HPRD-LS
and IntAct have a large overlap due to the curation of identical high-throughput
datasets (Table 3.3).
3.5.3 Assessment of protein-protein interactions
Functional analysis
Functional similarity of proteins has been used to predict (Rhodes et al., 2005;
Ben-Hur & Noble, 2005; Wu et al., 2006b) and assess their interactions (Lehner &
Fraser, 2004; Brown & Jurisica, 2005; Persico et al., 2005; Bader & Hogue, 2002;
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Functional Similarity using GO Domain Interactions using iPfam
Dataset AverageBPscore
GO as-
signments
in percent
Number of
homodimers
in percent
Average
information
content
Domain
assignments
in percent
Number of
DDI-validated
interactions (%)
Overlap in
percent
Bioverse-core 0.814 87.94 12.58 12.6 91.40 2090 (70.0) 51.92
HiMAP-core 0.793 92.07 0.00 12.6 92.33 3934 (48.2) 42.70
HiMAP 0.785 94.64 0.00 12.8 91.77 12764 (36.2) 35.02
HPRD-SS 0.634 91.20 6.78 12.8 89.36 6301 (25.2) 30.76
Bioverse 0.575 87.62 0.81 13.1 92.87 94569 (43.5) 25.70
Sanger-core 0.558 70.10 1.90 12.9 78.09 1049 (12.1) 26.62
IntAct 0.554 77.71 3.44 12.2 75.45 693 (15.8) 33.20
HomoMINT 0.525 63.85 5.81 12.3 75.90 992 (12.0) 35.24
OPHID 0.510 67.97 0.00 12.5 85.22 1528 (6.35) 16.45
HPRD-LS 0.488 78.32 1.52 12.6 81.72 169 (6.56) 20.92
CCSB-HI1 0.464 53.05 5.19 12.3 56.57 250 (16.0) 37.22
POINT 0.457 65.33 4.18 11.9 70.82 6818 (9.77) 30.32
Sanger 0.437 70.47 0.55 12.1 80.93 3016 (5.52) 21.63
HPRD-random 0.394 77.26 6.25 12.5 76.11 1598 (6.78) 38.27
MDC 0.390 57.99 1.48 12.7 65.22 51 (3.85) 23.01
Random 0.335 52.94 0.01 12.2 58.40 251 (1.43) 5.63
Table 3.5: Quality assessment using functional GO similarity and structural domain interactions.
The human interaction datasets are ranked by the average BPscore. For each dataset, the percentage
of interactions with biological process (BP) terms assigned to both interacting proteins is given next
to the percentage of homodimers, the fraction of protein self-interactions. The average information
content is calculated from the information content of the BP protein annotations. The percentage of
DDI-validated interactions using iPfam relates to the fraction of PPIs in which both proteins have
Pfam domain assignments. The rightmost column shows the overlap size of the subset of PPIs with
a BPscore ≥ 0.8 and the subset of all DDI-validated PPIs, relative to the size of the union of both
subsets.
von Mering et al., 2002; Sprinzak et al., 2003; Bader et al., 2004; Reguly et al.,
2006). A previous study showed that the application of similarity measures based
on the biological processes in which proteins are involved can be used to validate
PPIs (Guo et al., 2006). The BPscore measure, which uses the Gene Ontology
(GO) annotation (Harris et al., 2004) to calculate the similarity of biological
processes annotated to interacting proteins (Schlicker et al., 2006), was used.
For each dataset was calculated: (i) the average BPscore, (ii) the fraction of
PPIs in which both proteins are annotated with biological process terms, (iii)
the fraction of homodimers, and (iv) the average information content of the BP
protein annotations (Table 3.5). The values (ii)-(iv) were included to identify
possible bias that could aﬀect the BPscore. The fraction (ii) of annotated PPIs
varies greatly between datasets from 53.05% to 94.64%. HPRD-SS is enriched
with well-annotated pairs of interacting proteins while the Y2H datasets reach
much lower values (Table 3.5). However, one should bear in mind that Y2H re-
sults discover new interactions between proteins that are not yet as well studied
as in HPRD-SS. The values for the low numbers of homodimers (iii) and for
the average information content of each dataset (iv) negate a possibly biased
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Fig. 3.3: Dataset comparison using boxplots based on GO biological processes annotated to interacting
proteins. The datasets are ordered by the BPscore median from left to right. The area of each box is
proportional to the size of the corresponding dataset.
BPscore (Table 3.5). In particular, the average BPscore values ignoring homod-
imers are only slightly smaller than if homodimers are included. For instance,
the average BPscore of the Bioverse-core dataset containing the largest amount
of homodimers (411 out of 3,266) is 0.774 without homodimers compared to the
original value of 0.814. Altogether, there appears to be no overall diﬀerence in the
BP annotation quality of homodimers and other protein interactions that may
signiﬁcantly aﬀect the average BPscore.
In Table 3.5, the highest BPscore averages are found for Bioverse-core (0.814),
HiMAP-core (0.793), HiMAP (0.785), and HPRD-SS (0.634). The lowest scores
are assigned to Random (0.335), MDC (0.390), and HPRD-random (0.394). The
predicted datasets HomoMINT, OPHID, POINT, and Sanger reach values be-
tween 0.437 and 0.525, which are similar to the average BPscore obtained for
CCSB-HI1 (0.464) and HPRD-LS (0.488). The average BPscore increases in the
consensus sets from 0.533 ConSet2, 0.535 ConSet3, 0.538 ConSet4, 0.614 Con-
Set5 and 0.666 ConSet6. However, the latter value is not higher than the average
BPscore of Bioverse-core or HiMAP, and the size of ConSet6 is very small (484
interactions).
The top-ranking datasets, Bioverse-core, HiMAP-core, HiMAP, and HPRD-
SS are enriched by high-scoring interactions as can be seen in the BPscore box-
plots (Fig. 3.3) and the BPscore distributions (Fig. 3.4). The predicted datasets
Bioverse, HomoMINT, OPHID, POINT, Sanger, and Sanger-core show bimodal
distributions with frequent BPscore values in the range of 0.1-0.2 and of 0.9-1.0.
This pattern is similar to the one obtained from the experimental CCSB-HI1
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Fig. 3.4: Dataset comparison using histograms of the BPscore distribution. The BPscore similarity
values based on the biological processes annotated to interacting proteins are binned in 0.1-steps.
dataset and for HPRD-LS. (Fig. 3.3 and Fig. 3.4). Remarkably, the BPscore dis-
tribution of the MDC dataset is similar to those of the random datasets, but
slightly enriched with high BPscore values.
Furthermore, to compare the functional similarity of interacting proteins, not
only the quantitative measure BPscore was used but also a classiﬁcation approach
in which the interacting proteins are categorized according to the biological pro-
cesses annotated on GO. To this end, the frequency of PPIs was analyzed with
respect to 20 relevant biological processes from top levels of the GO hierarchy
(von Mering et al., 2002; Ge et al., 2001). In the case of datasets with many
accurate PPIs, a high density of interactions with both proteins in the same GO
category should be observed particularly along the diagonal of the computed
2D histograms (Fig. 3.5). The MDC dataset is the only dataset that does not
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clearly demonstrate this expectation. Apart from that, Fig. 3.5 visualizes appar-
ent bias and peculiarities of each human interaction dataset in functional terms.
For example, the categories `transport' and `secretion' as well as `biosynthesis'
and `amino acid and derivative metabolism' represent commonly related biologi-
cal processes except for the datasets MDC, HPRD-LS and IntAct. Among others,
the association of the categories `cell diﬀerentiation' with `development' as well
as `cell communication' with `behavior' is present in all predicted datasets and in
the literature-curated datasets HPRD-SS and IntAct, but not in the Y2H screens
CCSB-HI1 and MDC or in HPRD-LS. Also, some predicted datasets do not show
certain functional relationships, for instance, most protein interactions between
`electron transport' and `metabolism' are absent in the HomoMINT dataset, and
the categories `regulation of biological process' and `cell death' are not linked in
the datasets HomoMINT, POINT, and Sanger.
Structural domain interactions
Protein-protein interactions may be caused either by the physical contact of do-
main surfaces or by short peptides binding to domains (Albrecht et al., 2005;
Pawson & Nash, 2003). After decomposing interacting proteins into their consi-
tutent Pfam domains, those interactions explained by at least one of the 3,020
iPfam (Finn et al., 2005) domain-domain interactions (DDI) were considered as
`DDI-validated'. Each PPI was classiﬁed as validated, non-validated, or impos-
sible to evaluate because at least one of the two interacting proteins does not
contain known domains. However, it must be pointed out that this validation
method is only a simplistic measure and may result in incorrect classiﬁcations in
several cases. For instance, if the complex structure of two interacting domains
is not known yet and thus is missing in iPfam, the corresponding PPI would be
erroneously we assigned to the non-validated class. Another case of misclassiﬁca-
tion occurs when an interaction that does not take place in vivo is validated. For
example, interactions between proteins that are never expressed simultaneously
or present in diﬀerent cellular locations will be validated if they contain domains
interacting in iPfam.
Despite these shortcomings, the evaluation of PPIs based on iPfam DDIs yields
results comparable to those obtained by the computation of functional similarity
based on GO (Table 3.5 and Fig. 3.6). In particular, datasets with a high average
BPscore also have a large proportion of DDI-validated PPIs as follows: Bioverse-
core with BPscore 0.814 and 70.0% of DDI-validated interactions, HiMAP-core
with BPscore 0.793 and 48.2% of DDI-validated interactions, HiMAP with BP-
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Fig. 3.5: 2-D histograms of the distribution of PPIs according to the biological processes annotated to
the interacting proteins in each human interaction dataset. Each human interaction dataset is depicted
by a triangle matrix whose axes represent top levels of the GO hierarchy. The dot color in the histograms
reﬂects the protein interaction density that is the ratio of the number of PPIs assigned to the respective
matrix cell divided by the total number of PPIs possibly formed; the total number of possible PPIs
was derived by counting the members of the respective GO category, and the density was normalized
to 1,000 possible PPIs. The protein interaction density is not shown if the observed number of PPIs is
non-signiﬁcant (p-value ≥ 0.01, using Fisher's exact test as in case of the overlap computation). The
numbers along the axes represent the following GO categories: 1: cellular process; 2: cell communication;
3: cell diﬀerentiation; 4: cellular physiological process; 5: amino acid and derivative metabolism; 6:
cell death; 7: cell motility; 8: electron transport; 9: nucleobase, nucleoside, nucleotide and nucleic acid
metabolism; 10: transport; 11: development; 12: physiological process; 13: metabolism; 14: biosynthesis;
15: catabolism; 16: macromolecule metabolism; 17: secretion; 18: regulation of biological process; 19:
response to stimulus; 20: behavior.
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Fig. 3.6: Comparison of the average functional GO similarity BPscore values and the percentage of
validated structural domain-domain interactions in relation to the overall number of protein-protein
interactions with Pfam domain assignments as shown in Table 3.5.
score 0.785 and 36.2% of DDI-validated interactions. The high values obtained for
the HiMAP datasets are partially due to the fact that they have been compiled
by deriving putative DDIs from PPIs in HPRD ﬁrst and then using these DDIs to
predict other PPIs. High scores for the Bioverse datasets may be reached because
they additionally include known interactions from 3D complex structures, which
also results in a large number of DDI-validated interactions. Lower values are ob-
tained for the other predicted datasets of PPIs and the Y2H screens. For example,
only 16.0% and 3.8% of the PPIs in CCSB-HI1 (250 of 1,558) and MDC (51 of
1,326), respectively, could be DDI-validated, and the average BPscore values were
0.464 and 0.390, respectively. Moreover, the fraction of interactions DDI-validated
of MDC is close to the randomized datasets HPRD-random (BPscore 0.394 and
6.8%) and Random (BPscore 0.335 and 1.4%).
For each human dataset, the overlap of subsets of PPIs with high BPscore val-
ues not smaller than 0.8 with subsets containing all DDI-validated PPIs was ex-
amined (Table 3.5). Regarding Bioverse-core, HiMAP-core, and the Y2H dataset
CCSB-HI1, signiﬁcant overlaps with 51,9%, 42.7%, and 37.2%, respectively, are
observed. These overlaps may primarily consist of very reliable PPIs as judged
by both quality measures BPscore and DDI-validation.
Comparison with reference sets
Even though the analyses so far have pointed to the limited quality of experimen-
tal protein interaction datasets, both HPRD-SS and the combined Y2H datasets
3.5 Evaluation of the interaction networks 49
Computed ratios Number of PPIs inoverlap
Average
BPscore of
PPIs in overlap
DDI-validated
PPIs in overlap in
percent
Dataset TPR FPR LR PRS (%) NRS (%) PRS NRS PRS NRS
Use of HPRD dataset as PRS set
Bioverse-core 0.0390 1.80E-06 21405.0 1088 (33.31) 29 (0.89) 0.770 0.554 60.33 24.14
HPRD-SS 1.0000 6.60E-05 15189.9 27955 (100.0) 1050 (3.76) 0.620 0.471 25.22 14.11
HiMAP-core 0.0270 3.60E-06 7544.9 767 (8.68) 58 (0.66) 0.825 0.568 52.05 25.00
IntAct 0.0550 1.50E-05 3762.1 1543 (26.56) 234 (4.03) 0.676 0.369 34.66 6.22
HiMAP 0.0520 3.50E-05 1476.1 1454 (3.79) 562 (1.46) 0.818 0.573 49.38 8.85
HomoMINT 0.0290 3.30E-05 867.7 806 (7.41) 530 (4.88) 0.746 0.302 40.92 0.88
OPHID 0.0470 7.80E-05 597.2 1301 (4.60) 1243 (4.40) 0.752 0.318 40.43 3.17
Sanger-core 0.0190 3.30E-05 569.5 530 (4.76) 531 (4.77) 0.818 0.249 50.30 0.79
CCSB-HI1 0.0052 9.30E-06 559.1 146 (5.30) 149 (5.41) 0.829 0.247 62.40 0.00
HPRD-LS 0.0044 1.30E-05 329.1 124 (3.94) 215 (6.82) 0.717 0.361 26.61 4.64
POINT 0.1300 4.30E-04 300.4 3616 (3.67) 6867 (6.97) 0.740 0.302 42.59 1.34
Bioverse 0.1600 7.20E-04 225.6 4552 (1.95) 11512 (4.92) 0.738 0.463 64.18 33.49
MDC 0.0015 8.80E-06 165.9 41 (2.02) 141 (6.94) 0.809 0.296 66.67 0.00
Sanger 0.0290 2.60E-04 111.0 816 (1.21) 4196 (6.21) 0.802 0.273 44.52 0.97
HPRD-random 0.0160 2.50E-04 63.0 444 (1.43) 4021 (12.99) 0.963 0.294 79.56 0.53
Random 0.0001 1.70E-04 0.6 3 (0.01) 2702 (9.01) 0.494 0.272 0.00 0.40
Use of combined Y2H datasets as PRS set
CCSB-HI1 0.5800 9.30E-06 61802.2 2754 (100.00) 149 (5.41) 0.416 0.247 16.05 0.00
MDC 0.4300 8.80E-06 48210.8 2033 (100.00) 141 (6.94) 0.362 0.296 3.85 0.00
Bioverse-core 0.0075 1.80E-06 4150.8 36 (1.10) 29 (0.89) 0.891 0.554 88.57 24.14
HiMAP-core 0.0120 3.60E-06 3286.0 57 (0.65) 58 (0.66) 0.835 0.568 53.85 25.00
IntAct 0.0130 1.50E-05 857.4 60 (1.03) 234 (4.03) 0.752 0.369 50.00 6.22
HPRD-SS 0.0370 6.60E-05 560.5 176 (0.63) 1050 (3.76) 0.820 0.471 62.67 14.11
HomoMINT 0.0150 3.30E-05 460.6 73 (0.67) 530 (4.88) 0.825 0.302 53.33 0.88
HPRD-LS 0.0060 1.30E-05 451.0 29 (0.92) 215 (6.82) 0.553 0.361 30.43 4.64
HiMAP 0.0140 3.50E-05 410.5 69 (0.18) 562 (1.46) 0.817 0.573 53.23 8.85
Sanger-core 0.0130 3.30E-05 390.4 62 (0.56) 531 (4.77) 0.806 0.249 57.69 0.79
OPHID 0.0099 7.80E-05 126.4 47 (0.17) 1243 (4.40) 0.761 0.318 50.00 3.17
POINT 0.0390 4.30E-04 90.1 185 (0.19) 6867 (6.97) 0.84 0.302 59.62 1.34
Sanger 0.0180 2.60E-04 69.3 87 (0.13) 4196 (6.21) 0.802 0.273 54.17 0.97
Bioverse 0.0290 7.20E-04 40.7 140 (0.06) 11512 (4.92) 0.799 0.463 73.68 33.49
HPRD-random 0.0052 2.50E-04 20.8 25 (0.08) 4021 (12.99) 0.935 0.294 82.61 0.53
Random 0.0004 1.70E-04 2.5 2 (0.01) 2702 (9.01) 0.607 0.272 0.00 0.40
Table 3.6: Quality assessment using likelihood ratios. The human interaction datasets are ranked
by decreasing likelihood ratios (LR). The ratios TPR, FPR, and LR are computed using the positive
reference set (PRS) and the negative reference set (NRS). The PRS set consists either of HPRD-SS or
of the combined Y2H datasets. The number of PPIs in the overlap of the respective dataset with the
PRS or NRS sets, their average BPscore, and the percentage of DDI-validated PPIs are also listed.
CCSB-HI1 and MDC were used as substitutes of an ideal positive reference set
(PRS), which is not available yet for the human interactome. Also, a negative
reference set (NRS) was constructed from all possible 15,949,400 interactions be-
tween proteins annotated to localize in the cell nucleus with proteins to localize
in the membrane (Jansen et al., 2003). A likelihood ratio (LR) was calculated for
all datasets (Table 3.6). Additionally, the LR was plotted versus the number of
interactions in each dataset (Fig. 3.7).
Higher LRs indicate enrichment of a dataset with true positives in relation to
false positives, but the derived LR values can be taken only as a relative mea-
sure because the proportion of true positives in the PRS set is unknown. As can
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Fig. 3.7: Plots of the likelihood ratio (LR) vs. the number of interactions: (A) LR estimated using
HPRD-SS as PRS set, and (B) LR estimated using the combined Y2H datasets as PRS set.
be seen in Table 3.6, the rankings of the datasets by LR using either HPRD-SS
or the combined Y2H datasets are similar to each other and also to the rank-
ings based on the other applied quality measures. Like with the other rankings,
Bioverse-core, HiMAP-core, and HiMAP rank top and Sanger, POINT, CCSB-
HI1, MDC, and the randomized datasets rank at the bottom. The overlaps of
human PPI datasets with PRS sets exhibit both a high average BPscore and
an elevated number of DDI-validated PPIs when compared to the overall values
of each dataset (Table 3.5 and Table 3.6). Remarkably, these overlap values are
higher than the corresponding values for the PRS sets of HPRD-SS and the com-
bined Y2H datasets. This means that the PPIs in the overlaps seem to constitute
high-quality subsets of the respective PRS sets. In contrast, PPIs in the NRS
overlaps have a lower average BPscore and fewer DDI-veriﬁed PPIs than in the
PRS overlaps.
Bioverse-core and HiMAP-core have outstanding LR based on both HPRD-SS
and the combined Y2H datasets as PRS sets although they predict only 3,266
and 8,832 respectively (Table 3.6 and Fig. 3.7). In contrast, the complete Bioverse
dataset ranks drastically lower. Bioverse has an above-average BPscore (0.575)
and a high number of DDI-validated interactions (43.5%) with respect to the
other datasets, but it is ranked by LR near the bottom due to an exceptionally
high FPR. This may be caused by the primarily aim of Bioverse which is the
generation of a huge network containing many proteins and interactions to derive
functional predictions(McDermott et al., 2005). Nevertheless, the results show
that the overlap of Bioverse and the NRS set has an average BPscore of 0.463 and
33.5% of DDI-validated PPIs. Therefore, Bioverse predicts DDI-validated protein
interactions with high functional similarity, but many of those interactions may
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Dataset Number of
interactions
Average
BPscore
DDI-validated
PPIs in percent LR
PRS set
overlap (%)
NRS set
overlap (%)
IntAct (PA) 109 0.811 28.99 — 4 (3.67) 0 (0.00)
IntAct (X-ray) 160 0.777 85.29 11702.9 7 (4.38) 2 (1.25)
HPRD (3 pub.) 861 0.668 41.44 3343.7 16 (1.86) 16 (1.86)
HPRD (≥ 4 pub.) 497 0.668 48.31 1308.4 9 (1.81) 23 (4.63)
IntAct (≥ 4 pub.) 93 0.666 41.03 8359.2 5 (5.38) 2 (2.15)
IntAct (other) 605 0.660 31.88 3600.9 14 (2.31) 13 (2.15)
HPRD (2 pub.) 3048 0.654 33.10 1382.1 31 (1.02) 75 (2.46)
IntAct (Co-IP) 920 0.647 23.36 1800.4 14 (1.52) 26 (2.83)
IntAct (3 pub.) 192 0.637 20.25 6130.1 11 (5.73) 6 (3.13)
IntAct (2 pub.) 582 0.637 27.72 1671.8 7 (1.20) 14 (2.41)
HPRD (in vivo) 17417 0.611 22.84 462.2 98 (0.56) 709 (4.07)
HPRD (in vitro) 19616 0.603 25.63 649.7 130 (0.66) 669 (3.41)
HPRD (1 pub.) 26550 0.584 21.23 418.7 144 (0.54) 1150 (4.33)
HPRD (Y2H) 7964 0.554 17.17 1137.9 146 (1.83) 429 (5.39)
IntAct (1 pub.) 4942 0.515 13.64 583.6 37 (0.75) 212 (4.29)
IntAct (Y2H) 2289 0.493 14.69 1005.6 40 (1.75) 133 (5.81)
IntAct (TAP) 1993 0.457 5.25 45.2 1 (0.05) 74 (3.71)
Table 3.7: Comparison of HPRD and IntAct by number of publications and experimental technique. A
subset of protein interactions reported in exactly n publications is denoted by `n pub.' HPRD classiﬁes
experiments into three categories: in vivo, in vitro, and yeast two-hybrid. The IntAct classiﬁcation of
experimental techniques is based on a controlled vocabulary. Here, we regard only the most common
experimental techniques frequently found in IntAct: yeast two-hybrid (Y2H), tandem aﬃnity puriﬁca-
tion (TAP), co-immunoprecipitation (Co-IP), X-ray crystallography (X-ray), and protein array (PA).
All other techniques are labeled `other'. The datasets are ordered by decreasing BPscore.
be false, which suggests that Bioverse overpredicts considerably. This ﬁnding also
supports the approach introduced in this study of comparing human interaction
datasets with distinct quality measures in order to identify unfavorable biases of
diﬀerent kind in the datasets; the use of functional similarity or DDI validation
alone for the estimation of data quality could lead to misleading results.
When benchmarked against HPRD-SS, the experimental Y2H datasets CCSB-
HI1 and MDC as well as HPRD-LS rank in the lower half of the list of all datasets
due to a low number of PRS matches and a high number of NRS matches. This is
in agreement with the rankings obtained by the preceding assessments. Moreover,
the BPscores and the DDI-validation of the Y2H screens (Table 3.5) are similar
to those of the Y2H interactions in HPRD and IntAct (Table 3.7). Notably, the
CCSB-HI1 and the MDC interaction sets have similar FPR, but CCSB-HI1 has
about four times as many PPIs in the PRS set derived from HPRD-SS than MDC.
This reﬂects the trend found in the other quality assessments; the CCSB-HI1
dataset have scores that are better than the MDC dataset scores. Interestingly,
when benchmarked against the combined Y2H datasets, the LR values of HPRD-
SS (560.5) and IntAct (857.4) are closer to the LR values of some of the predicted
datasets, particularly HomoMINT (460.6). In contrast, much higher values are
obtained for the LRs of Bioverse-core (4,150.8) and HiMAP-core (3,286.0). This
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Fig. 3.8: Recall vs. precision plots using (let) HPRD or (right) the combined Y2H datasets as PRS
set. While recall equals the computed true positive rate (TPR = |Ei∩ PRS| / |PRS|), precision is
calculated by the following formula: |Ei∩PRS| / (|Ei∩ PRS|+ |Ei∩NRS|).
middle rank for HPRD-SS and IntAct agrees with the rankings obtained by the
other assessments described above. Since three diﬀerent quality measures give
similar results, this raises the question whether the literature-curated datasets
contain a surprisingly large fraction of false positives (Rual et al., 2005). A more
detailed analysis of those datasets indicates (Table 3.7) that protein interactions
supported by two or more publications achieve higher LR (above 1,300) mainly
due to a larger fraction of interactions that overlaps with the combined Y2H
datasets used as PRS. Interactions derived from X-ray crystallography, as anno-
tated in IntAct, have one of the highest LR (11,702) as well as a high average BP-
score (0.777) and a large number of DDI-validated interactions (85.29%). Those
values are comparable to the respective values of the top-ranking core datasets
in Table 3.5.
3.5.4 Recall and precision analysis
Precision values obtained by using the combined Y2H datasets CCSB-HI1 and
MDC as PRS appear much lower than the corresponding values obtained using
HPRD-SS as PRS, which is probably due to a considerable rate of false positives
in the Y2H screens (Fig. 3.8). In the recall vs. precision plot using HPRD-SS as
PRS, both HiMAP and OPHID datasets have much higher precision and recall
than datasets adjacent to them using the combined Y2H datasets as PRS. In the
case of HiMAP, it may be biased towards HPRD-SS because a previous release of
HPRD was originally used to evaluate the predicted PPIs of HiMAP. Remarkably,
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Dataset
Average
number of
neighbors
Maximum
number of
neighbors
γ of degree
distribution
Network
diameter
Average
shortest
path length
Average
clustering
coefficient
γ of clustering
coefficient
distribution
Bioverse 60.24 842 -1.1887 10 3.5035 0.4801 -0.1845
Bioverse-core 4.67 34 -1.7635 17 6.3159 0.5029 0.2160
HiMAP 13.26 159 -1.7441 18 5.1591 0.4401 -0.0965
HiMAP-core 6.09 44 -1.7982 26 9.3950 0.3156 0.1253
HomoMINT 4.95 68 -2.0799 12 4.9153 0.0650 -0.4486
OPHID 12.39 192 -1.4260 18 4.5375 0.1885 0.0904
POINT 16.26 522 -1.6927 10 3.5284 0.0889 -0.3508
Sanger 22.69 365 -1.4090 10 3.8715 0.2342 0.0039
Sanger-core 5.87 75 -1.8402 20 6.4511 0.1861 0.3704
CCSB-HI1 3.43 129 -1.5637 12 4.3581 0.0626 -0.7932
MDC 3.58 95 -1.5149 12 4.6248 0.0205 -0.8197
HPRD-LS 3.13 213 -1.3000 10 4.4327 0.0602 -1.1700
HPRD-SS 6.78 202 -1.8420 15 4.4627 0.1276 -0.4830
IntAct 3.83 181 -1.4450 18 5.1542 0.1022 -0.7890
Random 11.99 30 — 6 3.6986 0.0026 —
Table 3.8: Topological network parameters for each human protein interaction dataset. The degree
and clustering coeﬃcient distributions are ﬁtted to power laws with exponents γ.
the precision of the predicted datasets Bioverse-core and HiMAP-core is larger
than that of manually curated dataset HPRD-SS in the recall vs. precision plot
using the combined Y2H datasets as PRS, and the precision of the predicted
datasets Sanger-core, HiMAP, and HomoMINT are very close to the precision
of HPRD-SS. These interesting results suggest that predicted PPIs can be quite
reliable. The precisions of the two Y2H datasets using HPRD-SS as PRS are
signiﬁcantly diﬀerent (CCSB-HI1 with 0.389 versus MDC with 0.145).
3.5.5 Topological network analysis
Not only quality measures as detailed above, but also topological parameters
can be used to uncover potential bias in the networks formed by the diﬀerent
PPI datasets. The degree distribution, diameter, average shortest path length,
and clustering coeﬃcient (Shannon et al., 2003; Barabási & Oltvai, 2004) were
computed for all datasets (Table 3.8 and Fig. 3.9) except for HPRD-random,
which has the same topology as the complete HPRD (HPRD-SS and HPRD-LS)
by deﬁnition. The degree of a protein is deﬁned as the number of its interaction
partners. All networks (except for the random network) ﬁt a scale-free degree
distribution (Barabasi & Albert, 1999), which means that the probability P (k)
of proteins with k interactions decays as a power law: P (k) kλ. In the analysis, the
value of the exponent λ lies between -1.1887 and -2.0799 for all (non-randomized)
networks. However, the average number of neighbors varies considerably between
the datasets from 3.13 for HPRD-LS to 60.24 for Bioverse. The average clustering
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Fig. 3.9: Degree distributions together with the exponent λ of the ﬁtted power law.
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coeﬃcient, a measure of interaction density, also exhibits signiﬁcant diﬀerences
ranging from 0.0205 of MDC to 0.5029 of Bioverse-core.
To highlight the numeric diﬀerences the degree distributions are depicted not
only as plots of the number of interactions versus the number of proteins, but also
as 2D histograms, in which each axis represents the number of neighbors for one of
the two interacting proteins (Fig. 3.10). The 2D histograms particularly allow for
the visual identiﬁcation of further bias in the datasets. The HPRD-SS histogram
displays a high density of interactions between proteins with 1 to 10 neighbors,
and proteins with a large numbers of neighbors tend to interact preferentially
with proteins with few neighbors as expected from a scale-free network topology.
In detail, the CCSB-HI1, HomoMINT, HPRD-LS, HPRD-SS, IntAct, and MDC
display similar histograms (see Fig. 3.9 and Fig. 3.10). The HiMAP histogram also
resembles the HPRD-SS histogram except for the fact that interactions between
proteins of high degree are surprisingly frequent. For example, a cluster of 64 fully
connected proteins was identiﬁed, each protein having 101 interaction partners
for a total of 2,016 interactions ). All these proteins are members of the potassium
channel family and their amino acid sequences are closely related.
In general, the 2D histograms of the predicted datasets Bioverse-core, HiMAP-
core, HiMAP, OPHID, POINT, Sanger, and Sanger-core show an unexpected
abundance of interacting proteins with high degrees in contrast to the experi-
mental datasets CCSB-HI1, HPRD-LS, HPRD-SS, IntAct, and MDC. Hence, it
appears that, even though the networks of the predicted datasets are generally
scale-free, they contain some unfavorable bias towards interacting proteins with
numerous neighbors.
The frequencies of interactions in terms of protein length was analyzed in
addition to the computation of network parameters, (Fig. 3.11). However, no
particular bias in the datasets towards certain protein lengths was found. The
only exception is the HiMAP dataset that is inexplicably enriched with proteins
whose lengths exceed 750 amino acids.
3.5.6 Shared neighbors
As part of the topological analysis a new a graph measure called shared-neighbors
(SN) was deﬁned and integrated as part of the NetworkAnalyzer (Assenov et al.,
2008) plug-in for Cytoscape. The SN measure represents the count of the number
of directly connected nodes in common between any two nodes in a network.
Formally, for a network G with node set V and edge set E ⊆ V × V , the shared
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Fig. 3.10: 2-D histograms of degree frequency. The dot colors in the histograms reﬂect the number of
occurrences of two interacting proteins with speciﬁc degrees (number of interactions). The maximum
number N of occurrences in each dataset is given above the histograms; the notation max=N [X,Y]
refers to two interacting proteins of degrees X and Y.
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Fig. 3.11: 2D histograms of the distribution of PPIs according to the length of interacting proteins
binned in steps of 50 amino acids. Each human interaction dataset is depicted by a triangle matrix whose
axes represent the sequence lengths of interacting proteins. The dot color in the histograms reﬂects the
protein interaction density that is the ratio of the number of PPIs assigned to the respective matrix cell
divided by the total number of PPIs possibly formed; the total number of possible PPIs was derived
by counting the members of the respective protein length bin, and the density was normalized to 1,000
possible PPIs. The protein interaction density is not shown if the observed number of PPIs is non-
signiﬁcant (p-value ≥ 0.01, using Fisher's exact test as in case of the overlap computation). The matrix
entitled `MDC fragment length' was derived using the actual lengths of the protein fragments as used
in the Y2H screen in contrast to the matrix `MDC' whose proteins lengths belong to complete protein
sequences as in case of all other datasets.
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Fig. 3.12: Interolog mapping when multiple homologs of the original protein exist. The nodes A and
B represent proteins that are known to interact in one species (e.g. Caenorhabditis elegans). The nodes
A1-A4 are homologs of A, and the nodes B1-B3 homologs of B in other species (e.g. Homo sapiens). If
all possible combinations of interacting homologs are considered, any two homologs of A will share all
homologs of B as interacting neighbors and vice versa.
neighbors SN (v, w) for two nodes v, w ∈ V is given by
SN (v, w) = |{i ∈ V |(i, v) ∈ E & (i, w) ∈ E}|
SN can also be described as the number of paths of length two that connect a
pair of nodes.
In a molecular evolution context, pairs of proteins that share several neighbors
may arise by gene duplication events (Wagner, 2001; Barabási & Oltvai, 2004).
Before further divergence of the duplicated gene product, it would interact with
the same neighbors of the original gene product. After divergence, only some of
the neighbors may still be shared by both the duplicate and the original gene
products. Using the SN measure together with sequence identity can help to
uncover such evolutionary events. The measure can also help to detect funtionally
related proteins because it is known that they tend to share common interaction
partners.
In this analysis, the SN measure was primarily used to detect possible bias in
the topology of predicted protein interaction networks derived by the interolog
mapping method. This mapping method might result in an erroneously predicted
combinatorial expansion of new interactions if several homologs are found for each
of the proteins involved in the original interaction (Fig. 3.12). For example, if
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Fig. 3.13: Combinatorial expansion due to interologs mapping. Two original interactions (A) were
mapped in Bioverse to 317 PPIs between 27 proteins (B). In (B), the circle on top consists of cyclin-
dependent kinases derived by (1), while the proteins on the bottom are tyrosine kinases derived from
protein (2). This dense cluster proteins was revealed by the shared neighbors analysis.
some original interaction exists between proteins A and B with 4 and 3 homologs,
respectively, 12 new interactions could be derived (Fig. 3.2). Notably, any two
proteins homologous to A would share all proteins homologous to B and vice
versa.
A special case occurs if the original interaction is a homodimer represented as
self-loop. The interolog mapping of this self-loop may result in many interactions
between all homologs because any pair of interacting proteins will share all ho-
mologs as interacting neighbors (Fig. 3.13). The detection of the shared neighbors
for every pair of nodes in a predicted network would indicate whether a serious
problem with the network exists. Another approach to detect the same problem
would be the determination of all paralogous proteins in the network and the sub-
sequent check if they share the same neighbors. Although this alternative method
is possibly more precise, it would require additional information not contained in
the network itself. In this context, it is of interest that the Bioverse dataset has
been derived by allowing the mapping of even low-similarity proteins with the
aim of providing a very large dataset for further functional analyses (McDermott
et al., 2005). Accordingly, Bioverse overpredicts many PPIs and contains a large
number of false positives as reﬂected by Fig. 3.10 and revealed as well by the
quality assessment using the likelihood ratio.
The frequencies of shared neighbors are plotted in Fig. 3.14. In case of the
largest dataset Bioverse, there are pairs of proteins that share hundreds of neigh-
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Fig. 3.14: Frequency distribution of shared neighbors numbers. The histograms highlight some biases
in the predicted datasets which tend to have elevated frequencies for certain numbers shared neighbors.
For instance, in the case of HiMAP there are two bars having a frequency over 1,000 that correspond
to 69 and 97 shared neighbors.
bors (up to 817 neighbors) and thousands of pairs that share between 1 to 150
neighbors. Thus, Bioverse tends to overpredict due to low-similarity interolog
mappings as the one exempliﬁed in Fig. 3.13. In comparison pairs of proteins shar-
ing more than 50 neighbors are rare for the manually curated datasets HPRD and
IntAct and for the Y2H datasets, CCSB-HI1 and MDC, where a pair of proteins
rarely shares more than 20 neighbors.
Apart from Bioverse, other predicted datasets are found to contain large
amounts of shared proteins compared to the experimental datasets (Fig. 3.15).
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Fig. 3.15: Distributions of the number of shared neighbors in the diﬀerent datasets. Only numbers of
shared neighbors larger than two were included.
Large average neighborhood sizes also occur in the core datasets, but the max-
imum values are comparable to those in the Y2H datasets. Interestingly, Ho-
moMINT and POINT are the datasets that most closely resemble the experi-
mental data.
3.5.7 Comparison with manually curated datasets
To analyze the reliability of the protein interactions in the literature-curated
datasets further, the interactions in HPRD and IntAct were subdivided by the
number of publications reporting them and by the experimental technique (Ta-
ble 3.7). The in vivo and in vitro classiﬁcations of HPRD obtain similar scores in
all assessments, indicating that their reliabilities are similar. It is also apparent
that the more publications support a protein interaction, the higher are its scores.
Interestingly, PPIs derived from protein arrays have the highest BPscore (0.811)
and do not overlap with the NRS. However, this could be misleading because
all those PPIs come from the same publication. Moreover, as expected, X-ray
crystallography returns a very high number of DDI-validated PPIs (85.29%). In
contrast, the protein interactions derived from tandem aﬃnity puriﬁcation (TAP)
have the lowest overlap with the combined Y2H datasets (only 1 interaction), and
the number of DDI-validated interactions is the smallest (5.25%). Furthermore,
the Y2H interactions contained in HPRD and IntAct have a BPscore and frac-
tion of DDI-validated interactions similar to that of the Y2H dataset CCSB-HI1.
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Datasets such as HPRD in vivo and in vitro listed in Table 3.7 have higher BP-
score and number of DDI-validated interactions, but lower LR (using the com-
bined CCSB-HI1 and MDC datasets as PRS) than those Y2H interactions in
HPRD and IntAct. This might be explained by the idea that Y2H screens can
detect interactions not found by other methods.
3.5.8 Predicted interactions based on high-throughput data
PPIs in predicted human datasets are primarily derived from interologs using
high-throughput data (Table 3.2). For instance, the DIP database, used by Bio-
verse and POINT, contains 80% of PPIs detected by high-throughput experi-
ments. A similar portion is contained in MINT causing that only 6% of the PPIs in
HomoMINT are derived from small-scale experiments. The assessments also show
that predicted datasets such as Sanger derived solely from high-throughput exper-
iments perform similar to Y2H screens. Other predictions such as HomoMINT,
OPHID, and POINT that utilized many high-throughput interologs and rela-
tively few from small-scale experiments score only slightly better. The Sanger-
core dataset, which is based on interologs reported in more than one publication,
achieves higher assessment scores than the Sanger dataset. However, the Sanger-
core values of BPscore, DDI-validation, and LR assessment are still similar to
those of HomoMINT, OPHID, and POINT. The HiMAP datasets, which do not
only rely on interologs, achieve better performance are revealed by the assessment
results. The outstanding scores of Bioverse-core may be due to the inclusion of
PPIs from X-ray crystallography and, in contrast to Bioverse, due to the ap-
plication of a stringent sequence similarity threshold for establishing orthology.
Therefore, the results reported here suggest that predictions based on interolog
mapping can be as good as the original data used to derive them and even better
if appropriate ﬁlters and methods are additionally employed.
3.6 Summary
The quality of several comprehensive human protein interaction datasets was
compared and assessed based on diﬀerent criteria. This quantitative and qual-
itative analysis included six predicted datasets and three high-conﬁdence core
subsets, two literature-curated datasets, and two high-throughput Y2H datasets.
This analysis was based on the functional similarity of interacting proteins, the
validation of PPIs using structurally known protein domain interactions, and the
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evaluation of the contents of the datasets against positive and negative refer-
ence sets of PPIs. Also, the diﬀerent interaction sets were ranked based on the
scores assigned by the applied quality measures. Finally, the interaction network
topologies resulting from the datasets was investigated.
In summary, the ﬁndings reported here indicate that the datasets Bioverse-
core and HiMAP-core of predicted PPIs contain high-quality data in comparison
to other predicted datasets. The proposed assessments also support the view that
many PPIs of predicted datasets appear to be at least as reliable as the results
of Y2H screens. Therefore, it is useful to combine predicted and experimental
datasets to increase the coverage of the human interactome. This is particularly
important if one wants to use human networks in the context of diseases. However,
it is important to keep in mind that each dataset, even the literature-curated
datasets, (i) may have been optimized for one or the other quality measure, (ii)
contains a signiﬁcant amount of low-quality data, and (iii) seems to be biased
towards certain biological functions. For instance, DDI-validation may be biased
because Bioverse utilized structural information from PDB. Also, HiMAP inferred
PPIs from predicted DDIs and used GO-based functional similarity as well as an
older version of HPRD (August 2004, 17,462 interactions).
Presumably, the observed diversity of the datasets is mainly due to the dis-
tinct data sources used for the predictions and details of the interolog mapping
procedure. Nevertheless, the detected low overlap of datasets means that the
datasets can complement each other well. To this end, it would be helpful that
conﬁdence values are assigned to PPIs and that interaction datasets are carefully
described with methodological details and the original data sources. Moreover,
it was found that the examination of network topologies aids in the identiﬁca-
tion of further bias and artifacts produced by the prediction methods. However,
the discovered topological diversity also advises caution against possible misin-
terpretations when using topological parameters derived from the current human
datasets in biological applications.

4Analysis of Human Scaffold Proteins
This chapter describes the use of the integrative data warehouse for the com-
putational identiﬁcation of scaﬀold proteins (Ramírez & Albrecht, 2010), an im-
portant type of gene products involved in signaling cascades whose function is
the organization of higher order complexes through proteinprotein interactions.
The published results represent the ﬁrst attempt to estimate the number and
abundance of these proteins in the human proteome (Alexa et al., 2010). Before
this study, scaﬀold proteins were only identiﬁed fortuitously through direct ex-
perimentation. The identiﬁcation of scaﬀold proteins was possible thanks to the
cross linking of protein function, biological processes and protein-protein interac-
tions from diﬀerent public sources. This approach proves the advantages of local
data storage to cross link diverse sources of information.
4.1 Introduction
Signaling cascades determine how the cells respond to changes in their external
and internal environment. A multitude of signaling proteins with a broad sub-
strate speciﬁcity are in charge of mediating the signaling process. Thus, it is of
immense importance to understand how the cell achieves eﬃciency and accuracy
in signaling (Buday & Tompa, 2010). Scaﬀold proteins are a recently described
category of molecules inﬂuencing cellular signaling ﬁrst described in yeast by
Choi et al. (1994). Scaﬀold proteins bind to multiple enzyme or receptor proteins
although they itself are devoid of any catalytic activity. Their main role is to
colocalize several members of a catalytic pathway to speciﬁc areas of the cell
(Shaw & Filbert, 2009) and to permit a better ﬁne tuning of regulatory processes
through the coordination of positive and negative feedbacks. Because scaﬀold
proteins separate catalysis from molecular recognition, catalytic molecules can
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Fig. 4.1: Scaﬀold proteins bind to multiple signaling molecules simultaneously. They increase the ef-
ﬁcacy of a signaling pathway and help to localize signalling molecules to a speciﬁc cell compartment.
Scaﬀold proteins also regulate signal transduction by coordinating positive and negative feedback sig-
nals, and insulate binding partners from competing proteins. Image inspired by Shaw & Filbert (2009);
Zeke et al. (2009).
be re-used in distinct pathways by coupling with diﬀerent scaﬀold proteins while
avoiding cross-signaling (Bhattacharyya et al., 2006). Locasale et al. (2007) have
also indicated that scaﬀold proteins protect binding signalling molecules from
inactivation by phosphatases or from degradation (Fig.4.1).
Although scaﬀold proteins are considered fundamental to signaling process,
their identiﬁcation by sequence similarity methods have proven to be diﬃcult
they appear not to be evolutionarily related. Instead, it is supposed that scaﬀold
proteins have originated independently several times during the evolution of sig-
nalling systems and, as consequence, share little sequence identity (Zeke et al.,
2009). For this reason, scaﬀold proteins are mainly discovered fortuitously while
studying the function of well-known signaling proteins. To faciliate the discovery
of scaﬀold proteins Zeke et al. (2009) proposed an interaction-based deﬁnition to
systematically identify potential scaﬀold candidates in interactomes. This deﬁni-
tion is based on three common properties of scaﬀold proteins: (i) lack of intrinsic
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catalytic activity relevant for signaling, (ii) direct interaction with at least two
signaling proteins possessing catalytic or receptor activity (referenced here as
CRPs), and (iii) direct or indirect interaction of at least two CRPs with each
other. Because some scaﬀold proteins have properties (ii) and (iii) while having
some catalytic activity, the term classical scaﬀold proteins is used for those cases
having property (i) as well.
To explore this deﬁnition a comprehensive search for scaﬀold candidates using
the data warehouse was implemented. As a result, a reliable set of 250 candidate
scaﬀold proteins was identiﬁed. This proves that current public databases can be
eﬃciently mined using data warehouses to extract useful information otherwise
diﬃcult to obtain, as in the case of scaﬀold proteins.
4.2 Computational identification of scaffold
proteins
Using the Gene Ontology (GO) annotations as well as UniProtKB keywords,
3,185 human intracellular proteins involved with signal transduction were ini-
tially selected. From this list of signaling proteins, those fulﬁlling criterion (i)
were further selected. Besides a lack of catalytic activity, the ﬁrst criterion was
extended to exclude proteins known to bind nucleic acids, related to translation,
having receptor activity, being GTPase regulators or that are chaperons. Using
this extended criteria (i) a list of 649 proteins, referred here as special signaling
proteins (SSPs), was obtained.
Out of 9,814 proteins with at least two interacting proteins in the integrative
data warehouse, 282 interact with at least two CRPs according to property (ii).
Applying property (iii) reduces this number further to a ﬁnal set of 250 scaf-
fold candidates. A high-conﬁdence subset of 130 candidates was obtained by only
considering reliable SSP-CRP interactions reported in at least two scientiﬁc pub-
lications listed in PubMed. This threshold was based on the conclusions obtained
in the previous chapter. Self-interactions were ignored and indirect interactions
between two proteins were assumed to occur if both proteins bind another CRP.
Each scaﬀold candidate is found to interact on average with 9 CRPs and with
32 proteins overall. The high mean number of scaﬀold candidate binding partners
and the limited number of binding sites available for any protein suggests that
many scaﬀold candidates form various interaction platforms depending on cell
type, tissue speciﬁcity, location and time (Bhattacharyya et al., 2006). Alternative
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protein description gene symbol disease
cAMP-dependent protein kinase
type I-alpha regulatory subunit
PRKAR1A Intracardiac myxoma, primary pigmented nodular adrenocortical
disease 1 (PPNAD1), papillary thyroid carcinoma, type 1 carney
complex (CNC1)
Axin-1 AXIN1 Caudal duplication anomaly, hepatocellular carcinoma
SH3 domain-binding protein 2 SH3BP2 Cherubism
Keratin, type I cytoskeletal 18 KRT18 Familial cirrhosis
Alpha-synuclein SNCA Autosomal dominant lewy body parkinson disease 4 (PARK4),
familial parkinson disease type 1(PARK1), lewy body dementia
(DLB)
Suppressor of cytokine signaling 3 SOCS3 Atopic dermatitis 4 (ATOD4)
Insulin receptor substrate 1 IRS1 Noninsulin-dependent diabetes mellitus (NIDDM)
C-jun-amino-terminal
kinase-interacting protein 1
MAPK8IP1 Noninsulin-dependent diabetes mellitus (NIDDM)
NF-kappa-B inhibitor alpha NFKBIA Ectodermal dysplasia with t-cell immunodeficiency
CD2-associated protein CD2AP Focal segmental glomerulosclerosis 3 (FSGS3)
Huntingtin HTT Huntington disease (HD)
Nucleotide-binding oligomerization
domain-containing protein 2
NOD2 Blau syndrome, early-onset sarcoidosis, inflammatory bowel dis-
ease 1 (IBD1), susceptibility to psoriatic arthritis, susceptibility to
sarcoidosis 1 (SS1)
Caveolin-1 CAV1 Congenital generalized lipodystrophy type 3 (CGL3)
Adenomatous polyposis coli
protein
APC Adenomatous polyposis of the colon (APC), colorectal cancer
(CRC), gastric cancer, hereditary desmoid disease, medulloblas-
toma (MDB), mismatch repair cancer syndrome
14-3-3 protein epsilon YWHAE Miller-dieker lissencephaly syndrome (MDLS)
Na(+)/H(+) exchange regulatory
cofactor NHE-RF1
SLC9A3R1 Hypophosphatemic nephrolithiasis/ osteoporosis 2
Nephrin NPHS1 Congenital nephrosis finnish type 1 (NPHS1)
Sequestosome-1 SQSTM1 Paget disease of bone; pdb
Gap junction alpha-1 protein GJA1 Atrioventricular septal defect (AVSD), autosomal recessive ocu-
lodentodigital dysplasia, Hallermann-Streiff syndrome (HSS),
hypoplastic left heart syndrome, oculodentodigital dysplasia
(ODDD), syndactyly type 3
Hamartin TSC1 Focal cortical dysplasia of taylor (FCDT), lymphangioleiomy-
omatosis (LAM), tuberous sclerosis (TS)
Table 4.1: High conﬁdence scaﬀold candidates associated with inherited diseases (OMIM). Proteins
referred to scaﬀold or adaptor in the scientiﬁc literature are highlighted in bold. Those highlighted
proteins were found during the posterior validation of the scaﬀold candidates.
splice variants and their interaction patterns may also play an important role and
might have to be distinguished in the future to characterize scaﬀold candidate
complexes further. Notably, 35 scaﬀold candidates (14%) of all identiﬁed 250
scaﬀold candidates are already known to be contained in protein complexes, and
at least 184 scaﬀold candidates interact directly with each other, on average
with 3 other scaﬀold candidates, pointing to the possible formation of larger
supramolecular scaﬀold complexes (Fig. 4.3).
The obtained set of scaﬀold candidates is statistically enriched for speciﬁc
GO-based molecular functions, biological processes, and cellular components
(Fig. 4.2), some of which may be used to categorize scaﬀold candidates fur-
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Fig. 4.2: Enrichment of Gene Ontology annotations and Pfam families. The four histograms show
signiﬁcantly enriched Gene Ontology annotations and Pfam domain families for the 250 potential
scaﬀold proteins in comparison to all human signaling proteins found in this study (p-value < 0.001).
The x-axis represents the absolute number of potential scaﬀold proteins belonging to the respective
category.
ther. For instance, various metabolic and regulatory processes are signiﬁcantly
overrepresented in the scaﬀold candidate set compared to all signaling proteins.
Interestingly, 30 scaﬀold candidates are annotated as having `molecular adaptor
activity', out of 52 human proteins having such annotation. Indeed, GO deﬁnes
adaptor proteins as molecules having binding activity `that brings together two
or more molecules, permitting those molecules to function in a coordinated way'
and may be regarded as a subset of scaﬀold proteins (Zeke et al., 2009). Further
scaﬀold candidate characterization may also consider the protein domain com-
position because scaﬀold candidates and their interaction partners are frequently
enriched with certain Pfam domain families like PH as well as PDZ and SH2/SH3
used for signal transduction (Fig. 4.2) (Schelhorn et al., 2008; Pawson & Nash,
2003). In table 4.1 20 high-conﬁdence scaﬀold candidates that are associated with
inherited diseases are listed. In seven cases the involved proteins were associated
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scaffold protein identified in the study? reason criteria not fulfilled
KSR1 no annotated as catalytic (i)
KSR2 no annotated as catalytic (i)
JIP1 yes, high-confidence
JIP2 yes, high-confidence
JIP3 yes, high-confidence
JIP4 no not annotated as signaling
protein
(i)
β-arrestin 2 yes, high-confidence
Paxillin yes
Gab1 yes, high-confidence
Gab2 no protein without annota-
tions
(i)
Gab3 no protein without annota-
tions
(i)
PSD95 yes, high-confidence
Homer1 yes, high-confidence
Homer2 yes
Homer3 no catalytic binding partners
not known to interact.
(iii)
mAKAP no not annotated as signaling
protein
(i)
AKP79 yes, high-confidence
RACK1 yes, high-confidence
Table 4.2: Classical scaﬀold proteins used as validation set. The list, introduced by Zeke et al. (2009),
contained the best known human scaﬀold proteins at the time of the publication. The column `identiﬁed
in study?' shows whether the known scaﬀold was found in the computational search. High-conﬁdence
refers to the list of 130 scaﬀold candidates found by using a more stringent criteria for reliable protein-
protein interactions. Out of 18 known scaﬀold proteins, 10 were found in our study, eight of those in
the high-conﬁdence set.
with more than one disease. The gene product GJA1, for example, is associated
to six diﬀerent conditions.
4.3 Validation of scaffold candidates
The computational results were compared with a list of 18 human well studied
classical scaﬀold proteins published by (Zeke et al., 2009). The interactome search
found 10 of the 18 examples, eight of them in the high-conﬁdence set. The re-
maining eight proteins are missing for diﬀerent reasons: Homer3 does not have
property (iii) which may be just due to insuﬃcient interaction data in the cu-
rated databases; the other seven scaﬀold proteins could not be found in the search
because the required GO annotation or UniProtKB keyword was not present in
case of property (i). This is not surprising because the coverage of protein an-
notations is not complete (Fig. 5.4A). In detail, KSR1/2 are annotated with a
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Fig. 4.3: Huntingtin (Htt) interaction network with scaﬀold and adaptor proteins. Htt binds to a
number of scaﬀold and adaptor proteins forming supramolecular scaﬀold complexes.
debatable kinase activity (Kolesnick & Xing, 2004), JIP4 and RACK1 are not
annotated as being involved in signaling transduction, mAKAP is involved in
protein targeting, but not in signal transduction according to GO, and GAB2 as
well as GAB3 are not annotated at all (Table 4.2). All of the validated scaﬀold
candidates, except of GAB1 are annotated as membrane proteins, which agrees
well with the fact that 133 scaﬀold candidates (53%) are located to membranes
according to GO.
PubMed was searched for published abstracts containing the scaﬀold candidate
name, symbol or some synonym together with the words "scaﬀold*" or "adap-
tor". For 208 scaﬀold candidates (83%), at least one matching abstract could be
retrieved. Manual inspection of the abstracts for 50 of those candidates (20%)
conﬁrmed that many of them were referred to as scaﬀold or adaptor proteins in
the literature for over 70% of the studied cases (Table 4.3 and supplementary
Table A).
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symbol type pubmed id text snippet
AKAP12 scaffold 17686059 A-kinase anchor protein 12 (AKAP12) is a scaffold protein that partic-
ipates in mitotic regulation and others signalling processes and proba-
bly exerts tumour suppressor function.
scaffold 16442664 A-kinase anchoring proteins (AKAPs) define an expanding group of
scaffold proteins that display a signature binding site for the RI/RII
subunit of protein kinase A.
scaffold 17626016 SSeCKS (Src-suppressed C kinase substrate), also called
gravin/AKAP12, is a large scaffolding protein with metastasis
suppressor activity.
and others
EFS (SYN) scaffold 11867627 Instead, the pathway involved relies on increased tyrosine phosphory-
lation of, and recruitment of Crk to, the SRC substrate SIN/EFS. The
latter is a scaffolding protein structurally similar to the SRC substrate
Cas
scaffold 18256281 For over a decade, p130Cas/BCAR1, HEF1/NEDD9/Cas-L, and
EFS/SIN have defined the Cas (Crk-associated substrate) scaffold-
ing protein family.
HTT scaffold 12881483 We propose that HTT, together with HAP1, may function as a scaffold
for the activation of ND by MLK2.
scaffold 19269181 Overall, the predicted structure of huntingtin is consistent with a cel-
lular role as a scaffold protein.
scaffold 19429504 Unexpectedly, the faulty gene product, mutant huntingtin (mtHtt), is an
extremely large protein of 350 kDa and might act as a scaffold protein
regulating vesicle and organelle trafficking and signaling pathways.
INADL
(PATJ)
scaffold 17234746 Here we report, using a two-hybrid assay, a direct molecular interaction
between TSC2 C-terminal part and PDZ 2 and 3 of PATJ, a scaffold
member of the Crumbs 3 (CRB 3) complex in human intestinal epithe-
lial cells, Caco2.
scaffold 16697075 One evolutionarily conserved protein complex, which can be found
both in Drosophila and mammalian epithelial cells, is composed of
the transmembrane protein Crumbs/Crb3 and the scaffolding proteins
Stardust/Pals1 and DPATJ/PATJ, respectively, and localise
scaffold 15863617 A unified assembly mode revealed by the structures of tetrameric L27
domain complexes formed by mLin-2/mLin-7 and PATJ/Pals1 scaffold
proteins. AXIN1 almost all references mention it as a Scaffold
NPHS1
(Nephrin)
scaffold 18480178 Nephrin, an essential adhesion and scaffolding molecule expressed
in podocytes, emerged in this screen
scaffold 19443634 Within the glomerulus, the scaffolding protein nephrin bridges the
actin-rich foot processes that extend from adjacent podocytes to form
the slit diaphragm
PIK3R1
(p85)
scaffold 17024187 We show that p85 acts as a scaffold to bind Cdc42 and septin 2 si-
multaneously. p85 is thus involved in the spatial control of cytosolic
division through regulation of Cdc42 and septin 2, in a PI3K-activity
independent manner.
TANK scaffold 18353649 Recent data provide insight into the requirement for scaffold pro-
teins in complex assembly; NF-kappaB essential modulator coordi-
nates some IKK complexes, whereas TANK, NF-kappaB-activating
kinase-associated protein 1 (NAP1) or similar to NAP1 TBK1 adaptor
scaffold 17823124 we have identified TANK as a scaffold protein that assembles some
but not all IRF3/7-phosphorylating TBK1-IKKepsilon complexes
Table 4.3: Literature review of seven scaﬀold protein candidates obtained by our interactome search.
The complete table containing the literature review of all candidates manually inspected appears in
appendix A. Symbol: NCBI gene symbol; type: the protein is refereed to as `scaﬀold', `adaptor' or both
in the literature; pubmed id: NCBI PubMed identiﬁer; text snippet: extract from the abstract where a
description of the scaﬀold candidate is found.
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4.4 Huntingtin as scaffold protein
Huntingtin (Htt) is a multifunctional human protein involved in diverse cellular
processes such as synaptic signaling, transcriptional regulation, anti-apoptotic ac-
tivity, and vesicular traﬃcking (Caviston & Holzbaur, 2009; Imarisio et al., 2008).
A pathogenic expansion of the polyglutamine repeat region in the Htt sequence is
implicated in the neurodegenerative disorder Huntington's disease. Htt was iden-
tiﬁed as scaﬀold candidate in the computational search, and further literature
review conﬁrmed this ﬁnding. For instance, Htt is reported to act as scaﬀold pro-
tein by mediating the complex formation of the mitogen-activated protein kinase
kinase kinase 10 (MAP3K10), a JNK signaling pathway protein, and NeuroD,
a transcription factor (Marcora et al., 2003). In this protein complex, Htt binds
indirectly to NeuroD via the huntingtin-associated protein 1 (HAP1). Further-
more, Htt functions as scaﬀold when coordinating the binding of motor proteins
to vesicular cargo (Caviston & Holzbaur, 2009). Generally, Htt is known to inter-
act with dozens of proteins and at least ten CRPs including MAP3K10. Thus, Htt
may play a pronounced role as scaﬀolding protein in multiple signaling pathways.
Interestingly, Htt also associates with other signaling scaﬀold proteins like DLG4,
GIT1, ITSN and TRIP10 and the adaptor GRB2, the latter of which interacts
indirectly with other scaﬀold and adaptor proteins (Fig. 4.3). This observation
may particularly point to the formation of supramolecular scaﬀold complexes
containing Htt.
4.5 Summary
Using the deﬁnition proposed by Zeke et al., hundreds of human scaﬀold can-
didates were discoverd whose functional properties agree well with known scaf-
fold proteins. Nevertheless, experimental veriﬁcation and manual curation is still
needed. Based on the analysis, is estimated that the false positive and negative
rates of our results are below 4050%, but exact rates are diﬃcult to obtain. Con-
sidering these rates, ∼ 300 proteins may be a ﬁrst rough estimate of the overall
number of scaﬀold proteins in the human proteome.
Further reﬁnements of the molecular characteristics of scaﬀold proteins as well
as qualitative and quantitative advances in gene and protein function annotation
may result in an even more reliable list of scaﬀold candidates. However, an im-
portant note of caution is that the overall amount of currently available protein
interaction data for human is still small and of diﬀering quality (Zeke et al.,
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2009; Ramírez et al., 2007), which currently limits complete interaction-based
searches for scaﬀold candidates. Apart from that, while the computational search
used pairwise protein interactions because of the original deﬁnition given by Zeke
et al., whole scaﬀold complexes including stoichiometric data may also be iden-
tiﬁed experimentally by recent mass spectrometry-based techniques or found in
existing datasets of protein complexes using a deﬁnition similar to that of scaﬀold
candidates.
5Novel Search Method for the Discovery of
Functional Relationships
This chapter describes a novel search method for the discovery of biological re-
lationships based on the similarity of gene and protein annotations (?). This
method allows to quickly scan the data warehouse for genes or proteins that are
similarly annotated.
By using this novel method, called BioSim, the warehouse can now be interro-
gated in novel ways, for example to identify new gene-disease associations based
on known associations as will be shown in this chapter.
The BioSim method also facilitates the development of derived applications
such as the clustering of genes and proteins by function or the assessment of
protein-protein interactions which are discussed in the next chapter. These appli-
cations have a growing demand caused by the popularization of high-throughput
techniques in order to analyze and prioritize the resulting lists of genes and pro-
teins.
5.1 Introduction
Similarity search plays an important role in biological, pharmaceutical, and med-
ical investigations. For instance, the introduction of the BLAST algorithm by
Altschul et al. (1990) to search for similar sequences is considered a milestone
in genomics (Bahcall, 2007), and similarity search methods to mine databases of
three-dimensional molecule conformations have been important for drug discov-
ery (Willett et al., 1998). Presently, the growing availability of annotations that
characterize genes and proteins (Reeves et al., 2008) opens the new possibility
to ﬁnd biological relationships by similarity searches based on function, domain
composition, disease association, tissue expression, etc. For example, the iden-
tiﬁcation of similarly annotated genes and proteins can reveal new gene-disease
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associations (Aerts et al., 2006), suggest novel protein functions (Friedberg, 2006),
and indicate new drug targets (Chan et al., 2010).
In general, similarity searches compute pairwise similarities of a query with
the entities in a database to obtain a ranked list of high-scoring similarities. In
particular, a number of methods have been proposed for the quantiﬁcation of
pairwise similarities of gene and protein annotations. Most of those functional
similarity methods are based on Gene Ontology (GO) annotations (Chabalier
et al., 2007; del Pozo et al., 2008; Speer et al., 2004; Sevilla et al., 2005; Lord
et al., 2003; Popescu et al., 2006; Schlicker et al., 2006; Lerman & Shakhnovich,
2007; Mistry & Pavlidis, 2008; Pesquita et al., 2008; Benabderrahmane et al.,
2010). However, the last years have shown a dramatic growth in datasets that
result from high-throughput experiments and computational work and yield an-
notation sources that provide manifold information about, for instance, protein
interactions, signaling circuits, metabolic pathways, cellular localization, tissue
expression, disease associations, and protein domain architecture. Currently, only
one similarity search method explicitly takes multiple annotation sources into
account, namely, the kappa coeﬃcient used by the DAVID Gene Functional Clas-
siﬁcation Tool (Huang et al., 2007). In contrast, the integration of multiple an-
notation sources into a network structure is often applied in the context of gene
function prediction (Huttenhower et al., 2009; Warde-Farley et al., 2010; Wang
& Marcotte, 2010).
When developing eﬃcient methods for searching through gene and protein
annotation data, a particular task is the construction of data structures that
represent the annotations. Most methods rely on the graph structure of GO
to estimate quantitative semantic relationships among the gene/protein anno-
tations (Pesquita et al., 2009). However, the GO structure limits the inclusions of
non-ontological (i.e., non-GO) annotations into methods. A ﬂattened representa-
tion of the GO hierarchy solves this problem by storing the annotations as Boolean
arrays in which the presence and absence of annotations is recorded (Huang et al.,
2007). This representation implicitly contains the ontological relations and allows
for the inclusion of non-ontological annotations as part of the array. This avoids
the inference of relationships through the hierarchical structure of GO. GO-based
similarity methods that use this data structure are COS (Chabalier et al., 2007),
simGIC (Pesquita et al., 2008) and TO (Mistry & Pavlidis, 2008). Although
these methods do not consider annotation sources other than GO, they achieve
better performance than methods such as those of Resnik (1999) and Lin (1998)
that depend on the GO graph structure.
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In this chapter, we will introduce the new method BioSim for similarity
searches based on diverse annotation sources of gene and protein function and
extend the existing methods COS, kappa coeﬃcient, simGIC, and TO to utilize
annotations not only from GO, but from 22 major biological databases for human
genes and proteins. We will also compare the performance of BioSim with the
other methods in diﬀerent benchmarks.
5.2 Data sources
22 biological databases integrated in the data warehouse in 2009 were used for
this study. These include functional annotations from all three GO categories
(MF, molecular function; BP, biological process; CC, cellular component) and
from the UniProtKB controlled vocabulary of keywords. The data warehouse
also contains clusters of similar sequences from Ensembl protein families and from
UniRef90; protein domain architectures from Pfam and InterPro; metabolic and
signaling pathways from HumanCyc, KEGG, and Reactome; protein interactions
and protein complexes from CORUM, DIP, HiMAP, HPRD, IntAct, MINT, PDB,
and STRING; disease associations from OMIM; enzyme classiﬁcations from the
Enzyme nomenclature database; gene expression data for diﬀerent tissues and cell
lines from the Novartis Gene Atlas; Mammalian Phenotype Ontology annotations
of human genes as provided by the Mouse Genome Database; and orthologs of
protein sequences from OrthoMCL.
From the annotation sources, the functionally relevant features associated with
individual genes and proteins were extracted. In the following, these features
are referred as annotation terms, which correspond, for example, to a speciﬁc
molecular function (e.g. oxidoreductase activity), domain (e.g. SH2) or pathway
(e.g. glycolysis) annotated to genes and proteins. To enable comparisons between
functional similarity methods using multiple annotation sources and those using
only GO annotations, proteins with no available GO annotation were excluded.
This resulted in a list of 18,076 protein entries out of 20,177 manually reviewed
proteins in UniProtKB release 15.5.
5.3 Functional similarity methods
In the following, AX and AY denote the sets of annotation terms associated with
the gene products X and Y , respectively.
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BioSim
This novel method, developed during my Ph.D., is deﬁned as follows:
BioSim(X, Y ) =
∏
t∈{AX∩AY }
p(t)
Here, t ∈ {AX ∩ AY } is the set of common annotation terms between X and
Y and p(t) is the probability that both AX and AY contain term t by chance.
Since BioSim is the product of the probabilities p(t), a score of zero represents
the highest similarity and a score of one the lowest. This is in contrast to other
methods described below, except TO. The probability p(t) is estimated using the
cumulative hypergeometric distribution:
p(t) =
D∑
k=2
(
Nt
k
)(
N−Nt
D−k
)(
N
D
)
In this case, the cumulative hypergeometric distribution describes the probability
of getting at least 2 two proteins annotated with the same term in a sequence of D
draws, without replacement, from a population of N proteins. Nt is the number of
proteins annotated with term t and D is the sum of |AX | and |AY |. The resulting
probability not only depends on the frequency of the annotation term Nt but also
on D. This is an important feature of our method to account for the annotation
bias that exists for intensively studied genes and proteins. A pair of proteins
associated with many annotations terms (large D) has an increased probability
p(t) to share the annotation term t (i.e., a decreased functional similarity) in
comparison to a pair of proteins associated with few annotations terms (small
D).
Term overlap length (TO)
TO represents the number of annotations terms shared by two proteins X and
Y (Mistry & Pavlidis, 2008):
TO(X, Y ) = |{AX ∩ AY }|
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Kappa coefficient (KC)
This method is used in the well-known DAVID Gene Functional Classiﬁcation
Tool (Huang et al., 2007). It computes a normalized diﬀerence of the observed
number of annotation terms O(X, Y ) shared by two proteins X and Y, and the
expected number E(X, Y ) of shared annotation terms that are randomly cho-
sen (Huang et al., 2007). It is deﬁned as follows:
KC(X, Y ) =
O(X, Y )− E(X, Y )
1− E(X, Y )
In the following, we describe the simGIC and COS methods. Unlike the previ-
ous methods, they incorporate term weights based on the information content
(IC) (Resnik, 1995) of a term t:
IC(t) = − log Nt
N
Here, Nt is the number of proteins annotated with term t and N the total number
of proteins in our study.
simGIC
This method introduced by Pesquita et al. (2008) includes the summed informa-
tion contents of shared vs. all annotated terms for two proteins X and Y :
simGIC(X, Y ) =
∑
∀t∈{AX∩AY } IC(t)∑
∀t∈{AX∪AY } IC(t)
Cosine similarity (COS).
This classical method is deﬁned as follows (Salton et al., 1975):
COS(X, Y ) =
~AX · ~AY
| ~AX || ~AY |
Here, ~AX and ~AY are the annotation vectors of two proteins X and Y, respec-
tively. In each vector, the absence of an annotation term is represented by 0 and
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Fig. 5.1: Gene Ontology (GO) cellular component sub-tree (simpliﬁed version). Hypothet-
ical annotations of proteins A to D. The graphs highlight the sub-trees shared by A, B (a) and A, C
(b).
the presence by IC(t). This method was ﬁrst used in the context of functional
similarity by Chabalier et al. (2007).
5.4 Representation of ontological annotations
Annotations based on ontological or hierarchical structures such as those from
the Gene Ontology and Enzyme classiﬁcations were converted into a Boolean
array following the method used in (Mistry & Pavlidis, 2008; Pesquita et al.,
2008; Chabalier et al., 2007). In this method, not only the leaf terms found in
the annotation sources are included in the boolean array, but also all ancestors
of the term.
To illustrate the approach, consider the proteins A, B, C and D annotated
with the following GO terms:
• A:{Golgi membrane, plasma membrane}
• B:{nuclear membrane, plasma membrane}
• C:{plasma membrane}
• D:{nuclear membrane}
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A is more similar to B than to the rest because both are annotated as plasma
membrane proteins, but also share the common ancestor terms cell, membrane,
intracellular organelle, organelle membrane (Fig. 5.1). If no ancestor terms are
taken into account, then A and B will share only the annotation term plasma
membrane, which is the same term shared by A and C. Furthermore, A andD will
not share any term. If ancestor terms are included, A and D will share the four
annotations terms cell, membrane, intracellular organelle, organelle membrane.
5.5 Evaluation methods
Gold standard
To evaluate the performance of the functional similarity methods, we collected a
dataset composed of groups of proteins that are assumed to be functionally related
(to a certain extent) and contained in the list of 18,076 proteins with at least one
available GO annotation (as described previously). We use this dataset as gold
standard in our validation. The protein groups in the dataset were obtained from
four benchmark categories that we limited to at most 400 groups per category: (1)
400 groups containing curated protein complexes randomly selected from a total
of 2,030 complexes from CORUM; (2) 88 groups of sequence clusters containing
closely similar protein sequences based on UniRef90 clusters (sequences of at
least 90% identity) and thus with putatively similar functions; (3) 355 groups
consisting of reliable interaction partners from a total of 355 proteins with at
least two such reliable partners (here, an interaction is reliable if it is reported
in at least three diﬀerent publications); and (4) 400 groups composed of proteins
participating in metabolic and signaling pathways from KEGG and Reactome
(protein groups were selected randomly from a total of 424 available pathways).
Groups of more than 20 proteins were excluded as being too general. The average
group size had 6.7 proteins and the overall standard deviation was 4.3. In total,
the gold standard consisted of 1,243 groups containing 8,150 proteins (some of
the proteins were shared in diﬀerent groups). In the following, we will refer to
those groups as validation groups.
Benchmarking procedures
From each validation group, a query protein was randomly selected and the re-
maining group members were regarded as gold standard positives. To obtain
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ranked lists, pairwise functional similarity scores were computed between the
query protein and all other 18,076 protein entries used in our study. The same
evaluations were carried out using either only GO annotations or all aforemen-
tioned annotation sources (excluding the respective annotation source of the
benchmark category).
For baseline comparison, a dataset of 10,000 protein pairs was randomly cre-
ated and their functional similarity scores were computed using all methods.
To compute a background distribution of sequence similarity we computed
the BLAST bit scores (NCBI blastp version 2.2.22) for 100,000 protein pairs
randomly drawn from the list of studied proteins. Since the bit score of a protein
pair is not symmetric, the average bit score of the pair was used (Pesquita et al.,
2008).
Performance measures
The recall at a rank k is the number of positives in the k top ranks of the computed
ranking list divided by the total number of positives, i.e., the members of the
respective validation group. The average precision is the mean of the precisions
obtained for the ranks of all positives in the ranking list (Buckley & Voorhees,
2000). For example, in case of three positives found at ranks 2, 5, and 10, the
average precision would be (1/2 + 2/5 + 3/10)/3 = 0.4. The Precision at a rank
k is the number of positives in the k top ranks divided by k. The ﬁrst relevant
rank (FRR) is the best rank of a positive in some ranking list.
Score cut-offs for the functional similarity methods
Using the ranking lists obtained for each validation group, we identiﬁed the func-
tional similarity score that yielded 50 false positives. This number is a reasonable
threshold suggested by Gribskov & Robinson (1996) for their ROC50 method.
By averaging these functional similarity scores, suitable score cut-oﬀs were ob-
tained for every similarity method. We refer to these score cut-oﬀs as SC50. The
performance curves were generated using the ROCR package (Sing et al., 2005).
Disease associations
For each disease phenotype and each gene not associated with this phenotype,
we averaged the computed pairwise functional similarities to every disease gene
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Fig. 5.2: Performance of functional similarity methods. Average recall is plotted for diﬀerent top ranks
k using either multiple annotations sources (A) or only GO annotations (B). The average values were
obtained from benchmarking with 1,243 validation groups. See Fig. 5.3 for details on the performance
of the methods in each of the four benchmark categories.
of this phenotype. The averaged scores were used to obtain the ﬁnal ranking list
of unassociated genes.
curated complexes protein interactions similar sequences pathways total
method avg. prec. FRR avg. prec. FRR avg. prec. FRR avg. prec. FRR avg. prec. FRR
Multiple annotation sources
BioSim 0.49 1 0.21 5 0.55 2 0.42 1 0.39 2
COS 0.36 2 0.12 25 0.55 2 0.29 2 0.28 3
simGIC 0.35 2 0.13 22 0.52 1.5 0.30 2 0.28 3
TO 0.24 2 0.15 8 0.55 1 0.26 2 0.24 3
KC 0.25 3 0.10 83 0.48 1.5 0.23 3 0.21 5
Only GO annotations
BioSim 0.25 6 0.10 38 0.28 6 0.28 2 0.22 7
COS 0.23 5 0.11 54 0.36 2 0.28 2 0.22 5
simGIC 0.22 3 0.10 43 0.34 2.5 0.28 2 0.21 5
TO 0.19 7 0.09 27 0.12 30 0.23 4 0.17 11
KC 0.21 3 0.10 58 0.33 3 0.25 2 0.20 5
Table 5.1: Performance comparison of functional similarity methods using multiple annotation sources
vs. using only GO annotations, over all 1,243 validation groups. In bold, the highest values of each
category are highlighted. avg. precision: average precision, FRR: ﬁrst relevant rank.
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Fig. 5.3: Performance of functional similarity measures by validation group. Average recall plotted for
diﬀerent top ranks k in the four validation groups. (A) Results based on multiple annotation sources.
(B) Corresponding results using only GO annotations.
5.6 Performance of functional similarity methods
The performance of BioSim in identifying known functional similarities was com-
pared with that of four other methods: TO, KC, simGIC, and COS. Results were
averaged over all validation groups. While all methods showed similar perfor-
mance when using only GO annotations, the performance was improved when
considering multiple annotation sources (Fig. 5.2). Notably, BioSim achieved
better performance than the other methods. For instance, the top twenty hits
of BioSim had an average recall of 0.58. The second best method, COS, had an
average recall of 0.44 (Fig. 5.2A). The average precision of BioSim was 0.39,
which was signiﬁcantly higher than that of the other methods (p-value < 0.01,
Wilcoxon signed-rank test). Likewise, BioSim had a median value of 2 for the
FRR, surpassing the other methods (Table 5.1).
The overall performance of the methods varied for each benchmark category.
It was lower for all methods when using the protein-protein interactions cate-
gory and higher for the sequence clusters category (Fig. 5.3A and Table 5.1).
The combined average recall for all methods was almost one third lower in the
protein-protein interactions category than in the sequence clusters category (the
respective recalls were 0.29 and 0.75). The observed high performance when us-
ing the sequence clusters category is due to the tendency of the methods to
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rank similar sequences at the top. This can be explained, to some extent, by
annotation transfer between homologous protein sequences, by gene annotations
that are transferred to all encoded proteins, and by domain annotations that are
almost identical for similar sequences. Therefore, the tendency to rank similar
sequences at the top reduces the performance of the methods when using bench-
mark categories diﬀerent from sequence clusters because gold standard positives
are displaced to lower ranks.
5.7 Performance of GO vs. multiple annotation
sources
The use of multiple annotation sources improved the performance of four of the
ﬁve methods although they were not originally developed to handle multiple an-
notations (in contrast to BioSim). Much of this increase seems to be attributable
to the availability of more annotation terms per protein. The number of terms
annotated to each protein increased from a median of 7.5 GO terms to a median
of 15.0 annotation terms when all annotation sources were included (Fig. 5.6).
The TO method, which counts the number of common terms, but does not ac-
count for term speciﬁcity, improved its average precision from 0.17 to 0.24 when
all annotations were used.
Notably, the use of multiple annotation sources does not only increase the
number of annotation terms per protein, but also improves the speciﬁcity of the
annotations. While GO terms annotated to at most four proteins were available
for 8,096 proteins, this number doubled to 16,649 proteins in case of multiple
annotation sources when not only using GO. The positive eﬀect of the increased
annotation speciﬁcity on the performance can be observed with the three func-
tional similarity methods COS, simGIC, and BioSim. All three methods weight
annotation terms and showed the strongest performance improvement when mul-
tiple annotation sources were included.
In particular, BioSim was best able to take advantage of the increased number
and improved speciﬁcity of annotations terms, as shown by the near doubling of
its average precision (Table 5.1). In the case of BioSim, the functional similarity
between two proteins increases if both are annotated with speciﬁc terms (terms
that are annotated to few proteins) because the corresponding probabilities of
the terms are low. Additionally, since BioSim computes the product of the prob-
abilities of all terms shared by two proteins, a certain number of even less speciﬁc
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Fig. 5.4: Coverage of data sources. (A) Number of proteins annotated in each data source. (B) Number
of proteins per annotation term in each data source.
terms still increases the overall functional similarity. Annotations from protein-
protein interactions, sequence clusters, pathways, and disease associations are
normally the most speciﬁc and least abundant ones, annotated to no more than
a hundred proteins. In contrast, annotations as from cellular localization and tis-
sue expression frequently cover thousands of proteins; and annotations from GO,
UniProtKB keywords and protein domains span the whole range from just a few
proteins to thousands (Fig. 5.4).
As an example, we looked in detail at one known SNARE protein complex
formed by the proteins VAMP2, SNAP25, STX1a and CPLX1. These four pro-
teins are involved in the fusion of neurotransmitter-containing vesicles with the
pre-synaptic membrane (McMahon et al., 1995). When BioSim was applied us-
ing multiple annotation sources to compute the functional similarity of VAMP2
with each of the 18,076 human proteins in our study, SNAP25 achieved the top
rank 1 with the strongest functional similarity. The other two complex members
STX1a and CPLX1 were found at ranks 3 and 5, respectively. At rank 2 we found
PRKD3, a protein that interacts directly with VAMP2, and at rank 4 we found
VAMP1 who shares the Synaptobrevin domain with VAMP2. In contrast, when
BioSim made use of only GO annotations, the rankings of SNAP25, STX1a and
CPLX1 decreased to 25, 187, and 805, respectively. Speciﬁc annotations, which led
to the identiﬁcation of SNAP25 as functionally similar to VAMP2, included four
experimental results that reported the interaction between VAMP2 and STXa1
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and several shared pathways in Reactome such as the proteolytic cleavage of
SNARE complex proteins. Less speciﬁc annotations were a shared coiled-coil do-
main and a similar tissue expression proﬁle. When only GO annotations were
taken into account, ICA69 was the protein functionally most similar to VAMP2,
primarily, because both proteins are annotated with the term secretory granule
membrane. This term covers only 25 other proteins, none of which is SNAP25,
STX1a or CPLX1. The current knowledge about ICA69 is very limited. It might
play a functional role in the transport regulation of insulin secretory granule pro-
teins (Buﬀa et al., 2008) as well as in neurotransmitter transport as inferred by
sequence similarity in UniProtKB. However, ICA69 has not been associated with
the fusion of pre-synaptic vesicles.
In general, although GO annotations are expected to improve over time as
more information is added, the use of other annotation sources helps to bridge
the time until new data is incorporated. Furthermore, useful annotations to de-
rive functional similarities such as protein-protein interactions and disease asso-
ciations are not part of GO. Moreover, the use of multiple annotation sources can
also reduce the impact of incorrect annotations found in biological databases (Sch-
noes et al., 2009).
5.8 BioSim scoring versus other methods
BioSim distinguished functional relationships of gold standard positives from
those of randomly paired proteins better than the other methods. Gold standard
positives consistently received a BioSim score close to 0, while random pairs
obtained a score close to 1 (Fig. 5.5A). In particular, we plotted precision and
recall averages from our benchmark results for every method at diﬀerent score
cut-oﬀs (Fig. 5.5B). We also computed a score cut-oﬀ (SC50) that resulted in 50
false negatives on average. The obtained SC50 score cut-oﬀs, along with the score
range of each method from lowest to highest functional similarity, were: BioSim:≤
1.18× 10−9 (range [1; 0]), TO : ≥ 115 (range [0;∞)), KC : ≥ 0.360 (range [0; 1]),
simGIC : ≥ 0.096 (range [0; 1]), and COS : ≥ 0.101 (range [0; 1]). For COS and
simGIC, the second and third best methods, the SC50 score cut-oﬀs were very
close to zero, their non-similarity score; the recall at the respective SC50 cut-oﬀ
had a median of 0.50 and a distribution covering the whole range (see Fig. 5.5B).
In other words, for both methods, the SC50 cut-oﬀ resulted in very diﬀerent recalls
in each benchmarking group. The KC and TO methods had a recall median below
0.5 for their respective SC50 score cut-oﬀs. In comparison, the recall for BioSim
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Fig. 5.5: Comparison of functional similarity methods. (A) Histograms of the functional similarity
scores that were obtained for 6,907 pairs of gold standard positives and for 10,000 random pairs.
(B) Precision (straight lines) and recalls (dashed lines) are averaged at diﬀerent cut-oﬀs. The vertical
red lines highlight the SC50 score cut-oﬀs that yield, on average, 50 false positives. The box plots to
the left of the y-axis shows the distribution of recalls (light-blue) and precision (light-green) at this
cut-oﬀ. BioSim scores are in logarithmic scale for better visualization.
at the SC50 score cut-oﬀ had the highest median (0.82) and the corresponding
distribution concentrated around high values.
The limited consistency of the scores of COS, KC, simGIC, and TO is prob-
ably caused by annotation bias towards better studied molecules (Rhee et al.,
2008) as these methods appear to be best suited for unbiased data (Wang et al.,
2010). In our data warehouse, a handful of proteins have over thousand annota-
tions, while the majority has less than ten annotations. A similar pattern can be
observed when considering only GO annotations (Figs. 5.6 and 5.7). About 16%
of all proteins are annotated only with less speciﬁc terms such as the UniProtKB
keyword Receptor or the GO term protein binding. The functional similarity
of any two proteins sharing such terms is overestimated by the COS, KC and
simGIC methods, which yield the highest score of 1. This misleading result is
undistinguishable from a genuine functional similarity based on several shared
annotation terms.
Furthermore, the same methods tend to underestimate the genuine similarity
of any two proteins that are annotated with numerous terms and do not share a
large proportion of their annotation terms. For example, the cellular tumor anti-
gen TP53 (with 1,642 annotation terms including 332 literature-curated protein
interactions) shares approximately 19% of its annotation terms with the closely
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Fig. 5.6: Distribution bias in the annotation of human proteins. (A) Frequency plot of the
number of annotation terms per protein. Few proteins have many annotations, while a large number
of proteins are barely annotated. For instance, the protein with the most annotations is p53 with
1,642 annotation terms, which include 332 literature-curated protein-protein interactions. Generally,
proteins with a large number of annotations are very well studied due to strong biomedical interests.
On average, each protein is annotated with 29.7 terms. (B) Frequency plot of the number of proteins
per annotation term. Most annotation terms are speciﬁc for few proteins, while other terms are broad
and cover many proteins. The increased number of terms annotated to only two proteins is due to
pairwise protein-protein interactions.
related E3 ubiquitin-protein ligase MDM2, which is known to bind and inhibit
TP53 (Vassilev et al., 2004). Relevant terms indicate common metabolic and
signaling pathways, disease associations and protein interactions. However, the
remaining 81% of TP53 annotation terms that are not shared with MDM2 lead
to the following low functional similarity scores:
functional similarity score
method multiple sources only GO
COS 0.097 0.206
KC 0.120 0.379
simGIC 0.056 0.142
These functional similarity scores are even below the SC50 cut-oﬀs for the respec-
tive methods. This means that low functional similarity scores are often obtained
for truly functionally related proteins. Moreover, such low similarity scores are
also obtained when only GO annotations are considered.
The TO method, which is simply the count of annotation terms shared by
two proteins, avoids some of the described shortcomings by focusing only on
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Fig. 5.7: Distribution bias in the GO annotation of human proteins. (A) Frequency plot of
the number of GO terms per protein. (B) Frequency plot of the number of proteins with the same GO
term. Both distributions are similar to those in Fig. 5.6.
the shared annotations. However, it cannot distinguish those annotations that
occur by accident because it judges an event of two proteins sharing a rather
unspeciﬁc, frequent annotation term (e.g. protein binding) as likely as an event
of two proteins sharing a very speciﬁc, rare annotation term (e.g. actin ﬁlament
binding).
5.9 Functional similarity vs. sequence similarity
The correlation between the functional similarity of two proteins and their se-
quence similarity is often used to evaluate functional similarity methods (Pesquita
et al., 2008; Lord et al., 2003). In our results, rank correlations for all methods
were close to 0.1 when comparing BLAST bit scores and functional similarity
scores for 100.000 random pairs of proteins. This low correlation is likely due
to many protein pairs with almost no sequence similarity, but some functional
similarity (Fig. 5.8). To ﬁlter out protein pairs with low sequence similarity, we
discarded all pairs having a ln(bit score) below 3.3. This threshold was chosen
after observing that, for all methods, the averaged functional similarity scores
increases above this value. In total, 631 (0.63%) of the random pairs had a ln(bit
score) of at least 3.3. The rank correlations for these pairs were COS : 0.77, KC :
0.67, BioSim: 0.69, simGIC : 0.73, TO : 0.48.
Since BioSim showed a slightly lower correlation than COS and simGIC, we
additionally analyzed some interesting cases manually. Table 5.2 summarizes the
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Fig. 5.8: Comparison of functional similarity and sequence similarity scores. 100,000 random pairs of
proteins were analyzed. Sequence similarity is measured as ln(bit score). Green lines depict the average
functional similarity. Red lines illustrate the standard deviation. In each plot, the background contains
a scatter plot where darker colors indicate higher density of dots. A number of protein pairs with low
sequence similarity have some functional similarity in all cases.
manual inspection of annotations shared by the ﬁfteen pairs of proteins with the
highest sequence similarity bit score. Seven protein pairs do not share speciﬁc
annotation terms suitable for inferring a clear functional relationship. Accord-
ingly, the low BioSim scores of those pairs are above the previously determined
SC50 score cut-oﬀ of 1.18 × 10−9, which indicates a weak functional similarity.
In contrast, a true functional relationship between the remaining eight protein
pairs is more evident due to several shared speciﬁc annotations terms. This agrees
well with BioSim scores below or very close to the SC50 cut-oﬀ, which suggests
a considerable certainty of a real functional similarity. However, in contrast to
BioSim, the scores from the other methods do not allow a clear-cut distinction in
those cases as explained in the preceding Section 5.8. For example, the second and
ﬁfteenth rows in Table 5.2 are cases of low functional similarity scores for COS,
KC, and simGIC in contrast to BioSim although the respective proteins share
numerous annotations. This suggests that a meaningful comparison of scoring
methods based on the correlation of functional similarity and sequence similarity
is limited by the available annotation datasets and their overall characteristics
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Fig. 5.9: OMIM disease-associated genes and its top 10 most functionally similar genes. The BioSim
method was used to identify related genes for obesity (left) and the familial glioma of brain (right).
The black frames highlight the new genes POMC and BRCA2 found by using BioSim. The vertical
axis alphabetically lists the previously known disease genes. The horizontal axis ranks the most similar
genes from left (most similar) to right. The colors indicate the strength of the functional similarity
scores between the respective genes as computed by BioSim; lower scores indicate stronger similarity,
see depicted color bar.
and quality, which can also be aﬀected by annotation bias and incompleteness.
Since BioSim is particularly designed to be more sensitive to the number and
speciﬁcity of annotation terms in contrast to the other methods, its overall per-
formance depends more on the annotation datasets and the individual annotation
terms.
5.10 Discovery of disease-associated genes
Genes associated with the same disease phenotype tend to be functionally re-
lated (Schlicker et al., 2010; Vidal et al., 2011). Using BioSim, we ranked genes
based on their functional similarity to genes known to be associated with a par-
ticular OMIM disease phenotype (Amberger et al., 2009). To this end, for each
gene not associated with a disease phenotype, we averaged the computed scores
of its functional similarity to the previously known disease genes. The functional
similarity scores were computed using a snapshot of the data warehouse that con-
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tained only gene annotations from before January 1, 2009. We then compared our
results with an updated version of OMIM from October 31, 2009. This update
contained 54 new gene associations for 46 diseases. In the results, eleven of the
new genes were found at the top four ranks and twelve others between ranks 6
and 54 (Table 5.3 and Appendix Tables B.1B.23). The median rank of the new
genes was 9.5. This is a drastic improvement due to the use of multiple annota-
tion sources in contrast to the ranks obtained when using only GO annotations
with a resultant median of 133.5.
Figure 5.9 highlights two disease phenotypes: obesity, which had 17 associated
genes known before January 2009, and familial glioma of brain, which had seven
associated genes. The new gene POMC, which was added to the obesity pheno-
type in the updated version of OMIM, was found on the third rank. Annotations
shared by POMC and the other known disease genes included protein-protein
interactions (with AGRP, ENPP1, GHRL, MC3R and MC4R) and the anno-
tation term obesity from UniProtKB keywords, which covers POMC and 10
other obesity genes (Appendix Table B.6). The genes ranked ﬁrst and second,
LEP (leptin) and INS (insulin), are also related to obesity (Spiegelman & Flier,
2001) even if they are not among the genes of the speciﬁc obesity phenotype in
OMIM.
BRCA2, the new gene included into the updated version of OMIM for the
glioma of brain phenotype, achieved the ﬁrst rank of genes functionally related
to the disease. BRCA2 showed strong BioSim functional similarity to ﬁve of
the seven previously known genes for glioma of brain. Some of the annotations
shared by BRCA2 and the ﬁve disease genes are protein-protein interactions (with
ERBB2, MSH2 and PTEN), the joint disease association of BRCA2 and DMBT1
to medulloblastoma as well as of BRCA2 and PTEN to prostate cancer in OMIM,
and a number of GO and pathway annotations (Appendix Table B.1).
5.11 Summary
This chapter presented the novel method BioSim to compute and search for
functional similarities of genes and proteins based on diverse annotations such
as protein interactions, domain architectures, biological pathways, and disease
associations. BioSim was evaluated together with four other published methods.
All methods are fast to compute and just depend on the number of available
annotation terms; thus they can scale well to larger datasets.
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96 5 Novel Search Method for the Discovery of Functional Relationships
In the benchmarks, the use of multiple annotation sources resulted in im-
proved performance of most methods than the use of solely GO annotations.
BioSim achieved the best performance by consistently ranking functionally re-
lated proteins among the top two out of over 18,000 human gene products. BioSim
in contrast to other scoring methods might be particular useful for applications
based on functional similarity when consistent scores are especially desirable,
for example, for the quality assessment of protein-protein interactions (Ramírez
et al., 2007) and for the clustering of genes or proteins by function (Huang et al.,
2007). We also showed how BioSim can be applied to discover potential disease
genes.
6Web Portal to Analyze Genes and Proteins
This chapter describes BioMyn, a web portal that allows access to the data ware-
house presented in Chapter 2, and to the BioSimmethod introduced in Chapter 5.
The web portal facilitates the analysis of large sets of genes of proteins that are
submitted by the portal users in the context of all the information integrated in
the data warehouse. BioMyn oﬀers enrichment analysis that are complemented
with novel visualization methods to explore the results.
6.1 Introduction
One of the main challenges faced by bioinformaticians today is the development
of eﬃcient methods and techniques to interpret the results from high-throughput
experiments such as microarrays, yeast two-hybrid, proteomic methods based
on mass spectrometry, next-generation sequencing, and RNAi. Such technologies
usually generate lists containing hundreds of potentially relevant genes, which
need to be further investigated in order to understand their biological signiﬁcance
and their cellular roles. A common approach for the interpretation of results is
through data mining of the accumulated biological knowledge, typically by identi-
fying statistically over-represented annotations associated to the set of interesting
genes. This method, known as gene set enrichment analysis (Rivals et al., 2007),
is based on the assumption that sets of genes responsible for a biological activity
are likely to be selected together in an experiment.
Currently, there are dozens of tools that can perform enrichment analysis (see
reviews by Khatri & Dr ghici (2005) and Huang et al. (2009)); however, most of
them are limited to functional categories based on Gene Ontology (GO) (Ash-
burner et al., 2000), such as BiNGO (Maere et al., 2005), topGO (Alexa et al.,
2006), FatiGO (Al-Shahrour et al., 2004), and GoMiner (Zeeberg et al., 2003) just
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to name some of the popular tools. Few other enrichment analysis tools available
additionally include metabolic and signaling pathways such as GeneMAPP (Sa-
lomonis et al., 2007), ArrayXPath (Chung et al., 2005), WebGestalt (Zhang et al.,
2005), KEGG-spider (Antonov et al., 2008), SubpathwayMiner (Li et al., 2009),
PathExpress (Goﬀard et al., 2009), GFINDer (Masseroli et al., 2004) and KOBAS
(Masseroli et al., 2004). Some of these tools also oﬀer enrichments analysis for dis-
ease associations and orthologous groups in other species. Yet few of the available
tools allow comprehensive analysis using many other sources of information that
may be relevant for the interpretation of results like protein-protein interactions
(Vidal et al., 2011; Ideker & Sharan, 2008) and functional similarities (Pesquita
et al., 2009). Only DAVID (Huang et al., 2009) implements gene set enrichment
analysis using several annotation databases available together with other analy-
sis tools. However, the update cycle of DAVID takes between one and two years
while most of the gene and protein annotations are updated several times a year.
Here, we present BioMyn, a web portal for the analysis of human gene and
protein sets that is based on a large collection of annotations from diﬀerent bio-
logical sources that are integrated in our data warehouse (Table 2.2). Although
BioMyn focuses on enrichment analysis, it also presents predicted and experi-
mental protein-protein interactions and computes functional similarities to com-
plement the analyses. A wide variety of gene and protein identiﬁer systems are
supported to easily submit gene or protein sets. BioMyn also oﬀers a powerful
search engine based on CompleteSearch (Bast & Weber, 2007) for quickly search-
ing the integrated annotations.
The web portal seeks to improve how researchers analyze, manipulate, share,
ﬁnd, interact, and compare important experimental results more eﬀectively and
eﬃciently. The development of these features was guided from the feedback given
by biologists and on the experiences gained from several studies (Ramírez et al.,
2007; Ramírez & Albrecht, 2010; Reiss et al., 2011).
6.2 Concept
BioMyn aims to facilitate the bioinformatic analysis of gene or protein sets by
oﬀering access to integrated human gene and protein annotations and to pow-
erful data mining tools. The web front-end of BioMyn acts as an interface that
translates tasks and results to the end-user from the integrative data warehouse
and from the data analysis tools, which are written in R (R Development Core
Team, 2011).
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Fig. 6.1: Portal structure overview. The BioMyn web portal is divided into several modules that are
located in diﬀerent servers and developed using various programming languages and tools. Central to
BioMyn is the database warehouse containing the integrated information from diﬀerent biological data
sources. The data warehouse uses the relational database MySQL to eﬃciently store and search the
data. The analysis tools, written in the R language, compute the BioSim similarity and the enrichments
of genes and proteins based on the integrated data. The CompleteSearch (Bast & Weber, 2007) server
allows the creation of complex queries over the integrated annotations. The data warehouse is fed by
several programs written using the Python programming language to collect, process and unify the
data from the diﬀerent biological databases. Finally, the web portal, which is developed using PHP
and Javascript, allows public access to the diﬀerent components.
BioMyn is composed of three modules: (i) the enrichment analysis module, (ii)
the protein-protein interaction module, and (iii) the functional similarity module.
Since BioMyn allows researchers to submit their own set of genes or proteins for
analysis, an important aspect for the functioning of the site is the mapping of the
submitted identiﬁers to a uniﬁed scheme. This is achieved by using the mapping
algorithm developed to integrate the plethora of identiﬁers found in data sources,
which was discussed in Chapter 2.
BioMyn also has a powerful search engine based on CompleteSearch (Bast
& Weber, 2007) that allows quick searches over the integrated annotations. The
results from the queries are protein sets that can be further analyzed with our
data mining tools. For instance, using CompleteSearch all human kinases (as
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annotated in the Gene Ontology) that are known to be involved in a disease
(as reported by OMIM) can be easily retrieved without the need to write SQL
commands.
The web portal also presents the integrated annotations stored in the data
warehouse on a gene-by-gene or protein-by-protein basis, similar to other websites
like GeneCards (Safran et al., 2010) and NextProt (http://nextprot.org). This,
however, is not the main goal of BioMyn and these views exist to browse the
results from the analysis tools.
An overview of the structure of web portal is depicted in Fig. 6.1.
6.3 Uploading gene and protein sets
BioMyn analysis starts by uploading a set of human genes or proteins identiﬁers
of any size. The user is not conﬁned to any particular identiﬁer system (see
Section 2.2, page 8) but, for uniﬁcation purposes, all set members are mapped
to either the Entrez Gene (Maglott et al., 2007) or UniProtKB (The UniProt
Consortium, 2010) identiﬁer systems, as chosen by the user. These are the most
widely used identiﬁers for genes and proteins. Alternatively, the BioMyn search
engine can be used to obtain a set of genes to analyze all human transcription
factors (Section 6.8).
Once a set has been uploaded, the ﬁrst view is that of a treemap containing
the diﬀerent biological databases integrated into the data warehouse (Table 2.2).
Treemaps (Shneiderman, 1992) are visual representations of quantities that use
available space eﬃciently using rectangles. In BioMyn, the rectangles have an area
proportional to the number of genes from the submitted set that are associated
with an annotation in the respective database (Fig. 6.2). The number of genes
can be seen by positioning the mouse over any of the rectangles.
By clicking in any of the rectangles, representing the distinct biological
databases, the user is taken to a new treemap containing the enrichment analysis
results for the selected database, for instance GO biological process or KEGG.
6.4 Enrichment analysis
Enrichment of an annotation term means that the user set contains more genes or
proteins annotated with that term than what would be expected from a random
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Fig. 6.2: Overview of data sources. After loading a set of genes or protein identiﬁers, BioMyn shows
a treemap in which the squares represent each of the biological databases containing an annotation for
any of the genes or proteins submitted by the user. The area of the rectangles is proportional to the
number of genes or proteins having an annotation in the respective biological database.
selection containing the same number of genes as those in the set. Similarly,
depletion means that fewer genes or proteins are associated with that annotation
term than randomly expected. The results from the enrichment and depletion
test are p-values that indicate the probability of obtaining the observed counts
compared to random expectations. BioMyn uses the hypergeometric distribution
to compute p-values as recommended by Rivals et al. (2007).
The p-value computed for each annotation term as well as the number of genes
or proteins expected to be annotated with the term can be seen by directing the
mouse pointer over any of the treemap rectangles. The rectangle colors vary from
red and orange for those annotation terms that are enriched (overrepresented) in
the submitted gene or protein set, to grey for cases that match the random expec-
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Fig. 6.3: Enrichment analysis. Enriched pathways found in KEGG (Kanehisa et al., 2008) for a
selection of 1,320 human transcription factors. The red and orange colors are assigned to enriched
pathways, the green and blue colors are assigned to depleted pathways, and the grey color is for cases
that are not enriched or depleted. The enrichment and depletion p-values and other information are
shown in a pop-up window that appears by hovering the mouse over the treemap rectangles. The link
for analyzing a subset of proteins appears at the botton of this pop-up window. The visualization and
enrichment options on top of the treemap allow ﬁltering the results by p-value, and by the number of
proteins in either the user set or in the background. There is also the option to use another submitted
set as a background for the computation of enrichments, and the option to change the rectangle area
to be proportional to the expected number of proteins from the set instead of the default number of
observed proteins annotated to the respective annotation term.
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tation, and ﬁnally to green and blue for depleted (underrepresented) annotation
terms.
Apart from the treemap, results can also be visualized as a histogram, as a
table, or can be exported for further analysis in an electronic spreadsheet ﬁle
format.
Enrichment analysis options
Adjusting p-values
The computed p-values help to decide if the hypothesis that an annotation term
is enriched or depleted should be rejected or accepted. However, p-values should
be corrected in order to avoid erroneous conclusions when numerous p-values are
evaluated as in the case of the enrichment analysis in which p-values are computed
for hundreds of annotation terms; this adjustment of p-values is called multiple
testing correction.
The enrichment analysis of BioMyn is accompanied by several multiple testing
correction options to adjust p-values. While a given p-value may be appropriate
for each individual test, it is not for the set of all tests. The methods oﬀered are:
Bonferroni, Holm (Holm, 1979), Benjamini & Hochberg (Benjamini & Hochberg,
1995), and Benjamini & Yekutieli (Benjamini & Yekutieli, 2001). The Bonferroni
and Holm procedures lower the p-values to ensure that the overall probability of
declaring an enrichment as significant is maintained at some significant level, for
example 0.05.
The Bonferroni and Holm methods, however, are considered too conservative
for many practical cases in which researchers prefer a small proportion of false
positives as a trade-oﬀ for getting a larger set of signiﬁcant hypothesis (Kerr,
2009). As an alternative, the Benjamini & Hochberg (BH) and the Benjamini
& Yekutieli (BY) methods control the false discovery rate (FDR), which is the
expected proportion of false positive ﬁndings among the enrichments declared
signiﬁcant (i.e. rejected null hypotheses). For the BH and BY methods the re-
ported values, analog to the p-values, are called q-values (Storey, 2002). As an
example, the expected number of false positives is 1% for the set of enrichments
having a q-value <= 0.01.
104 6 Web Portal to Analyze Genes and Proteins
Selecting a background set
The computation of p-values and q-values is based on the distribution of anno-
tation terms in a background. By default, the computation of p-values uses a
background distribution containing all human genes or proteins that have an an-
notation in the selected database; however, any other background set, chosen by
the user, can be used as well. BioMyn includes the option to select one of the sub-
mitted sets as background instead of the default. Improper use of a background
set can invalidate the results. For example, the enrichment analysis of a group of
interesting genes from a study that is based on all human kinases should use, as
background, this same set of all human kinases; otherwise, the enrichment anal-
ysis will identify annotations terms already enriched in the background set. In
the case of kinases, these annotation terms are for instance, phosphotransferase
function, intra-cellular location, and the participation in signaling transduction
pathways.
Generating subsets of genes
The selection of a subset of genes or proteins from a submitted set is useful to
further study smaller groups of genes that share an annotation term, for instance,
that participate in a particular signaling pathway. Subsets can also be used to
ﬁlter a submitted set, for example, from a set of proteins, a subset containing
only proteins expressed in brain tissues can be created to focus the analysis. In
BioMyn, subsets are created from annotation terms (Fig. 6.3). Subsequently, the
set of genes or proteins having the selected annotation term is automatically
loaded into BioMyn as a new set that can be further analyzed and explored.
Filtering the results
Often, the enrichment analysis results contain hundreds of annotation terms that
render the visualization of the results diﬃcult. Using the option to ﬁlter the re-
sults, the user can concentrate on certain parts of the visualization. The ﬁltering
options control which annotation terms are shown based on enrichment or deple-
tion p-value, number of genes or proteins from the submitted set annotated with
the term, and the number of genes or proteins in the background annotated with
the term (Fig. 6.3).
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(A)
(B)
Fig. 6.4: Protein-protein interactions. BioMyn reports all experimentally veriﬁed and predicted
protein-protein interactions known between the set of genes or proteins submitted by the user. (A) View
of experimentally derived protein-protein interactions. (B) View of predicted protein-protein interac-
tions.
Visualizing ancestor terms from ontologies
The data warehouse contains diﬀerent types of annotations including ontological
annotations characterized by a hierarchical structure (See Section 2.4.1, page 18).
In cases such as GO, the visualization of the enrichment analysis is hindered by
the sheer amount of relations and terms found in such hierarchical structure.
Thus, to avoid cluttering the view, all ancestor terms are hidden by default. This
feature can be changed easily if needed.
Also, in the case of the GO, only the so called `slim' terms are shown by default.
The GO slim (http://www.geneontology.org/GO.slims.shtml) is a subset of
GO containing only few broad categories, manually chosen for summarizing the
GO annotations.
6.5 Protein-protein interactions
The protein-protein interactions section of BioMyn lists all experimental and pre-
dicted interactions that occur between the genes or proteins in the submitted set.
Figure 6.4 shows an example of the results where each interaction appears in a
separate row. The columns list the databases providing the interaction informa-
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tion. Each dot represents an experiment supporting the interaction or, in the case
of a prediction, each dot indicates a diﬀerent evidence. The dots are linked to
the source database where further details of the interaction can be found. Those
interactions having the highest number of experimental support or, in the case of
predictions, with the highest number of methods predicting the interaction are
placed on top. The list of interactions can be easily exported for further analysis
to Cytoscape (Smoot et al., 2011) or other network visualization software.
Currently, BioMyn presents experimental interactions from BioGrid (Stark
et al., 2011), DIP (Salwinski et al., 2004), HPRD (Prasad et al., 2009), IntAct
(Kerrien et al., 2007) and MINT (Ceol et al., 2010); and predicted interactions
from HiMap (Rhodes et al., 2005), HomoMINT (Persico et al., 2005), I2D (Brown
& Jurisica, 2005), PIPs (McDowall et al., 2009), and STRING (Jensen et al.,
2009).
6.6 Functional similarity
The functional similarity module of the portal uses the BioSim method intro-
duced in the previous chapter to identify protein pairs having similar annota-
tion terms from the user submitted set. When using this module, a network is
shown containing the top twenty proteins having the highest functional similarity
(Fig. 6.5). Besides reporting the functional similarities, BioMyn also facilitates
the navigation through the annotation terms shared between genes or proteins
(Fig. 6.6). This is of importance to let the researchers understand and assess the
similarities found.
The functional similarity scores can be downloaded for further analysis.
For example, the results can be clustered using the Cytoscape plugin cluster-
Maker (http://www.cgl.ucsf.edu/cytoscape/cluster/clusterMaker.html)
and GLay (Su et al., 2010).
6.7 Search engine
BioMyn uses CompleteSearch (Bast & Weber, 2007) to index its large catalog of
annotations. The search engine accepts full-text query strings related to annota-
tions terms, and gene and protein identiﬁers, symbols and synonyms. Searches
can be narrowed by adding contextual search terms that are separated from the
search query by a colon. For example, to search for the pro-insulin gene using its
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Fig. 6.5: Functional similarity network. The genes or proteins from the submitted set having
the highest BioSim functional similarity score are shown as a network. In this network, the edges
represent genes or proteins from the user submitted set and the edges indicate a functional similarity.
Thicker edges indicate a stronger functional similarity. By clicking over any of the edges, a summary
of the shared annotation terms is shown. The ﬁgure shows the similarities found for a set of human
transcription factors. A summary of the shared annotation terms can be seen in the lower part of the
image for the proteins: POU domain, class 4 transcription factor 2 (POU4F2), and the POU domain,
class 4 transcription factor 3 (POU4F3). Further information about the shared annotation terms is
found by following the links found in this summary as shown in Fig. 6.6.
symbol, the query is: `symbol:INS'. The built-in auto-complete function helps to
ﬁnd the right term and context names while typing.
Search terms can be combined using the OR operator represented by the pipe `|'
character, the AND operator which is assumed by default, and the NOT operator
represented by the minus `-' character.
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Fig. 6.6: Shared annotations between two proteins. This ﬁgure shows all protein complexes
in which the transcription factors RuvB-like1 and RuvB-like2 participate, according to the CORUM
database (Ruepp et al., 2008). The hypertext links in the `Annotation' column point to the original
biological databases. Besides complexes, other shared annotations can be seen by following the links in
the right panel.
The search results are complemented with additional information classiﬁed
into: `Pathway/Process', `Function', `Component', and `Disease'. These informa-
tion contain frequent annotation terms found within the search results.
The set of proteins matching the search query can be automatically loaded as
a user set for which all the analysis tools presented before can be used. In this
way, the search engine serves as a second entry point to BioMyn analysis tools
and can facilitate the bioinformatic analysis of available annotations.
6.8 Case study
We used the search engine to obtain a set of human transcription factors from
the data warehouse using the annotations found in two database sources: GO
and UniProtKB Keywords. The GO term for transcription factor is: sequence-
speciﬁc DNA binding transcription factor activity that corresponds to the identi-
ﬁer: GO:0003700 (http://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0003700). In
UniProtKB Keywords, the term for transcription factor is Activator (http://
www.uniprot.org/keywords/KW-0010). Using the search query `GO:0003700 | key-
words:activator' we obtained a set of 1,320 proteins. This set was subsequently
loaded into BioMyn for further analysis.
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Fig. 6.7: BioMyn search Engine Search results for the query `GO:0003700 | keywords:activator'
used for retrieving transcription factors. `GO:0003700' is the GO identiﬁer for this type of proteins that
are named `activators' in UniProtKB Keywords. The pipe character is the OR operator. The result list
shows the ﬁrst 300 proteins that match the search query. The annotations for each of these proteins
can be seen by following the link in the column `BioMyn annotations'. Alternatively, a new set can be
submitted following the link on the right called `Analyze in BioMyn'. The boxes above the results table
contain additional information useful to reﬁne the search. Each box lists up to ten annotations terms,
sorted in decreasing order by the number of proteins having such annotation term from the search
results. This number is shown in parentheses after the annotation term name and source. Clicking over
any of the annotation terms found in the rectangles adds the respective term to the search query.
We analyzed the GO biological processes associated with the set of transcrip-
tion factors. The default background was used since the set was obtained from all
human proteins having GO or UniProtKB Keyword annotations. The Benjamini
& Hochberg method was used to correct for multiple testing instead of the more
stringent Bonferroni or Holm methods. Electronic annotations were excluded by
selecting the annotations from the GO Biological Process manual. Using the de-
fault GO slim visualization of BioMyn we could identify the following enriched
GO terms: transcription, chromosome organization and embryo development. The
GO term transcription should be obviously enriched because all proteins in the
set are transcription factors. Most other GO slim terms appear depleted, for
example: signal transduction, response to stress and immune system process.
Besides GO biological processes we also studied the protein domain composi-
tion of the set of transcription factors. Transcription factors are usually charac-
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Fig. 6.8: Transcription factor domains. Enriched Pfam domains and Pfam domain architectures
for human transcription factors. Here, we show the enriched Pfam domains found in a set of 1,320 hu-
man transcription factors. We compared the results with common Pfam domain architectures (domain
combinations) found for the same set.
terized by several DNA binding domains including the Helix-Loop-Helix (HLH)
domain (Massari & Murre, 2000), the Homeobox domain (Levine & Hoey, 1988),
and several zinc ﬁnger domains (Wolfe et al., 2000; Laity et al., 2001). We used
BioMyn to identify enrichments for Pfam protein domain annotations and for
Pfam architectures (Finn et al., 2008). Pfam domain architectures correspond
combinations of domains found in multi-domain proteins. In many cases there
are diﬀerent domains within a protein, but is also not rare to ﬁnd repetitions of
the same domain within a protein.
Our analysis of transcription factor domains found the previously mentioned
domains and others that had been reported elsewhere (Vaquerizas et al., 2009)
(Fig. 6.8). Interestingly, the analysis of domain architectures identiﬁed several
groups of domains that often appear together like the zF-C4 and Hormone re-
ceptors which are only found individually in eight cases out of 44. Similarly, the
POU and OAR domains are always found in conjunction with the Homeobox
domain and never independently. The zinc ﬁnger C2H2 often appears in groups
of 3 or 4 repetitions in 22% of the proteins having that domain (Fig. 6.8).
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We generated a subset containing 74 transcription factors belonging to the
enriched GO term chromosome organization to investigate the protein domain
composition characterizing the subset. For the enrichment analysis of this subset
we also selected Pfam domains, the Benjamini & Hochberg method for multiple
testing correction, and as background we chose the set containing the original
1,320 transcription factors. The results show that transcription factors annotated
as participating in chromosome organization are depleted in the Homeobox do-
main, one of the most commonly found domain of transcription factors in our
analysis (Fig. 6.8). However, Levine & Hoey (1988) argues that the Homeobox
domain is mostly involved in developmental processes which would explain the
scarcity of transcription factors in chromosome organization.
The subset of transcription factors was found enriched with the SET and PHD
ﬁnger-domains. Proteins having the SET domain methylate lysine amino acids
from histones while the PHD ﬁnger domain apparently is a protein-protein in-
teraction domain that binds tri-methylated lysines on target histones. Ten of
the eleven transcription factors having the PHD domain also contain other do-
mains like MOZ_SAS whose function is unclear and zf-CXXC that binds to non-
methylated CpG dinucleotides. We also found that eight of the eleven proteins
having the PHD domain often interact with each other.
These results may point to the formation of protein complexes composed of
PHD-containing proteins responsible for the activation of genes that are regulated
by the lysine methylation of histones.
6.9 Summary
The BioMyn web portal allows a multiple-perspective analysis of human gene
and protein sets based on the integrated annotations from dozens of biological
databases. The goal of the web portal is to aid in the interpretation of such sets
that are often the result of high-throughput experiments. Using BioMyn, the
visualization of enrichment analysis for user-submitted sets is straightforward,
allowing the researcher to concentrate on the analysis of the results rather than
acquiring the integrated information.
BioMyn is useful for exploratory analysis of the submitted sets and for the
generation and testing of hypotheses. We showed how the portal can be used to
study diﬀerent aspects of a set of proteins, including enrichment analysis of anno-
tations, protein-protein interactions (experimental and predicted) and functional
similarity relations based on the method presented in the previous chapter. The
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oﬀered analyses implement novel uses of visualization techniques and incorporate
fast and easy-to-use searching capabilities over most of the annotations known
for human genes and proteins.
BioMyn results can be easily saved for further analysis using spreadsheets,
R (R Development Core Team, 2011), and Cytoscape (Smoot et al., 2011) to
complement the analysis.
Although BioMyn has not been oﬃcially released yet, it receives about twenty
daily visitors that are mostly browsing the portal. A manuscript describing
BioMyn is in preparation.
Currently, the web portal most similar to BioMyn is the popular site DAVID (Huang
et al., 2007). An advantage of DAVID is the various model organisms for which in-
tegrated annotations are available and some additional analysis modules oﬀered.
However, in my opinion our web portal is more user-friendly, provides better vi-
sualization and navigation tools, oﬀers uniﬁcation for genes and proteins (DAVID
only uniﬁes gene annotations), and allows the creation of subsets for further anal-
ysis. BioMyn also has more up-to-date annotations as DAVID is only updated
annually.
7Conclusions
This closing chapter summarizes the work presented in this thesis and presents
the perspectives and future directions. Additionally, this chapter shows several
ongoing projects within our research group that are supported by the data ware-
house and related data mining and visualization tools. Finally, this dissertation
concludes with a perspective about current data integration endeavors and future
outcomes.
7.1 Summarizing remarks
Current experimental and computational high-throughput methods are generat-
ing biological data at unprecedented speeds. The possibility to interrogate whole
cellular systems at the level of genes, proteins and metabolites has spawned cell-
wide studies focusing on the dynamics and interactions of cellular elements. Such
comprehensive studies are part of what is known as systems biology, a relatively
new branch of biology aimed at understanding complex cellular processes. Scien-
tists have used high-throughput technologies to accumulate a tremendous amount
of data that, in order to be useful, needs to be analyzed and interpreted in the
context of all other information available. To ease such analysis, integrative repos-
itories aggregating and merging biological knowledge are required.
The construction of such integrative repositories, however, has proven to be a
challenging task due to the inherent complexities of the data found in biological
databases and to the spread of knowledge in multiple places. Moreover, such
repositories need to oﬀer appropriate data mining and analysis tools that are
easily accessible through simple interfaces to promote their use and adoption by
the biological and medical researchers.
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The work presented in this dissertation had addressed these challenges by (i)
creating an integrative repository containing millions of annotations from over
30 major molecular biology databases related to human genes and proteins, (ii)
proposing and validating a data mining method to identify similarly annotated
gene products, and (iii) developing a web portal to analyze large sets of genes
submitted by users using the integrated annotations in the repository.
The integrative repository uses a data warehousing model in which informa-
tion is periodically downloaded from more than 30 biological databases and lo-
cally stored in a relational database for eﬃcient searches. The integrated bio-
logical databases contain information about co-expressed genes, disease associa-
tions, drug associations, metabolic and signaling pathways, molecular functions,
orthologous species groups, phenotype associations, protein complexes, protein
domain classiﬁcations, protein-protein interactions, predicted protein-protein in-
teractions, sequence clusters, sub-cellular locations and gene expression in tissues.
The integrated data contained in the data warehouse was used to support two
important studies presented in this thesis. In the ﬁrst study, we assessed the re-
liability of human protein-protein interactions either predicted by computational
methods or produced by the yeast two-hybrid high-throughput method (Ramírez
et al., 2007). For this study we used the information from several protein-protein
interaction sources stored in the data warehouse together with protein domain
information and Gene Ontology associations that were used to assess the inter-
action data. The results revealed less reliable interactions from high-throughput
experiments than from computational predictions and manually curated interac-
tions. We also found that highly reliable interactions were those reported in at
least three diﬀerent experiments. This comprehensive study was highlighted in
the editorial section of the Proteomics journal where it was ﬁrst published and is
frequently cited in studies discussing the reliability of yeast two-hybrid results.
The predicted and experimental interactions collected into the data warehouse
for this study have been instrumental in subsequent studies from our research
group (Schlicker et al., 2007; Tress et al., 2007; Schlicker et al., 2010; Blanken-
burg et al., 2009b; Kacprowski, 2010) and the new topological measure introduced
in Chapter 3 shared neighbors was integrated as part of the Cytoscape plug-in
called NetworkAnalyzer (Assenov et al., 2008).
In a second study, we combined protein-protein interactions with protein func-
tions and signaling pathways contained in the data warehouse to predict an im-
portant type of proteins involved in signaling cascades called scaﬀold proteins
(Ramírez & Albrecht, 2010). Before this study, the few scaﬀold proteins known
had been found by chance through direct methods. Our analysis is considered
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the ﬁrst attempt to estimate the number and abundance of these proteins in the
human proteome (Alexa et al., 2010).
Having a solid infrastructure for storing integrated information allowed us
to devise a computational method for the discovery of biological relationships
based on the similarity of gene and protein annotations. This method, called
BioSim, overcomes the disadvantages associated to other similar methods that
are only available for genes and proteins annotated with GO terms (?). Our re-
sults demonstrated that the use of annotations from multiple sources drastically
improved the performance of our method. Using this method we were able to
accurately identify known disease-gene associations, thus opening the possibility
for future prediction of disease-causing genes.
Finally, we set up a web portal to oﬀer public access to the data warehouse
and to the BioSim method. This web portal is called BioMyn and can be reached
via the following URL: http://biomyn.de. The BioMyn web portal is optimized
for the analysis of large sets of genes or proteins submitted by the portal users.
BioMyn allows enrichment analysis based on the integrated data and is comple-
mented by novel visualization methods to explore the results. The web portal
oﬀers tremendous advantages to biological and medical researchers that are now
able to concentrate directly on the analysis of their data rather than acquiring
the integrated information. Sets of genes or proteins can be easily imported to
BioMyn and the diﬀerent analysis can be also easily exported and saved. The
web portal has been successfully used to analyze a list of candidate genes ob-
tained in a RNA interference screen targeting kinases of cultured cells infected
with hepatitis C virus (Reiss et al., 2011).
In summary, the data warehouse presented in this dissertation is a powerful
resource that facilitates large-scale analyses of data. To support this claim, we
described two important studies including the assessment of predicted protein-
protein interactions (Ramírez et al., 2007) and the computational discovery of
scaﬀold proteins (Ramírez & Albrecht, 2010). The integrated information of the
data warehouse allowed us to develop a new method to search similarly annotated
proteins likely to be functionally related (?). Lastly, we developed the web por-
tal BioMyn to facilitate the analysis of large sets of genes. Using BioMyn, the
interpretation and analysis of system-wide results that take into account the ac-
cumulated biological knowledge is greatly simpliﬁed by the access to search and
mining methods based on the integration of molecular biology databases.
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7.2 Perspectives
Ongoing projects
Several ongoing research projects are currently exploiting the practical utility of
the data warehouse.
• The BioSim method is being used to assess a large protein-protein interac-
tion network obtained to investigate the exocytosis of presynaptic vesicles in
neurons. This is a cooperation with the Max Planck Institute for Biophysical
Chemistry in Göttingen, Department of Neurobiology.
• The enrichment analysis tools from BioMyn are used to investigate candidate
proteins obtained from an interference RNA screen involving cells infected
with the Dengue virus. This project is a cooperation with the Department for
Molecular Virology at the University of Heidelberg.
• BioMyn is used to run exploratory analysis on genes associated to Crohn's
disease by identifying enriched and depleted cellular pathways. This is a coop-
eration with the University Hospital of Kiel supported by the National German
Research Network (NGFN) for environmental diseases.
Enhancements to the data warehouse and methods
An avalanche of biological data is expected to arrive in the following years, mostly
from inexpensive next-generation sequencing technologies (Africa, 2010; Metzker,
2010). Also, the completion of the human interactome using improved yeast two-
hybrid methods is foreseen to reach near completion in the next few years (Vidal
et al., 2011). Meanwhile, new molecular knowledge, specially regarding gene and
protein regulation, has resulted in the creation of novel biological databases de-
voted to epigenomics (Fingerman et al., 2011; Turinsky et al., 2011), microRNA
targets (Yang et al., 2011; Kaya et al., 2011), and transcription factor binding
sites (Portales-Casamar et al., 2010; Yamashita et al., 2010).
These new sources of information will need to be revised and integrated into
the data warehouse in order to keep it up-to-date. Additionally, the abundant
information available for model organisms such as mouse, yeast and ﬂy, need to be
added to the data warehouse. Besides facilitating the analysis and interpretation
of the high-throughput data from these organisms, this new information will
also permit us to transfer annotations between organisms. Such future steps are
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simpliﬁed by the database structure, which allows to add new information easily.
Currently, the inclusion of mouse data is underway.
The methods introduced in Chapter 3 to assess protein-protein interactions
can now be improved by the BioSim method. Using BioSim, protein-protein in-
teractions can be evaluated using data sources integrated in the data warehouse.
This will increase the scope of the methods and improve the reliability of the
assessments.
The interaction within available services developed in our group at the Max
Planck for Informatics, such as EpiExplorer (http://cosgen.bioinf.mpi-inf.
mpg.de) and FunSimMat (Schlicker et al., 2010), is another interesting area for
further development. EpiExplorer allows the quick analysis of a large number of
genetic features from genomic regions submitted by the users. To complement
EpiExplorer results, the sets of genes located in regions interesting to the user
can be automatically imported into BioMyn to explore the associated annotations
for those genes. FunSimMat allows the user to obtain a list of proteins probably
related to a given disease. These results could be directly analyzed using the
diﬀerent tools from the BioMyn web portal. At the moment, this integration is
being prepared in our research department.
In order to extend the usage of the data warehouse, the integration with popu-
lar stand-alone software such as Cytoscape (Smoot et al., 2011) can be provided.
Mike Wininger, a summer student at the MPII, already developed a plug-in for
Cytoscape that connects to our servers, collect annotations from the data ware-
house, and shows this information in the Cytoscape window. This plug-in can be
further developed to retrieve and show enrichments for groups of genes as well
as BioSim similarities from our servers. More generally, programmatic access to
the data warehouse can be added using common protocols like SOAP, REST and
PSICQUIC (Aranda et al., 2011).
Finally, BioMyn still needs to be exposed to more researchers who will provide
further feedback for improvement. For this, a manuscript presenting the web por-
tal is being prepared.
Wider perspective of the data integration field
Data integration will continue to be an issue in the upcoming years, mostly moti-
vated by the growing demand of studies that require access to multiple sources of
information. Although diverse methods to integrate biological information exist,
prevalent diﬃculties discussed in this dissertation related to data format, location,
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availability, and content hamper integrative solutions. An important limitation of
biological data integration is that it is virtually impossible to construct a deﬁni-
tive integrative repository able to capture all the speciﬁc aspects and details of
the data maintained by biological databases. Therefore, integrative repositories
necessarily need to make choices and ignore some of the available information
to merge disparate data sources. Nevertheless, it is feasible to integrate a large
fraction of the available information into solutions that address speciﬁc problems
such as the one presented here.
Researchers working in data integration actively encourage the transition to-
wards a Semantic Web (http://www.w3.org/2001/sw/) (Berners-Lee et al., 2001)
for the life sciences (Ruttenberg et al., 2009; Neumann, 2005; Goble & Stevens,
2008). Under the Semantic Web, information needs to be formated using standard
languages that encourage the clear deﬁnition of relations that are structured using
ontologies. Such standardization of the information already facilitates integration
by homogenizing the diverse data models available. Furthermore, current stan-
dards used in the life sciences such as the Biological Pathway Exchange (BioPAX)
Demir et al. (2010) request that external identiﬁers for diﬀerent reference systems
should be provided along with the semantic data. This will greatly facilitate the
identiﬁcation of common biological entities such as genes or proteins.
The Semantic Web will allow computers to interpret and make assertions
of the semantic data and, in turn, improve current search methods based on
the matching of keywords. For this, a number of software is already available
such as the query language SPARQL (Prud'hommeaux & Seaborne, 2008) and
semantic reasoners (software able to make logical inferences) such as Pellet
(http://pellet.owldl.com/), and Jena (http://openjena.org).
However, for the life sciences Semantic Web to work, databases should pro-
vide the information using a semantic format based on the Resource Description
Framework (RDF) or derived languages such as the Web Ontology Language
(OWL) and the aforementioned BioPAX (Ruttenberg et al., 2009). This content
should be delivered through standardized web services. In practice, this means
that many biological databases will have to program new software and transform
their data in order to participate, something that is unlikely to happen in the
near future. Furthermore, the use of the semantic formats to share the data needs
to be carefully controlled. As discussed in Section 2.2, page 13, data currently
available in such formats is hard to use because of deviations from the standard
that are speciﬁc to each data provider.
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To circumvent these hurdles, workﬂow and view integration software as well
as data warehouses like BioMyn have developed speciﬁc modules to access the
available information using the current format. Naturally, the availability of se-
mantic data will simplify much of the integration processes but, until such data
becomes widely accessible, the use of the information in its present form is the
only option.
However, data warehouses such as BioMyn are well prepared to make a
quick transition towards semantic data analysis. In fact, the organization of the
database schema of our data warehouse resembles the structure of one of the cor-
nerstones of the Semantic Web, the Resource Description Framework (RDF) used
to store semantic data. The RDF format uses expressions composed of a subject,
a predicate and an object for the conceptual description of the information. The
database schema of BioMyn contains the following matching tables to elaborate
RDF expressions: Molecule, Participant and MolecularConcept. Because of
the performed uniﬁcation steps, the data already present into our data warehouse
is probably more amenable for semantic searches than some semantic data found
somewhere else.
In conclusion, I believe that a transition towards a Semantic Web in the life
sciences is slowly happening. Data warehouses, as the one presented in this the-
sis, are in an advantageous situation because they can easily adapt to semantic
queries and analyses by converting the information they already store into a se-
mantic format. Thus, such data warehouses don't need to wait for other biological
databases to provide their contents in the appropriate semantic format, instead
they can quickly start using the available software to run semantic searches and
analysis.
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Appendix

AManually validated scaffold proteins
1
4
2symbol type pubmed id text snippet
AKAP12 scaffold 17686059 A-kinase anchor protein 12 (AKAP12) is a scaffold protein that participates in mitotic regulation and others signalling
processes and probably exerts tumour suppressor function.
scaffold 16442664 A-kinase anchoring proteins (AKAPs) define an expanding group of scaffold proteins that display a signature binding
site for the RI/RII subunit of protein kinase A.
scaffold 17626016 SSeCKS (Src-suppressed C kinase substrate), also called gravin/AKAP12, is a large scaffolding protein with metas-
tasis suppressor activity.
and others
AKAP9
(AKAP350)
scaffold 14569596 Recently, we demonstrated that several CLIC proteins, including CLIC4, interact with AKAP350. AKAP350 is concen-
trated at the Golgi apparatus, centrosome, and midbody and acts as a scaffolding protein for several protein kinases
and phosphatases.
scaffold 12163481 The protein kinase A-anchoring proteins (AKAPs) are defined by their ability to scaffold protein kinase A to specific
subcellular compartments.
scaffold 12163479 AKAP350 can scaffold a number of protein kinases and phosphatases at the centrosome and the Golgi apparatus.
and others
APC scaffold 19434056 The PDZ-proteins also promote functional nicotinic innervation of the neurons, as does the scaffold protein APC and
transmembrane proteins such as neuroligin and the EphB2 receptor.
BCAR1
(p130Cas)
scaffold 18256281 For over a decade, p130CAS/BCAR1, HEF1/NEDD9/CAS-L, and Efs/Sin have defined the CAS (Crk-associated
substrate) scaffolding protein family.
adaptor 19357231 Phosphorylation of the adaptor protein p130Cas was inversely related to phagocytosis
adaptor 19064994 Exposure to L. major resulted in degradation of the phosphorylated adaptor protein p130Cas and the protein-tyrosine
phosphatase-PEST
and others
BIRC2 adaptor 18997792 The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-kappaB
(NF-kappaB) signaling in resting cells by targeting NF-kappaB-inducing kinase (NIK) for ubiquitin-dependent degra-
dation
Continued on next page
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4
3
symbol type pubmed id text snippet
CD81 scaffold 15004227 These data reveal a potential role for tetraspanins CD9 and CD81 as GPCR scaffolding proteins
CRK (CRKII) adaptor 18599349 One family of adaptor molecules includes the CRKII/CRKL proteins that are also involved in the regulation of lym-
phocyte function.
adaptor 19350053 CRK adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal
adhesions and enhanced cell migration.
adaptor 18981215 Experiments with cultured neurons have shown that when Dab1 is phosphorylated on tyrosine, it activates Akt and
provides a scaffold for assembling signaling complexes, including the paralogous CRK and CRKL adaptors
and others
DAB1 adaptor/ scaf-
fold
18981215 These results show that Reelin-induced Akt stimulation and DAB1 turnover are not sufficient for normal development
and suggest that DAB1 acts both as a kinase switch and as a scaffold for assembling signaling complexes in vivo.
They also call DAB1 ’adapto
adaptor 10827173 Signaling through these receptors requires the interaction of their cytoplasmic tails with the intracellular adaptor
protein Disabled-1 (DAB1).
DBNL (ABP1,
HIP-55,
SH3P7)
adaptor 15798181 ABP1 acts as an adaptor protein in the localization or concentration of Sjl2 during late stages of endocytic vesicle
formation.
adaptor 14729663 We found that the cytoplasmic adaptor HIP-55, a Src/Syk-kinases substrate and member of the drebrin/ABP1 family
of actin-binding proteins
adaptor 14718626 The CD2v protein of African swine fever virus interacts with the actin-binding adaptor protein SH3P7.
adaptor 19725075 Further analysis of HIP-55 revealed that this adaptor protein becomes increasingly associated with both Syk and
integrin beta3 upon platelet activation.
and others
DOK1/2
(P62DOK)
adaptor 16338067 DOK1 is an adaptor tyrosine kinase substrate with tumor-suppressive activity.
adaptor 16823827 The data in this report show that both the DOK1 and the DOK2 adaptor proteins are constitutively expressed in the
myelomonoblastic leukemia cell line
adaptor 11254695 p62(dok) belongs to a newly identified family of adaptor proteins.
and others
Continued on next page
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4
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EFS (SYN) scaffold 11867627 Instead, the pathway involved relies on increased tyrosine phosphorylation of, and recruitment of Crk to, the SRC
substrate SIN/EFS. The latter is a scaffolding protein structurally similar to the SRC substrate Cas
scaffold 18256281 For over a decade, p130Cas/BCAR1, HEF1/NEDD9/Cas-L, and EFS/SIN have defined the Cas (Crk-associated sub-
strate) scaffolding protein family.
FADD adaptor 19583773 Fas-associated protein with death domain (FADD) is an essential adaptor protein in death receptor-mediated signal
transduction
adaptor 18661484 To investigate the role of the apoptosis adaptor molecules TRADD and FADD in the development of hematological
diseases, patient samples were screened for mutations in these genes.
adaptor 9582077 When activated, membrane-bound receptors for Fas and tumour-necrosis factor initiate programmed cell death by
recruiting the death domain of the adaptor protein FADD to the membrane.
and others
FRS2/3 adaptor 16887332 FRS2/3 are homologs that function as adaptor proteins to mediate signaling of multiple receptor tyrosine kinases.
adaptor 16702953 Unique role of FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling path-
ways.
GIPC1
(SYNECTIN)
adaptor 15459234 CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis
adaptor 16467373 The PDZ adaptor protein SYNECTIN bound the longer splice variant, Syx1, which was targeted to the plasma mem-
brane in a SYNECTIN-dependent manner
scaffold 16940428 SYNECTIN (GIPC1), a receptor scaffold protein, has been isolated by our laboratory as a syndecan-4 cytoplasmic
domain binding partner that regulates important aspects of cell motility
scaffold 15356268 We show that recruitment of GAIP (RGS19) by the dopamine D2 receptor (D2R), a GPCR, required the scaffold pro-
tein GIPC (GAIP-interacting protein, C terminus) and that all three were coexpressed in neurons and neuroendocrine
cells
and others
HTT scaffold 12881483 We propose that HTT, together with HAP1, may function as a scaffold for the activation of ND by MLK2.
scaffold 19269181 Overall, the predicted structure of huntingtin is consistent with a cellular role as a scaffold protein.
scaffold 19429504 Unexpectedly, the faulty gene product, mutant huntingtin (mtHtt), is an extremely large protein of 350 kDa and might
act as a scaffold protein regulating vesicle and organelle trafficking and signaling pathways.
Continued on next page
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INADL (PATJ) scaffold 17234746 Here we report, using a two-hybrid assay, a direct molecular interaction between TSC2 C-terminal part and PDZ 2
and 3 of PATJ, a scaffold member of the Crumbs 3 (CRB 3) complex in human intestinal epithelial cells, Caco2.
scaffold 16697075 One evolutionarily conserved protein complex, which can be found both in Drosophila and mammalian epithelial
cells, is composed of the transmembrane protein Crumbs/Crb3 and the scaffolding proteins Stardust/Pals1 and
DPATJ/PATJ, respectively, and localise
scaffold 15863617 A unified assembly mode revealed by the structures of tetrameric L27 domain complexes formed by mLin-2/mLin-7
and PATJ/Pals1 scaffold proteins. AXIN1 almost all references mention it as a Scaffold
IRS1/2 scaffold 19564410 Here we demonstrate the physical association of these signaling pathways using a proteomic approach that identified
insulin-regulated complexes of JIPs together with IRS scaffold proteins
adaptor 11024460 Interleukin-9 (IL-9) stimulation results in JAK, STAT and IRS1/2 phosphorylation. The role of IRS adaptor proteins in
IL-9 signaling is not clear
adaptor 19671761 In addition, we find that levels of other components of the signaling pathway such as the adaptor proteins IRS1 and
IRS2
adaptor 11024460 The role of IRS adaptor proteins in IL-9 signaling is not clear. We show that IL-9 induces IRS2 ...
and others
MAGI1 scaffold 18971469 MAGI-1, a candidate stereociliary scaffolding protein, associates with the tip-link component cadherin 23.
scaffold 19017743 TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.
scaffold 19403801 MAGI-1 is a scaffolding protein that allows formation of complexes between certain transmembrane proteins, actin-
binding proteins, and others regulatory proteins.
and others
MLLT4 (AF-6,
AFADIN)
scaffold 16819513 The AF-6/MLLT4 gene, telomeric of PARK2, encodes the AFADIN scaffold protein, which is essential for epithelial
integrity.
scaffold 17473018 The human AF-6, a scaffold protein between cell membrane-associated proteins and the actin cytoskeleton, plays
an important role in special cell-cell junctions and signal transduction.
adaptor 18593353 AFADIN additionally serves as an adaptor protein by further binding many scaffolding proteins
and others
MAPKSP1
(MP1)
adaptor/ scaf-
fold
15263099 Taken together, the presented work provides insight into the spatial regulation of MAPK signaling, illustrating how p14
and MP1 collaborate as an endosomal adaptor/scaffold complex
Continued on next page
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scaffold 19289794 On these LEs, we also identified the p14-MP1 scaffolding complex and activated extracellular signal-regulated kinase
1/2.
scaffold 19177150 p18 specifically binds to the p14-MP1 complex, a scaffold for MEK1.
and others
NF2 (Merlin) adaptor 16341207 Merlin is an adaptor protein with a FERM domain and it is thought to transduce a growth-regulatory signal.
NPHS1
(Nephrin)
scaffold 18480178 Nephrin, an essential adhesion and scaffolding molecule expressed in podocytes, emerged in this screen
scaffold 19443634 Within the glomerulus, the scaffolding protein nephrin bridges the actin-rich foot processes that extend from adjacent
podocytes to form the slit diaphragm
PIK3R1 (p85) scaffold 17024187 We show that p85 acts as a scaffold to bind Cdc42 and septin 2 simultaneously. p85 is thus involved in the spatial
control of cytosolic division through regulation of Cdc42 and septin 2, in a PI3K-activity independent manner.
RASSF1
(RASSF1A)
scaffold 17878233 Current evidence supports the hypothesis that RASSF1 serves as a scaffold.
scaffold 18641684 The failure of recombinant RASSF1A to activate recombinant Aurora-A indicates that RASSF1A may not activate
Aurora-A directly and suggests that RASSF1A may function as a scaffold to bring together Aurora-A and its activa-
tor(s).
RPTOR (Rap-
tor)
scaffold 16824195 4E-BP1 has been shown to associate with the scaffold protein raptor through its TOS and RAIP motifs to be recog-
nized by mTOR.
adaptor 19439614 We demonstrate that mTOR exerts its effects on oligodendrocyte differentiation through two distinct signaling com-
plexes, mTORC1 and mTORC2, defined by the presence of the adaptor proteins raptor and rictor, respectively
scaffold 18722121 The scaffolding protein Raptor binds to mTOR and recruits substrates to the rapamycin-sensitive mTOR complex 1
(mTORC1).
scaffold 16354680 Raptor directly binds to and serves as a scaffold for mTOR-mediated phosphorylation of IRS-1 on Ser636/639
and others
SHC2
(SHCB,
SLI)
adaptor 12006576 The signaling adapters SHCB and ShcC, but not ShcA, are thought to be the primary Shc adaptor proteins in neurons
as both are highly expressed in both the developing and adult nervous system.
Continued on next page
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adaptor 15893635 Shc family of adaptor (including SHCB and ShcC) molecules has been demonstrated to play an important role during
the transition from proliferating neural stem cells to postmitotic neurons.
adaptor 17409413 The Src homology and collagen (Src) family of adaptor proteins comprises six Shc-like proteins encoded by three loci
in mammals (Shc, Rai, and SLI)
SLC9A3R1
(NHERF1,
EBP50)
adaptor 19073137 The adaptor protein NHERF1 has previously been implicated in MRP4 internalization in non-polarized cells.
adaptor 19857202 The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T cells and the
immunomodulating effect of cAMP.
scaffold 19591839 Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1.
and others
SOCS3 adaptor 14707129 Suppressor of cytokine signaling (SOCS) proteins are a family of Src homology 2-containing adaptor proteins.
adaptor 15541651 Regulation of the immune system by SOCS family adaptor proteins.
adaptor 18948053 The SOCS box can also add unique features to individual SOCS proteins: it can function as an adaptor domain as
was demonstrated for SOCS3, or as a modulator of substrate binding in case of CIS.
SPTBN1
(ELF)
adaptor 16650383 We have shown that loss of ELF, a stem cell adaptor protein, disrupts TGF-beta signaling through Smad3 and Smad4
localization
adaptor/ scaf-
fold
12543979 Disruption of the adaptor protein ELF, a beta-spectrin, leads to disruption of transforming growth factor-beta (TGF-
beta) signaling by Smad proteins in mice.
adaptor 16359909 TGF-beta signaling mediator Smads are tightly dependent on modulation by adaptor proteins, such as ELF, SARA,
filamin, and crkl as well as ubiquitinators, such as PRAJA and SMURFs.
and others
SQSTM1
(p62)
scaffold 17229006 Mutations in SQSTM1, which encodes an important scaffold protein in this pathway, have been found to be a common
cause of classical Paget’s disease of bone (PDB)
scaffold 19850933 Using a combined Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-proteomics methodology, we
identified the cytoplasmic scaffold protein p62 as the molecular target of IDR-1
scaffold 18174161 Sequestosome 1 (SQSTM1)/p62 is an interacting partner of the atypical protein kinase C zeta/iota and serves as a
scaffold for cell signaling and ubiquitin binding,
Continued on next page
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adaptor 19765191 In cells lacking p62, the existence of mutant SOD1 in acidic autolysosomes decreased, suggesting that p62 can
function as an adaptor between mutant SOD1 and the autophagy machinery.
and others
TANK scaffold 18353649 Recent data provide insight into the requirement for scaffold proteins in complex assembly; NF-kappaB essen-
tial modulator coordinates some IKK complexes, whereas TANK, NF-kappaB-activating kinase-associated protein
1 (NAP1) or similar to NAP1 TBK1 adaptor
scaffold 17823124 we have identified TANK as a scaffold protein that assembles some but not all IRF3/7-phosphorylating TBK1-
IKKepsilon complexes
TICAM1
(TRIF)
adaptor 19648648 LPS and lauric acid enhanced the association of TLR4 with MD-2 and downstream adaptor molecules, TRIF and
MyD88
adaptor 15032644 TLR intracellular domains could then specifically recruit several adaptor proteins including MyD88, TIRAP/MAL, TRIF,
and TOLLIP.
adaptor 19825364 TIR domain-containing adaptor protein (TRIF) is an adaptor protein in Toll-like
and-more
TOLLIP adaptor 17113392 Our findings suggest that TOLLIP functions as an endosomal adaptor linking IL-1RI, via Tom1, to the endosomal
degradation machinery.
adaptor 15032644 TLR intracellular domains could then specifically recruit several adaptor proteins including MyD88, TIRAP/MAL, TRIF,
and TOLLIP.
adaptor 11751856 The adaptor protein TOLLIP was identified initially as an intermediate in interleukin (IL)-1 signaling
TRAF2/3/5 scaffold 16299380 Central role of the scaffold protein tumor necrosis factor receptor-associated factor 2 (TRAF2) in regulating endo-
plasmic reticulum stress-induced apoptosis.
adaptor 18997792 The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-kappaB
(NF-kappaB) signaling in resting cells by targeting NF-kappaB-inducing kinase (NIK) for ubiquitin-dependent degra-
dation ...
adaptor 19198591 Depletion of membrane cholesterol inhibited the assembly of an IL-12-inducing CD40 signalosome containing the
adaptors TRAF2, TRAF3 and TRAF5
adaptor 17991829 DUBA bound tumor necrosis factor receptor-associated factor 3 (TRAF3), an adaptor protein essential for the IFN-I
response
Continued on next page
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TRIP10
(CIP4)
scaffold 12456510 Altogether, these data suggest that CIP4/Felic constitute a novel family of cytoskeletal scaffolding proteins, integrating
Src and Cdc42 pathways.
adaptor 17785506 Thus, CIP4 is an important cytoskeletal adaptor that functions after filamentous actin accumulation and Cdc42
adaptor 19632321 Cdc42-Interacting Protein-4 (CIP4) family adaptors
TXN (Thiore-
doxin, TRX)
scaffold 19177362 OptGraft: A computational procedure for transferring a binding site onto an existing protein scaffold TXN.
scaffold 17875722 Expression of a scaffold protein (Thioredoxin) ....
scaffold 16827663 Upon immunization, the V3 peptide-inserted TRX scaffold was able to generate anti-V3 antibodies ...
and others
WASF2
(WAVE2)
adaptor 15899863 We find that Tiam1 contributes to both of these processes by binding to IRSp53, an adaptor protein that is an effector
for both Rac and Cdc42. Tiam1 directs IRSp53 to Rac signaling by enhancing IRSp53 binding to both active Rac and
the WAVE2 scaffold.
YWHAZ (14-
3-3 zeta)
scaffold 19218246 these results show that 14-3-3 (zeta):Shc scaffolds can act as multivalent signaling nodes for the integration of both
phosphoserine/threonine and phosphotyrosine pathways to regulate specific cellular responses.
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Table B.1: Familial glioma of brain. Annotation terms shared by BRCA2 and the disease-associated genes. The column `size' gives the total number
of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 MSH2
STRING Protein interactions 2 ERBB2
STRING Protein interactions 2 PTEN
OMIM MEDULLOBLASTOMA; MDB 8 DMBT1
GO BP response to X-ray 12 MSH2
HIMAP Indirect interaction 12 MSH2
OMIM PROSTATE CANCER 14 PTEN
GO BP manual regulation of epithelial cell proliferation 19 ERBB2
HIMAP Indirect interaction 27 MSH2
GO BP mammary gland development 29 ERBB2
GO BP negative regulation of DNA metabolic process 30 MSH2
GO BP response to ionizing radiation 34 MSH2
GO BP double-strand break repair 40 MSH2
GO BP aging 44 MSH2
HIMAP Indirect interaction 45 MSH2
GO BP regulation of epithelial cell proliferation 46 ERBB2
GO BP response to UV 47 MSH2
GO MF single-stranded DNA binding 49 MSH2
GO BP manual response to organic substance 50 PPARG
GO BP cell maturation 52 PPARG
GO BP DNA damage response, signal transduction 54 MSH2
GO BP response to nutrient 60 PPARG
GO BP germ cell development 62 MSH2
GO BP developmental maturation 67 PPARG
KEGG Pancreatic cancer 72 ERBB2
GO BP gonad development 72 MSH2
GO BP reproductive structure development 74 MSH2
GO BP manual response to hormone stimulus 77 PPARG
GO BP manual response to endogenous stimulus 79 PPARG
GO BP gland development 80 ERBB2
GO BP regulation of DNA metabolic process 81 MSH2
GO BP development of primary sexual characteristics 81 MSH2
GO BP response to nutrient levels 92 PPARG
GO BP DNA recombination 92 MSH2
GO BP in utero embryonic development 96 MSH2
GO BP response to extracellular stimulus 98 PPARG
GO BP sex differentiation 102 MSH2
GO BP response to light stimulus 105 MSH2
GO BP response to organic substance 105 PPARG
GO MF structure-specific DNA binding 105 MSH2
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Table B.2: Epidermolytic palmoplantar keratoderma. Annotation terms shared by KRT1 and the disease-associated genes. The column `size' gives
the total number of genes sharing the respective annotation.
annotation source description size genes
OMIM Palmoplantar keratoderma, nonepidermolytic 2 KRT16
IntAct Protein interaction 4 KRT9
IntAct Protein interaction 16 KRT9
Keyword Disease Palmoplantar keratoderma 16 KRT9, KRT16
IntAct Protein interaction 17 KRT9
IntAct Protein interaction 24 KRT9
IntAct Indirect interaction 24 KRT9, KRT16
MINT Indirect interaction 24 KRT9, KRT16
MINT Indirect interaction 27 KRT9
InterPro Prion protein 31 KRT9, KRT16
IntAct Protein interaction 33 KRT9
IntAct Indirect interaction 34 KRT9
IntAct Protein interaction 35 KRT9
IntAct Protein interaction 37 KRT9, KRT16
IntAct Protein interaction 50 KRT9, KRT16
IntAct Protein interaction 62 KRT9, KRT16
InterPro Keratin, type I 63 KRT9, KRT16
GO MF manual structural constituent of cytoskeleton 66 KRT9, KRT16
Pfam architecture Filament 66 KRT9, KRT16
InterPro Filament 68 KRT9, KRT16
HPRD Indirect interaction 68 KRT9
GO MF structural constituent of cytoskeleton 71 KRT9, KRT16
Pfam family Intermediate filament protein 74 KRT9, KRT16
Keyword Cellular component Intermediate filament 77 KRT9, KRT16
GO BP manual epidermis development 80 KRT9, KRT16
GO BP manual ectoderm development 88 KRT9, KRT16
GO BP manual tissue development 136 KRT9, KRT16
Keyword Cellular component Keratin 153 KRT9, KRT16
GO BP epidermis development 154 KRT9, KRT16
InterPro Prefoldin 159 KRT16
GO BP ectoderm development 168 KRT9, KRT16
GO CC intermediate filament 177 KRT9, KRT16
GO CC intermediate filament cytoskeleton 178 KRT9, KRT16
GO BP tissue development 331 KRT9, KRT16
GO MF manual structural molecule activity 351 KRT9, KRT16
GO CC manual cytoskeleton 477 KRT9, KRT16
GO BP manual organ development 502 KRT9, KRT16
GO MF structural molecule activity 596 KRT9, KRT16
GO CC cytoskeletal part 772 KRT9, KRT16
GO BP manual system development 869 KRT9, KRT16
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Table B.3: Antley-Bixler syndrome. Annotation terms shared by FGFR1 and the disease-associated genes. The column `size' gives the total number
of genes sharing the respective annotation.
annotation source description size genes
OMIM Pfeiffer syndrome 2 FGFR2
OMIM Jackson-Weiss syndromeS 2 FGFR2
PDB complexes Indirect interaction 2 FGFR2
PDB complexes Indirect interaction 3 FGFR2
IntAct Indirect interaction 4 FGFR2
InterPro Fibroblast growth factor receptor 4 FGFR2
HPRD Indirect interaction 4 FGFR2
GO MF fibroblast growth factor receptor activity 5 FGFR2
GO MF manual fibroblast growth factor receptor activity 5 FGFR2
Keyword Disease Craniosynostosis 8 FGFR2
HPRD Indirect interaction 11 FGFR2
Pfam architecture I-set 12 FGFR2
HPRD Indirect interaction 13 FGFR2
HPRD Indirect interaction 14 FGFR2
Reactome pathway Signaling by FGFR 22 FGFR2
Reactome pathway FGFR ligand binding and activation 22 FGFR2
GO BP manual cell growth 22 FGFR2
GO BP manual fibroblast growth factor receptor signaling pathway 25 FGFR2
GO BP fibroblast growth factor receptor signaling pathway 26 FGFR2
GO BP manual growth 29 FGFR2
GO BP cell growth 41 FGFR2
GO MF manual transmembrane receptor protein tyrosine kinase activity 47 FGFR2
ENZYME Receptor protein-tyrosine kinase 52 FGFR2
GO MF manual transmembrane receptor protein kinase activity 59 FGFR2
GO MF transmembrane receptor protein tyrosine kinase activity 64 FGFR2
Keyword Ligand Heparin-binding 64 FGFR2
GO MF manual protein tyrosine kinase activity 69 FGFR2
GO MF transmembrane receptor protein kinase activity 81 FGFR2
GO MF heparin binding 83 FGFR2
KEGG Prostate cancer 89 FGFR2
ENZYME Protein-tyrosine kinases 89 FGFR2
GO BP manual regulation of cell size 91 FGFR2
Table B.4: Cardiofaciocutaneous syndrome. Annotation terms shared by MAP2K1 and the disease-associated genes. The column `size' gives the
total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 KRAS
STRING Protein interactions 2 MAP2K2
STRING Protein interactions 2 BRAF
IntAct Protein interaction 3 BRAF
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Table B.4: (continued)
annotation source description size genes
HIMAP Indirect interaction 3 MAP2K2
Reactome pathway ERK activation 4 MAP2K2
IntAct Protein interaction 4 MAP2K2, BRAF
HIMAP Indirect interaction 5 MAP2K2
HIMAP Indirect interaction 6 MAP2K2
IntAct Protein interaction 7 MAP2K2
Reactome pathway MEK activation 7 MAP2K2, KRAS
Reactome pathway RAF phosphorylates MEK 7 MAP2K2, KRAS
MINT Indirect interaction 7 MAP2K2
HIMAP Indirect interaction 7 MAP2K2
ENZYME Mitogen-activated protein kinase kinase 8 MAP2K2
HPRD Indirect interaction 8 MAP2K2
Reactome pathway MAP kinase cascade 9 MAP2K2, KRAS
IntAct Proteins interacting with MEK1 10 BRAF
HIMAP Indirect interaction 10 MAP2K2
Reactome pathway SHC-mediated signaling 12 MAP2K2, KRAS
HIMAP Indirect interaction 12 MAP2K2
Reactome pathway SOS-mediated signaling 13 MAP2K2, KRAS
Reactome pathway SHC-related events 14 MAP2K2, KRAS
Reactome pathway Signaling to p38 via RIT and RIN 14 MAP2K2, KRAS, BRAF
Reactome pathway Frs2-mediated activation 16 MAP2K2, KRAS, BRAF
Reactome pathway Prolonged ERK activation events 17 MAP2K2, KRAS, BRAF
Reactome pathway ARMS-mediated activation 17 MAP2K2, KRAS, BRAF
IntAct Protein interaction 17 MAP2K2, BRAF
HPRD Indirect interaction 17 MAP2K2
ENZYME Dual-specificity kinases (those acting on Ser/Thr and Tyr 20 MAP2K2
HPRD Indirect interaction 21 MAP2K2
IntAct Indirect interaction 24 MAP2K2
IntAct Protein interaction 26 MAP2K2
Reactome pathway Signaling to RAS 26 MAP2K2, KRAS
KEGG Thyroid cancer 28 MAP2K2, KRAS, BRAF
Reactome pathway Signaling to ERKs 34 MAP2K2, KRAS, BRAF
Reactome pathway IRS-mediated signaling 36 MAP2K2, KRAS
Reactome pathway IRS-related events 38 MAP2K2, KRAS
Reactome pathway Signaling by Insulin receptor 39 MAP2K2, KRAS
Reactome pathway Insulin receptor signaling cascade 39 MAP2K2, KRAS
KEGG Bladder cancer 42 MAP2K2, KRAS, BRAF
Table B.5: Folate-sensitive neural tube defects. Annotation terms shared by MTHFR and the disease-associated genes. The column `size' gives the
total number of genes sharing the respective annotation.
annotation source description size genes
HIMAP Indirect interaction 6 MTR, MTHFD1, MTRR
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Table B.5: (continued)
annotation source description size genes
HumanCyc reductive acetyl coenzyme A pathway 8 MTHFD1
Reactome pathway Metabolism of folate and pterins 8 MTHFD1
HIMAP Indirect interaction 10 MTR, MTHFD1
HIMAP Indirect interaction 10 MTR, MTHFD1, MTRR
HumanCyc folate transformations 11 MTR, MTHFD1
GO BP methionine metabolic process 12 MTR, MTHFD1, MTRR
HIMAP Indirect interactions 14 MTR, MTHFD1, MTRR
ENZYME Oxidoreductases acting on the CH-NH group of donors with
NAD(+) or NADP(+) as acceptor
15 MTHFD1
KEGG One carbon pool by folate 16 MTR, MTHFD1
GO MF oxidoreductase activity, acting on the CH-NH group of donors,
NAD or NADP as acceptor
17 MTHFD1
HIMAP Indirect interaction 17 MTHFD1, MTRR
ENZYME Oxidoreductases acting on the CH-NH group of donors. 21 MTHFD1
GO BP sulfur amino acid metabolic process 22 MTR, MTHFD1, MTRR
GO BP aspartate family amino acid metabolic process 23 MTR, MTHFD1, MTRR
HIMAP Indirect interaction 25 MTR, MTRR
GO MF oxidoreductase activity, acting on the CH-NH group of donors 27 MTHFD1
Reactome pathway Metabolism of vitamins and cofactors 44 MTHFD1
Reactome pathway Metabolism of water-soluble vitamins and cofactors 44 MTHFD1
GO BP sulfur metabolic process 89 MTR, MTHFD1, MTRR
Keyword Ligand Flavoprotein 101 MTRR
Keyword Ligand FAD 110 MTRR
Keyword Ligand NADP 153 MTHFD1, MTRR
GO BP cellular amino acid metabolic process 218 MTR, MTHFD1, MTRR
GO BP cellular amino acid and derivative metabolic process 292 MTR, MTHFD1, MTRR
GO MF manual oxidoreductase activity 333 MTRR
GO BP amine metabolic process 338 MTR, MTHFD1, MTRR
GO BP nitrogen compound metabolic process 387 MTR, MTHFD1, MTRR
OrthoMCL Campylobacter jejuni subsp. jejuni NCTC 11168 435 MTHFD1
OrthoMCL Thermotoga maritima MSB8 439 MTR, MTHFD1
OrthoMCL Wolinella succinogenes DSM 1740 447 MTR, MTHFD1
GO BP carboxylic acid metabolic process 483 MTR, MTHFD1, MTRR
OrthoMCL Streptococcus pneumoniae TIGR4 486 MTHFD1
GO BP organic acid metabolic process 487 MTR, MTHFD1, MTRR
OrthoMCL Aquifex aeolicus VF5 491 MTHFD1
OrthoMCL Chlorobium tepidum TLS 516 MTR
Keyword Molecular function Oxidoreductase 527 MTHFD1, MTRR
OrthoMCL Synechococcus sp. WH 8102 543 MTR, MTHFD1
OrthoMCL Coxiella burnetii RSA 493 558 MTHFD1
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Table B.6: Obesity. Annotation terms shared by POMC and the disease-associated genes. The column `size' gives the total number of genes sharing the
respective annotation.
annotation source description size genes
STRING Protein interactions 2 AGRP
STRING Protein interactions 2 MC4R
STRING Protein interactions 2 GHRL
STRING Protein interactions 2 SDC3
STRING Protein interactions 2 ENPP1
STRING Protein interactions 2 MC3R
HPRD Indirect interaction 3 AGRP
HPRD Indirect interaction 3 MC4R
HPRD Indirect interaction 8 AGRP
Keyword Disease Obesity 29 ENPP1, CARTPT, ADRB3, UCP1, FTO,
PPARG, MC4R, AGRP, UCP3, NR0B2
Keyword PTM Amidation 44 GHRL
GO MF manual hormone activity 55 AGRP
KEGG Adipocytokine signaling pathway 67 AGRP
GO BP regulation of blood pressure 77 CARTPT, ADRB2, ADRB3, PPARG
Keyword Molecular function Hormone 83 GHRL
GO BP neuropeptide signaling pathway 87 CARTPT, AGRP
GO MF hormone activity 107 GHRL, AGRP
GO BP manual generation of precursor metabolites and energy 142 ENPP1, ADRB3
GO BP circulatory system process 151 CARTPT, ADRB2, PPARG
GO BP blood circulation 154 CARTPT, ADRB2, ADRB3, PPARG
Keyword PTM Cleavage on pair of basic residues 270 CARTPT
GO BP generation of precursor metabolites and energy 306 ENPP1, ADRB3
GO BP manual cell-cell signaling 389 GHRL
Table B.7: Autosomal recessive deafness-1A. Annotation terms shared by GJB6 and the disease-associated genes. The column `size' gives the total
number of genes sharing the respective annotation.
annotation source description size genes
OMIM Deafness, autosomal dominant 3A; DFNA3A 2 GJB2
Pfam architecture Connexin 3 GJB2
Keyword Disease Palmoplantar keratoderma 16 GJB2
Pfam architecture Connexin, Connexin_CCC 18 GJB2
InterPro Connexin, N-terminal 20 GJB2
GO CC connexon complex 21 GJB2
Pfam family Connexin 21 GJB2
Pfam family Gap junction channel protein cysteine-rich domain 21 GJB2
Keyword Disease Ectodermal dysplasia 23 GJB2
Keyword Cellular component Gap junction 26 GJB2
GO CC gap junction 27 GJB2
GO BP manual sensory perception of sound 47 GJB2
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Table B.7: (continued)
annotation source description size genes
GO BP manual sensory perception of mechanical stimulus 47 GJB2
GO BP sensory perception of sound 83 GJB2
GO BP sensory perception of mechanical stimulus 86 GJB2
Keyword Disease Deafness 98 GJB2
GO CC cell-cell junction 156 GJB2
GO BP manual sensory perception 229 GJB2
GO BP manual cognition 249 GJB2
Keyword Cellular component Cell junction 371 GJB2
GO BP manual neurological system process 423 GJB2
GO CC cell junction 461 GJB2
Mammalian Phenotype hearing/vestibular/ear phenotype 480 GJB2
GO BP manual system process 625 GJB2
GO BP sensory perception 787 GJB2
Table B.8: Autosomal idiopathic short stature. Annotation terms shared by GHR and the disease-associated genes. The column `size' gives the total
number of genes sharing the respective annotation.
annotation source description size genes
IntAct Protein interaction 2 GH1
IntAct Protein interaction 2 GH1
IntAct Protein interaction 2 GH1
PDB complexes human growth hormone bound to single receptor 2 GH1
PDB complexes structural plasticity at the hgh:hghbp interface 2 GH1
PDB complexes human growth hormone with its soluble binding protein 2 GH1
PDB complexes human growth hormone mutant g120r with its soluble binding
protein
2 GH1
PDB complexes human growth hormone and extracellular domain of its receptor 2 GH1
DIP Protein interaction 2 GH1
STRING Protein interactions 2 GHSR
STRING Protein interactions 2 GH1
GO BP manual regulation of multicellular organism growth 4 GH1, GHSR
GO BP manual positive regulation of multicellular organism growth 4 GH1, GHSR
GO BP positive regulation of tyrosine phosphorylation of Stat5 protein 10 GH1
GO BP response to estradiol stimulus 10 GH1
GO BP manual response to estradiol stimulus 10 GH1
GO BP positive regulation of tyrosine phosphorylation of Stat3 protein 11 GH1
GO BP regulation of tyrosine phosphorylation of Stat5 protein 12 GH1
GO BP cellular response to hormone stimulus 13 GHSR
GO MF peptide hormone binding 15 GHSR
GO BP regulation of tyrosine phosphorylation of Stat3 protein 17 GH1
GO BP manual positive regulation of growth 19 GH1, GHSR
GO BP positive regulation of multicellular organism growth 20 GH1, GHSR
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Table B.8: (continued)
annotation source description size genes
GO BP manual response to estrogen stimulus 20 GH1
GO BP positive regulation of tyrosine phosphorylation of STAT protein 21 GH1
GO BP positive regulation of JAK-STAT cascade 23 GH1
GO BP regulation of tyrosine phosphorylation of STAT protein 28 GH1
GO BP manual response to steroid hormone stimulus 28 GH1
GO MF hormone binding 29 GHSR
GO BP regulation of JAK-STAT cascade 34 GH1
Keyword Disease Dwarfism 34 GH1, SHOX
GO BP response to estrogen stimulus 36 GH1
GO BP positive regulation of peptidyl-tyrosine phosphorylation 37 GH1
GO BP positive regulation of growth 43 GH1, GHSR
GO BP regulation of multicellular organism growth 46 GH1, GHSR
GO BP regulation of peptidyl-tyrosine phosphorylation 52 GH1
GO BP positive regulation of protein amino acid phosphorylation 54 GH1
GO BP response to steroid hormone stimulus 60 GH1
GO BP positive regulation of phosphorylation 62 GH1
GO BP positive regulation of phosphorus metabolic process 63 GH1
Table B.9: Hypogonadotropic hypogonadism. Annotation terms shared by FGFR1 and the disease-associated genes. The column `size' gives the
total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 KISS1R
STRING Protein interactions 2 PROK2
STRING Protein interactions 2 NELF
Keyword Disease Kallmann syndrome 4 PROK2
GO BP manual MAPKKK cascade 95 PROK2
GO BP MAPKKK cascade 149 PROK2
GO BP manual protein kinase cascade 211 PROK2
GO BP manual protein amino acid phosphorylation 286 PROK2
GO BP protein kinase cascade 309 PROK2
GO BP manual phosphorylation 359 PROK2
GO BP manual phosphate metabolic process 444 PROK2
GO BP manual phosphorus metabolic process 444 PROK2
GO BP manual post-translational protein modification 494 PROK2
GO BP manual regulation of biological quality 563 PROK2
GO MF manual transmembrane receptor activity 589 KISS1R
GO BP regulation of cell proliferation 598 KISS1R
Mammalian Phenotype renal/urinary system phenotype 605 KISS1R
GO BP protein amino acid phosphorylation 609 PROK2
GO BP manual intracellular signaling cascade 631 PROK2
GO BP manual cell surface receptor linked signal transduction 674 KISS1R
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Table B.9: (continued)
annotation source description size genes
GO BP manual protein modification process 679 PROK2
GO BP manual biopolymer modification 706 PROK2
GO BP phosphorylation 740 PROK2
GO MF manual receptor activity 750 KISS1R
Mammalian Phenotype digestive/alimentary phenotype 790 KISS1R
GO BP manual system development 869 PROK2
GO BP phosphate metabolic process 899 PROK2
GO BP phosphorus metabolic process 899 PROK2
GO BP manual cellular protein metabolic process 996 PROK2
GO MF manual molecular transducer activity 996 KISS1R
GO MF manual signal transducer activity 996 KISS1R
GO BP manual anatomical structure development 1002 PROK2
GO BP post-translational protein modification 1031 PROK2
GO BP regulation of biological quality 1058 PROK2
GO BP manual multicellular organismal development 1082 PROK2
GO BP intracellular signaling cascade 1134 PROK2
GO BP manual protein metabolic process 1158 PROK2
GO MF transmembrane receptor activity 1247 KISS1R
GO BP manual developmental process 1268 PROK2
GO BP protein modification process 1299 PROK2
Table B.10: Noninsulin-dependent diabetes mellitus. Annotation terms shared by PPARG and the disease-associated genes. The column `size' gives
the total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 RETN
STRING Protein interactions 2 IL6
STRING Protein interactions 2 SLC30A8
STRING Protein interactions 2 IRS1
STRING Protein interactions 2 GPD2
STRING Protein interactions 2 KCNJ11
STRING Protein interactions 2 IRS2
GO BP manual cellular response to insulin stimulus 4 ENPP1
GO BP manual fat cell differentiation 6 TCF7L2
GO BP manual response to insulin stimulus 7 ENPP1
GO BP manual response to peptide hormone stimulus 7 ENPP1
GO BP cellular response to insulin stimulus 8 ENPP1
GO BP manual cellular response to hormone stimulus 8 ENPP1
GO BP regulation of fat cell differentiation 9 ENPP1
HPRD Indirect interaction 12 HNF4A
GO BP cellular response to hormone stimulus 13 ENPP1
GO BP manual glucose homeostasis 15 TCF7L2, WFS1, HNF1A
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Table B.10: (continued)
annotation source description size genes
GO BP manual carbohydrate homeostasis 15 TCF7L2, WFS1, HNF1A
Pfam architecture zf-C4 15 HNF4A
OMIM OBESITY 17 ENPP1
GO BP response to insulin stimulus 17 ENPP1
GO BP manual lipid homeostasis 19 HNF4A
HPRD Indirect interaction 19 HNF4A
HPRD Indirect interaction 23 HNF4A
GO BP fat cell differentiation 26 TCF7L2
GO MF fatty acid binding 26 HNF4A
HPRD Indirect interaction 26 HNF4A
KEGG Thyroid cancer 28 TCF7L2
GO BP manual response to nutrient 29 GCGR
Keyword Disease Obesity 29 RETN, ENPP1
GO BP response to peptide hormone stimulus 34 IRS2, ENPP1, IRS1
GO BP glucose homeostasis 36 TCF7L2, WFS1, HNF1A, GCK, PDX1,
NEUROD1
GO BP lipid homeostasis 36 LIPC, HNF4A
GO BP carbohydrate homeostasis 36 TCF7L2, WFS1, HNF1A, GCK, PDX1,
NEUROD1
GO BP manual regulation of blood pressure 38 GCGR
Pfam architecture zf-C4, Hormone_recep 38 HNF4A
GO BP manual response to nutrient levels 40 GCGR
HIMAP Indirect interaction 42 HNF4A
Keyword Disease Diabetes mellitus 42 WFS1, HNF1A, ABCC8, KCNJ11, GCK,
GCGR, HNF4A, RETN, ENPP1,
MAPK8IP1, HNF1B, PDX1, IRS1,
NEUROD1, SLC30A8
HPRD Indirect interaction 43 HNF4A
Pfam family Zinc finger, C4 type (two domains) 44 HNF4A
InterPro Vitamin D receptor 45 HNF4A
GO BP manual response to extracellular stimulus 45 GCGR
InterPro Zinc finger, nuclear hormone receptor-type 46 HNF4A
InterPro Steroid hormone receptor 46 HNF4A
Pfam family Ligand-binding domain of nuclear hormone receptor 46 HNF4A
InterPro Nuclear hormone receptor, ligand-binding, core 47 HNF4A
InterPro Nuclear hormone receptor, ligand-binding 47 HNF4A
GO MF steroid hormone receptor activity 49 HNF4A
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Table B.11: Susceptibility to atypical hemolytic uremic syndrome-1. Annotation terms shared by CFI and the disease-associated genes. The
column `size' gives the total number of genes sharing the respective annotation.
annotation source description size genes
HIMAP Indirect interaction 9 CFH
HIMAP Indirect interaction 9 CFH
HIMAP Indirect interaction 15 CFH
HIMAP Indirect interaction 26 CFH
GO BP complement activation, classical pathway 28 CD46
Keyword Biological process Complement pathway 28 CD46
GO BP humoral immune response mediated by circulating
immunoglobulin
29 CD46
HIMAP Indirect interaction 30 CFH, CD46
HIMAP Indirect interaction 32 CFH, CD46
HIMAP Indirect interaction 35 CFH, CD46
GO BP activation of plasma proteins involved in acute inflammatory
response
36 CFH, CD46
GO BP complement activation 36 CFH, CD46
HIMAP Indirect interaction 37 CFH, CD46
HIMAP Indirect interaction 41 CFH, CD46
GO BP immunoglobulin mediated immune response 47 CD46
GO BP B cell mediated immunity 48 CD46
HIMAP Indirect interaction 49 CFH, CD46
HIMAP Indirect interaction 49 CFH, CD46
Keyword Biological process Innate immunity 56 CFH, CD46
GO BP lymphocyte mediated immunity 59 CD46
HIMAP neighbors Indirect interactioncomplement component 1, r subcomponent 64 CFH, CD46
GO BP adaptive immune response based on somatic recombination of
immune receptors built from immunoglobulin superfamily
domains
65 CD46
GO BP adaptive immune response 65 CD46
GO BP activation of immune response 66 CFH, CD46
KEGG Complement and coagulation cascades 68 CFH, CD46
GO BP leukocyte mediated immunity 68 CD46
GO BP humoral immune response 68 CFH, CD46
GO BP acute inflammatory response 74 CFH, CD46
GO BP positive regulation of immune response 96 CFH, CD46
GO BP immune effector process 100 CFH, CD46
GO BP innate immune response 122 CFH, CD46
GO BP positive regulation of response to stimulus 137 CFH, CD46
GO BP regulation of immune response 152 CFH, CD46
GO BP positive regulation of immune system process 166 CFH, CD46
Keyword Biological process Immune response 199 CFH, CD46
GO BP regulation of response to stimulus 245 CFH, CD46
GO BP regulation of immune system process 270 CFH, CD46
GO BP inflammatory response 274 CFH, CD46
GO BP response to wounding 408 CFH, CD46
GO BP defense response 539 CFH, CD46
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Table B.12: Noninsulin-dependent diabetes mellitus. Annotation terms shared by SLC2A4 and the disease-associated genes. The column `size'
gives the total number of genes sharing the respective annotation.
annotation source description size genes
Reactome pathway Glucose uptake 9 GCK
GO BP manual glucose homeostasis 15 TCF7L2, WFS1, HNF1A
GO BP manual carbohydrate homeostasis 15 TCF7L2, WFS1, HNF1A
IntAct neighbors Indirect interactionDeath domain-associated protein 6 30 TCF7L2
GO BP glucose homeostasis 36 TCF7L2, WFS1, HNF1A, GCK, PDX1,
NEUROD1
GO BP carbohydrate homeostasis 36 TCF7L2, WFS1, HNF1A, GCK, PDX1,
NEUROD1
KEGG Type II diabetes mellitus 42 ABCC8, KCNJ11, IRS2, PDX1, IRS1
Keyword Disease Diabetes mellitus 42 WFS1, HNF1A, ABCC8, KCNJ11, GCK,
GCGR, HNF4A, RETN, ENPP1,
MAPK8IP1, HNF1B, PDX1, IRS1,
NEUROD1, SLC30A8
Reactome pathway Metabolism of vitamins and cofactors 44 ENPP1
Reactome pathway Metabolism of water-soluble vitamins and cofactors 44 ENPP1
KEGG Adipocytokine signaling pathway 67 AKT2, IRS2, IRS1
Reactome pathway Glucose metabolism 70 GCK
HPRD Indirect interaction 73 AKT2
Reactome pathway Metabolism of carbohydrates 87 GCK
GO CC manual cell surface 123 VEGFA, ENPP1
KEGG Insulin signaling pathway 136 AKT2, IRS2, IRS1
GO CC manual membrane-bounded vesicle 174 VEGFA, SLC30A8
GO CC microsome 176 KCNJ11, IRS1
GO CC vesicular fraction 182 KCNJ11, IRS1
GO CC manual vesicle 184 VEGFA, SLC30A8
GO BP manual chemical homeostasis 199 TCF7L2, WFS1, HNF1A, KCNJ11,
HNF4A, ENPP1, SLC30A8
GO CC cell surface 234 VEGFA, ENPP1
GO BP manual carbohydrate metabolic process 247 ABCC8, KCNJ11
GO BP manual homeostatic process 251 TCF7L2, WFS1, HNF1A, KCNJ11,
HNF4A, ENPP1, IL6, SLC30A8
GO CC manual endomembrane system 296 WFS1
Mammalian Phenotype adipose tissue phenotype 299 HNF1A, GPD2, GCGR, RETN, AKT2,
IRS2, IRS1
GO BP chemical homeostasis 361 LIPC, TCF7L2, WFS1, HNF1A,
KCNJ11, GCK, HNF4A, ENPP1, PDX1,
NEUROD1, SLC30A8
GO CC cytoplasmic membrane-bounded vesicle 400 VEGFA, SLC30A8
GO MF manual substrate-specific transmembrane transporter activity 404 ABCC8, SLC30A8
GO CC membrane-bounded vesicle 407 VEGFA, SLC30A8
GO CC manual organelle membrane 424 WFS1
Keyword PTM Ubl conjugation 428 TCF7L2, MAPK8IP1
GO MF manual transmembrane transporter activity 437 ABCC8, SLC30A8
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Table B.12: (continued)
annotation source description size genes
GO MF manual substrate-specific transporter activity 471 ABCC8, SLC30A8
GO BP carbohydrate metabolic process 472 ABCC8, KCNJ11, GCK, GPD2, PDX1
GO CC cytoplasmic vesicle 522 VEGFA, SLC30A8
GO BP homeostatic process 529 LIPC, TCF7L2, WFS1, HNF1A,
KCNJ11, GCK, HNF4A, ENPP1, PDX1,
NEUROD1, IL6, SLC30A8
GO CC vesicle 534 VEGFA, SLC30A8
GO BP manual regulation of biological quality 563 TCF7L2, WFS1, HNF1A, KCNJ11,
GCGR, HNF4A, VEGFA, ENPP1,
PDX1, IL6, SLC30A8
GO MF manual transporter activity 575 ABCC8, SLC30A8
Table B.13: Autosomal recessive deafness-1A. Annotation terms shared by GJB3 and the disease-associated genes. The column `size' gives the total
number of genes sharing the respective annotation.
annotation source description size genes
GO MF gap junction channel activity 7 GJB2
GO MF wide pore channel activity 8 GJB2
Pfam architecture Connexin, Connexin_CCC 18 GJB2
InterPro Connexin, N-terminal 20 GJB2
GO CC connexon complex 21 GJB2
Pfam family Connexin 21 GJB2
Pfam family Gap junction channel protein cysteine-rich domain 21 GJB2
Keyword Cellular component Gap junction 26 GJB2
GO CC gap junction 27 GJB2
Keyword Disease Deafness 98 GJB2
GO CC cell-cell junction 156 GJB2
Keyword Cellular component Cell junction 371 GJB2
GO MF channel activity 394 GJB2
GO MF passive transmembrane transporter activity 394 GJB2
Mammalian Phenotype no phenotypic analysis 424 GJB2
GO CC cell junction 461 GJB2
GO MF transmembrane transporter activity 868 GJB2
Mammalian Phenotype embryogenesis phenotype 992 GJB2
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Table B.14: Autosomal recessive dyskeratosis congenita. Annotation terms shared by NHP2 and the disease-associated genes. The column `size'
gives the total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 NOP10
GO BP pseudouridine synthesis 14 NOP10
GO CC small nucleolar ribonucleoprotein complex 16 NOP10
GO BP RNA modification 39 NOP10
Keyword Biological process Ribosome biogenesis 45 NOP10
Keyword Biological process rRNA processing 54 NOP10
GO BP rRNA processing 83 NOP10
GO BP rRNA metabolic process 86 NOP10
GO BP ribosome biogenesis 113 NOP10
GO BP ncRNA processing 157 NOP10
GO BP ribonucleoprotein complex biogenesis 164 NOP10
GO BP ncRNA metabolic process 201 NOP10
Keyword Molecular function Ribonucleoprotein 305 NOP10
GO CC nucleolus 399 NOP10
GO CC ribonucleoprotein complex 422 NOP10
GO BP RNA processing 505 NOP10
GO BP RNA metabolic process 838 NOP10
Table B.15: Orofacial cleft-1. Annotation terms shared by MTHFR and the disease-associated genes. The column `size' gives the total number of genes
sharing the respective annotation.
annotation source description size genes
HIMAP Indirect interaction 6 MTR
HIMAP Indirect interaction 10 MTR
HumanCyc folate transformations 11 MTR
GO BP methionine metabolic process 12 MTR
HIMAP neighbors Indirect interactionspermine synthase 14 MTR
KEGG One carbon pool by folate 16 MTR
GO BP sulfur amino acid metabolic process 22 MTR
GO BP aspartate family amino acid metabolic process 23 MTR
HIMAP Indirect interaction 25 MTR
GO BP sulfur metabolic process 89 MTR
GO BP cellular amino acid metabolic process 218 MTR
GO BP cellular amino acid and derivative metabolic process 292 MTR
GO BP amine metabolic process 338 MTR
GO BP nitrogen compound metabolic process 387 MTR
OrthoMCL Thermotoga maritima MSB8 439 MTR
OrthoMCL Wolinella succinogenes DSM 1740 447 MTR
GO BP carboxylic acid metabolic process 483 MTR
GO BP organic acid metabolic process 487 MTR
OrthoMCL Chlorobium tepidum TLS 516 MTR
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Table B.15: (continued)
annotation source description size genes
OrthoMCL Synechococcus sp. WH 8102 543 MTR
OrthoMCL Geobacter sulfurreducens PCA 618 MTR
OrthoMCL Brucella suis 1330 705 MTR
OrthoMCL Yersinia pestis CO92 733 MTR
GO CC manual cytosol 736 MTR
OrthoMCL Vibrio cholerae O1 biovar eltor str. N16961 743 MTR
OrthoMCL Shigella flexneri 2a str. 301 758 MTR
OrthoMCL Salmonella enterica subsp. enterica serovar Typhi str. CT18 781 MTR
OrthoMCL Ralstonia solanacearum GMI1000 812 MTR
OrthoMCL Escherichia coli W3110 817 MTR
OrthoMCL Agrobacterium tumefaciens str. C58 830 MTR
GO CC cytosol 892 MTR
OrthoMCL Rhodopirellula baltica SH 1 894 MTR
Table B.16: Alzheimer disease. Annotation terms shared by APP and the disease-associated genes. The column `size' gives the total number of genes
sharing the respective annotation.
annotation source desc size genes
IntAct Protein interaction 2 APBB2
IntAct Protein interaction 2 APBB2
DIP Protein interaction 2 A2M
STRING Protein interactions 2 SORL1
STRING Protein interactions 2 BLMH
STRING Protein interactions 2 APBB2
STRING Protein interactions 2 A2M
HPRD Indirect interaction 16 A2M
HPRD Indirect interaction 19 PLAU
GO CC platelet alpha granule lumen 33 A2M
GO CC manual platelet alpha granule lumen 33 A2M
GO CC cytoplasmic membrane-bounded vesicle lumen 35 A2M
GO CC vesicle lumen 35 A2M
GO CC manual cytoplasmic membrane-bounded vesicle lumen 35 A2M
GO CC manual vesicle lumen 35 A2M
GO CC platelet alpha granule 45 A2M
GO CC manual platelet alpha granule 45 A2M
HPRD Indirect interaction 53 A2M
Reactome pathway Exocytosis of Alpha granule 59 A2M
GO BP extracellular matrix organization 60 APBB2
Reactome pathway Platelet degranulation 61 A2M
Reactome pathway Response to elevated platelet cytosolic Ca++ 65 A2M
GO CC manual secretory granule 68 A2M
HPRD Indirect interaction 70 NOS3
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Table B.16: (continued)
annotation source desc size genes
GO BP axon guidance 78 APBB2
Reactome pathway Platelet Activation 80 A2M
GO CC manual cytoplasmic vesicle part 80 A2M
Reactome pathway Formation of Platelet plug 83 A2M
Keyword Molecular function Serine protease inhibitor 84 A2M
Keyword Biological process Endocytosis 86 SORL1
GO CC apical part of cell 92 NOS3
GO MF serine-type endopeptidase inhibitor activity 93 A2M
Table B.17: Susceptibility to atypical hemolytic uremic syndrome-1. Annotation terms shared by CFHR1 and the disease-associated genes. The
column `size' gives the total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 CFH
HIMAP Indirect interaction 32 CFH, CD46
HIMAP indirect interaction 35 CFH, CD46
GO BP activation of plasma proteins involved in acute inflammatory
response
36 CFH, CD46
GO BP complement activation 36 CFH, CD46
HIMAP Indirect interaction 37 CFH, CD46
HIMAP Indirect interaction 39 CFH, CD46
HIMAP Indirect interaction 40 CFH, CD46
HIMAP Indirect interaction 41 CFH, CD46
HIMAP Indirect interaction 49 CFH, CD46
Pfam family Sushi domain (SCR repeat) 49 CFH, CD46
InterPro Sushi/SCR/CCP 54 CFH, CD46
InterPro Complement control module 55 CFH, CD46
Keyword Domain Sushi 56 CFH, CD46
GO BP activation of immune response 66 CFH, CD46
GO BP humoral immune response 68 CFH, CD46
GO BP acute inflammatory response 74 CFH, CD46
GO BP positive regulation of immune response 96 CFH, CD46
GO BP immune effector process 100 CFH, CD46
GO BP positive regulation of response to stimulus 137 CFH, CD46
GO BP regulation of immune response 152 CFH, CD46
GO BP positive regulation of immune system process 166 CFH, CD46
GO BP regulation of response to stimulus 245 CFH, CD46
GO BP regulation of immune system process 270 CFH, CD46
GO BP inflammatory response 274 CFH, CD46
GO CC manual extracellular space 292 CFH
GO CC manual extracellular region part 401 CFH
GO BP response to wounding 408 CFH, CD46
1
6
8
Table B.17: (continued)
annotation source description size genes
GO BP defense response 539 CFH, CD46
GO CC extracellular space 587 CFH
GO BP immune response 616 CFH, CD46
GO BP response to external stimulus 677 CFH, CD46
GO CC manual extracellular region 726 CFH
GO CC extracellular region part 860 CFH
GO BP immune system process 870 CFH, CD46
Table B.18: Endometrial cancer. Annotation terms shared by MHL3 and the disease-associated genes. The column `size' gives the total number of
genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 MSH6
Keyword Disease Hereditary nonpolyposis colorectal cancer 7 MSH6
GO MF mismatched DNA binding 16 MSH6
GO BP mismatch repair 22 MSH6
KEGG Mismatch repair 23 MSH6
GO BP meiosis I 33 MSH6
GO MF double-stranded DNA binding 62 MSH6
GO CC nuclear chromosome part 71 MSH6
GO BP M phase of meiotic cell cycle 79 MSH6
GO BP meiosis 79 MSH6
GO BP meiotic cell cycle 81 MSH6
GO BP DNA recombination 92 MSH6
GO CC nuclear chromosome 102 MSH6
GO MF structure-specific DNA binding 105 MSH6
GO MF chromatin binding 115 MSH6
Keyword Biological process DNA repair 160 MSH6
Keyword Biological process DNA damage 178 MSH6
GO BP DNA repair 254 MSH6
GO BP M phase 265 MSH6
GO BP manual DNA metabolic process 275 MSH6
GO BP cellular response to DNA damage stimulus 288 MSH6
GO CC chromosomal part 295 MSH6
GO BP response to DNA damage stimulus 327 MSH6
GO BP cell cycle phase 336 MSH6
GO BP cellular response to stress 340 MSH6
GO BP cellular response to stimulus 363 MSH6
GO CC chromosome 366 MSH6
GO BP chromosome organization 390 MSH6
GO BP DNA metabolic process 445 MSH6
GO BP cell cycle process 476 MSH6
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Table B.18: (continued)
annotation source description size genes
GO BP cell cycle 671 MSH6
GO MF manual DNA binding 818 MSH6
GO BP manual nucleobase, nucleoside, nucleotide and nucleic acid metabolic
process
882 MSH6
GO BP organelle organization 974 MSH6
GO MF manual nucleic acid binding 1096 MSH6
GO MF ATP binding 1314 MSH6
GO BP response to stress 1329 MSH6
GO MF adenyl ribonucleotide binding 1329 MSH6
GO CC nuclear part 1377 MSH6
GO MF adenyl nucleotide binding 1409 MSH6
Table B.19: Susceptibility to atypical hemolytic uremic syndrome-1. Annotation terms shared by CFHR3 and the disease-associated genes. The
column `size' gives the total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 3 CFH
STRING Protein interactions 3 CFH
Pfam architecture Sushi, Sushi, Sushi, Sushi 5 CD46
HPRD neighbors Indirect interaction 24 CFH, CD46
Pfam family Sushi domain (SCR repeat) 49 CFH, CD46
InterPro Sushi/SCR/CCP 54 CFH, CD46
InterPro Complement control module 55 CFH, CD46
Keyword Domain Sushi 56 CFH, CD46
GO CC manual extracellular space 292 CFH
GO CC manual extracellular region part 401 CFH
GO CC extracellular space 587 CFH
GO CC manual extracellular region 726 CFH
GO CC extracellular region part 860 CFH
Table B.20: Mitochondrial neurogastrointestinal encephalopathy syndrome. Annotation terms shared by POLG and the disease-associated
genes. The column `size' gives the total number of genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 TYMP
GO BP mitochondrial genome maintenance 5 TYMP
GO BP mitochondrion organization 93 TYMP
GO BP DNA replication 170 TYMP
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Table B.20: (continued)
annotation source description size genes
GO BP manual DNA metabolic process 275 TYMP
GO BP DNA metabolic process 445 TYMP
GO BP cellular biopolymer biosynthetic process 750 TYMP
GO BP biopolymer biosynthetic process 751 TYMP
GO MF manual transferase activity 794 TYMP
GO BP manual nucleobase, nucleoside, nucleotide and nucleic acid metabolic
process
882 TYMP
GO BP cellular macromolecule biosynthetic process 945 TYMP
GO BP organelle organization 974 TYMP
GO BP macromolecule biosynthetic process 986 TYMP
ENZYME Transferases 1109 TYMP
Keyword Disease Disease mutation 1509 TYMP
Keyword Molecular function Transferase 1535 TYMP
GO BP nucleobase, nucleoside, nucleotide and nucleic acid metabolic
process
1596 TYMP
GO BP cellular biosynthetic process 1603 TYMP
Mammalian Phenotype immune system phenotype 1611 TYMP
GO MF transferase activity 1645 TYMP
GO BP biosynthetic process 1687 TYMP
GO BP manual cellular biopolymer metabolic process 1716 TYMP
GO BP manual cellular macromolecule metabolic process 1770 TYMP
GO BP cellular component organization 1840 TYMP
Mammalian Phenotype nervous system phenotype 1865 TYMP
GO BP manual biopolymer metabolic process 1890 TYMP
GO BP manual macromolecule metabolic process 1941 TYMP
GO CC manual cytoplasmic part 2149 TYMP
GO MF manual catalytic activity 2332 TYMP
GO BP manual cellular metabolic process 2467 TYMP
GO BP manual primary metabolic process 2500 TYMP
GO BP developmental process 2638 TYMP
GO BP manual metabolic process 2802 TYMP
GO BP response to stimulus 2843 TYMP
GO CC manual cytoplasm 3042 TYMP
GO BP cellular biopolymer metabolic process 3304 TYMP
GO BP cellular macromolecule metabolic process 3444 TYMP
GO BP biopolymer metabolic process 3809 TYMP
GO BP macromolecule metabolic process 3961 TYMP
GO CC cytoplasmic part 4118 TYMP
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Table B.21: Colorectal cancer. Annotation terms shared by CCND1 and the disease-associated genes. The column `size' gives the total number of
genes sharing the respective annotation.
annotation source description size genes
STRING Protein interactions 2 APC
STRING Protein interactions 2 EP300
STRING Protein interactions 2 PIK3CA
STRING Protein interactions 2 TP53
STRING Protein interactions 2 AKT1
STRING Protein interactions 2 AXIN2
GO BP response to UV-A 3 AKT1
GO BP manual response to UV-A 3 AKT1
GO BP manual positive regulation of cyclin-dependent protein kinase activity 6 AKT1
GO BP positive regulation of cyclin-dependent protein kinase activity 7 AKT1
IntAct neighbors Indirect interactionSerine/threonine-protein phosphatase
PP1-gamma catalytic subunit
16 TP53
HPRD Indirect interaction 18 EP300
HPRD Indirect interaction 21 EP300
MINT Indirect interaction 22 TP53
GO BP response to endoplasmic reticulum stress 23 TP53
GO BP ER-nuclear signaling pathway 26 TP53
KEGG Thyroid cancer 28 TP53, NRAS
GO BP manual positive regulation of cell cycle 28 AKT1
GO BP manual response to UV 31 AKT1
GO BP manual G1/S transition of mitotic cell cycle 33 AKT1
HPRD Indirect interaction 34 AKT1
HPRD Indirect interaction 34 TP53
HPRD Indirect interaction 36 EP300
HIMAP Indirect interaction 40 AURKA, BUB1B
KEGG Bladder cancer 42 TP53, NRAS
GO BP positive regulation of cell cycle 43 AKT1
HPRD Indirect interaction 45 TP53, EP300
GO BP G1/S transition of mitotic cell cycle 46 AKT1
HPRD Indirect interaction 46 AKT1
GO BP response to UV 47 TP53, AKT1
GO BP manual regulation of cyclin-dependent protein kinase activity 47 APC, AKT1
Table B.22: Osteogenic sarcoma. Annotation terms shared by TP53 and the disease-associated genes. The column `size' gives the total number of
genes sharing the respective annotation.
annotation source description size genes
MINT 2 CHEK2
STRING Protein interactions 2 RB1
STRING Protein interactions 2 CHEK2
PDB complexes Indirect interaction 3 RB1
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Table B.22: (continued)
annotation source description size genes
Keyword Disease Li-Fraumeni syndrome 3 CHEK2
IntAct Indirect interaction 4 RB1
MINT Indirect interaction 5 RB1
HPRD Indirect interaction 6 RB1
HPRD Indirect interaction 7 CHEK2
IntAct Indirect interaction 11 CHEK2
GO BP response to gamma radiation 14 CHEK2
GO BP manual DNA damage response, signal transduction resulting in
induction of apoptosis
15 CHEK2
OMIM Breast cancer 16 CHEK2
HPRD Indirect interaction 16 RB1, CHEK2
MINT Indirect interaction 17 RB1, CHEK2
IntAct Indirect interaction 22 RB1
GO BP DNA damage response, signal transduction resulting in
induction of apoptosis
23 CHEK2
GO CC manual PML body 24 RB1, CHEK2
GO CC PML body 25 RB1, CHEK2
GO BP manual induction of apoptosis by intracellular signals 28 CHEK2
GO BP DNA damage checkpoint 32 CHEK2
GO BP response to ionizing radiation 34 CHEK2
GO BP DNA integrity checkpoint 35 CHEK2
KEGG Bladder cancer 42 RB1
GO BP induction of apoptosis by intracellular signals 42 CHEK2
GO BP manual DNA damage response, signal transduction 42 CHEK2
Table B.23: Mitochondrial complex I deﬁciency. Annotation terms shared by NDUFA11 and the disease-associated genes. The column `size' gives
the total number of genes sharing the respective annotation.
annotation source description size genes
CORUM Respiratory chain complex I (lambda
subunit) mitochondrial
16 NDUFS6, NDUFV1, NDUFS1, NDUFS2, NDUFS4
CORUM Respiratory chain complex I
(holoenzyme), mitochondrial
44 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
HumanCyc NAD/NADH phosphorylation and
dephosphorylation
44 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
Keyword Biological process Respiratory chain 58 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
Reactome pathway Electron Transport Chain 76 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
Keyword Biological process Electron transport 101 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO BP electron transport chain 113 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
KEGG Oxidative phosphorylation 128 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
Keyword Cellular component Mitochondrion inner membrane 186 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC mitochondrial inner membrane 280 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
1
7
3
Table B.23: (continued)
annotation source description size genes
GO CC organelle inner membrane 297 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO BP generation of precursor metabolites and
energy
306 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC mitochondrial membrane 359 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC mitochondrial envelope 378 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC mitochondrial part 535 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC organelle envelope 548 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC envelope 549 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO BP oxidation reduction 604 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
Keyword Cellular component Mitochondrion 793 NDUFAF4, NDUFS6, NDUFA1, NDUFV1, NDUFAF2, NDUFS1,
NDUFS2, NDUFS4
GO CC organelle membrane 933 NDUFS6, NDUFA1, NDUFV1, NDUFS1, NDUFS2, NDUFS4
GO CC mitochondrion 989 NDUFAF4, NDUFS6, NDUFA1, NDUFV1, NDUFAF2, NDUFS1,
NDUFS2, NDUFS4
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